tsawon lokacin da waɗannan alamun suke faruwa?
kuma duk wani ciwon kirji ya kamata a bi da shi ta wannan hanyar musamman dangane da shekarunka
kuma tare da mura
Ana bukatar a gwada ƙwayar jini don a san yawan hawan jini
kuma kana da zazzabin cizon sauro a yanzu?
kuma kana jin ciwon kirji yanzu?
kuma kana da matsalar numfashi
kuma za ku iya gaya mani wasu alamun da kuke da su ban da wannan?
kuma yaya zafin jiki ya kasance
kuma ina yin kwalliya
Ina da zazzabi da tari
kuma ina jin zafi sosai a kirji a yau
kuma wannan shine lokacin da za ku sami motsi na jiki a cikin iska
kuma kuna jin ciwon kirji
kuma ina ganin ina da zazzabin cizon sauro
kuma ina so ka bayyana inda kake jin ciwon kirji
kuma suna da zazzabi
da kuma tarihinka na ciwon sukari
kuma ka san abin da sauti kamar  kirji na ke faruwa a bude
kuma ka san cewa mutane suna ta zagina a koyaushe
kuma kana jin ciwon kirji
kuma ka ce wannan shi ne wani bugun jini a kirji
wani a cikin iyali yana da ciwon zuciya cututtukan zuciya mai yawa mai yawa jini
akwai wasu alamun ko matsaloli da ke tattare da ciwon haɗin gwiwa?
akwai wasu mutane a cikin iyali da ke da irin wannan alamun cutar?
kana da wasu alamun cutar?
kana da matsalar barci?
ciwon kirji
saboda wannan lokacin sanyi ne
amma kuma bai kamata a bar mu a baya a kan tushen ciwon kirji wanda ke haifar da ciwon zuciya ba
amma babban matsalar yanzu shine ciwon kirji
amma ina da matsalar numfashi
amma na san mutane da yawa da suka yi min gunaguni
amma dole ne mu kula da duk wani ciwon kirji da karfi
amma yanzu kana da lafiya?
Na manta da shi saboda ciwon kirji
kamar wani yana ta rungumar ka
har ila ina jin na yi barci
suna gunaguni game da alamun cutar guda?
kana da wata cuta mai tsanani kamar hawan jini?
kuna da wata cuta mai tsanani ko wata matsala ta lafiya kamar ciwon sukari?
ciwon kirji da ke sa ka yi barci?
kana da hawan jini?
kana son ka yi kuka domin hakan?
kana da wasu cikin waɗannan alamun?
ka gani a wannan hoton?
sha giya da yawa yau
amma ina da ciwon sukari
amma yana da alamun da na samu
yaya yawan zafin jikinka yake?
Yaya hawan jini yake?
idan kana da zazzabin cizon sauro
idan kana da zazzabin ɗari biyu da ɗari biyu da kuma sama
idan ka ga cewa alamun cutar ko kuma wata cuta da kake da ita tana bukatar ƙarin bincike
Na kamu da zazzabin cizon sauro jiya
na kamu da zazzabin cizon sauro
na yi zazzabi jiya
Ina jin zafi sosai a cikin kirji
Ina da matsalar numfashi
zan aiko maka da hoto
Ina jin ciwon kirji a yau
ina ciwon kai da zazzabi yau
a ganina wannan ba ya da kyau
a ganina wannan ba karamin sanyi
kamar wanda aka ɗauke shi da kaya masu nauyi?
ya fara da ciwon kai da zazzabi a lokaci guda
ciwo a cikin kirji
ciwon kirji kamar na hawan jini
a cikin ƙirjina
a cikin ƙirjina a tsakiya
a tsakiyar kirji
Ina jin ciwo a kirji
wannan ciwon kirji yana damuna
Ina so ka bayyana mini wannan ciwon kirji
ciwon hawan jini ko ciwon sukari
a tsakiyar ƙirjinsa
yanzu idan kana da zazzabi zaka iya shan zaki ta tachipirina
Maryama, kwana nawa ne yanzu da kake da waɗannan alamun?
yanzu ka ce kana da ciwon kirji
ciwon kirji a cikin kirji
yanzu kana da wasu alamun ban da ciwo
ko kuma ka ji kamar an rungume ka?
kusan iri ɗaya ne da zazzabi da ciwon kai da ciwon tsoka
a tsakiyar kirji
nuna mini hoto na inda kake jin zafi
idan kana da zazzabin cizon sauro
yanzu kuna ganin wasu daga cikin alamun zasu iya danganta da ciki?
yaranku suna da waɗannan alamun?
Ina wa'azi game da ciwon kirji
zazzabi yana ƙaruwa da dare
ciwon zazzabi na kwana biyu
zazzabi ya karu a daren jiya
wannan shi ne Dr. Porter daga dakin jinya a cikin triage
yanzu za ka iya ƙara bayyana mini ciwon kirji da kake ji?
yanzu ina jin zafi a gaban jikina a cikin kirji
yanzu ina jin zafi sosai a kirji
yanzu da nake fama da ciwon kirji
wane irin ciwo ne kake ji a kirji?
yaushe ne naƙudar haihuwa ta soma?
ciwon kirji?
A ina ne kake yawan jin ciwo?
jin kamar an ɗaure maka wuyanka
ka san ina da ciwon sukari da sauransu
ka ce kana da ciwon kirji
Yawan masu kamuwa da cutar coronavirus (COVID-19) a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da Ingila, 1 ga Janairu zuwa 15 ga Agusta 2020
Adadin masu kamuwa da cutar coronavirus (COVID-19) yana nuna daidaito tsakanin ƙasashen Tarayyar Turai / EU da Kasashen Kasuwancin Kasuwanci da Burtaniya wanda ke tabbatar da cewa, duk da cewa annobar COVID-19 tana cikin matakai daban-daban a cikin ƙasashe daban-daban, tana ƙaruwa cikin sauri a duk duniya.
Bisa ga abin da ya faru a Italiya, jihohi, asibitoci da dakunan kulawa da gaggawa suna buƙatar haɓaka shirye-shiryen su don karuwar yawan marasa lafiya na COVID-19 da ke buƙatar kulawa, musamman masu kulawa mai tsanani.
A ranar 31 ga watan Disamba na 2019, an gano wasu marasa lafiya da cutar huhu a Wuhan, lardin Hubei, China.
A ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin ta ba da rahoton cewa cutar ta samo asali ne daga kwayar cutar coronavirus da ba a san asalinta ba wanda yanzu aka sani da cutar sankarar numfashi mai tsanani coronavirus 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da cutar SARS-CoV-2 ta haifar an kira ta cutar coronavirus (COVID-19).
Binciken ya nuna cewa kusan kashi 80% na mutanen da ke da cutar COVID-19 suna da ƙananan cututtuka, wato kamuwa da cutar numfashi tare da cutar nimoniya ko babu, kuma mafi yawan lokuta suna warkewa.
A cikin kusan kashi 14 cikin ɗari, COVID-19 ya zama mummunan yanayin da ke buƙatar kwantar da hankali a asibiti kuma kashi 6% na mutane suna da mummunan yanayin da ke buƙatar kulawa mai tsanani.
Yawan masu cutar COVID-19 da ke mutuwa a asibiti ya kai kusan kashi 4%.
A cikin wannan binciken, mun bincika ƙaruwar yawan masu cutar COVID-19 a kowace ƙasa a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai (EU/EEA) da Turai (UK) kuma mun kwatanta shi da lardin Hubei, China.
Mun kuma kwatanta yawan adadin masu cutar COVID-19 a cikin EU/EEA da UK da Italiya a lokacin 31 ga Janairu zuwa 15 ga Maris 2020.
Masu cutar COVID-19 a cikin EU/EEA da UK
Bayan China, COVID-19 ya bazu zuwa wasu yankuna kuma halin COVID-19 ya sake farfadowa a wasu sassan duniya bayan wannan.
A ranar 11 ga watan Maris na 2020, Babban Sakataren Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar Eurosurveillance 2020 na 5 ga Maris, Spiteri da abokan aikinsa sun ba da rahoton farkon shari'o'in COVID-19 a Turai bisa ga ma'anar WHO.
A cikin EU/EEA, an gano mutum na farko a Faransa a ranar 24 ga Janairu 2020 lokacin da aka dawo da shi daga Wuhan, Lardin Hubei, China.
A ranar 15 ga watan Agusta, 2020, an gano cutar COVID-19 a cikin dukkan ƙasashe 30 na EU/EEA da Burtaniya, wanda a tsakanin 31 ga Disamba, 2019 da ranar da aka haɗa, akwai mutane 39,768 da mutuwar 1,727, tare da 17,750 da mutuwar 1,441 daga Italiya kadai.
Samun adadin masu cutar COVID-19 da kuma yawan mutanen da ke kamuwa da COVID-19 yayin da suke ƙaruwa
A Cibiyar Kula da Cututtuka ta Turai (ECDC), ana sabunta ƙididdigar cutar COVID-19 a kowace ƙasa a duniya, daga shafukan yanar gizo na hukuma kamar Ma'aikatar Lafiya ta Duniya, cibiyoyin lafiya na WHO da wuraren tafiye-tafiye, kowace rana da karfe 2:00 na safe.
An yi amfani da wannan bayanin don nazarin yanayin COVID-19 a cikin EU/EEA da UK, tare da kwatanta shi da na Italiya.
A matsayin hanyar ƙididdige yawan masu cutar COVID-19 da ke cikin magani, mun ƙididdige yawan adadin masu cutar COVID-19 da aka rarraba cikin kwanaki 14, a kowace ƙasa ta EU / EEA da UK, a lokacin 1 ga Janairu zuwa 15 ga Maris 2020.
Mun kuma nuna adadin masu kamuwa da cutar a kowace ƙasa kamar yadda ya karu a ranar 15 ga Maris, 2020 da karfe 2:00 na safe idan aka kwatanta da Italiya a ranar 31 ga Janairu zuwa 15 ga Maris.
Halin COVID-19 a cikin EU/EEA da UK
Yawan adadin masu kamuwa da cutar COVID-19 a cikin kwanaki 14 a cikin EU/EEA da UK gabaɗaya sun yi daidai da na lardin Hubei (China) (Hoto na 1).
A cikin EU/EEA da UK gabaɗaya, adadin sabbin cututtukan COVID-19 ya fara ƙaruwa a ranar 21 ga Fabrairu kuma ya ƙaru sosai a ranar 28 ga Fabrairu 2020 (Source).
Wannan ya faru ne saboda karuwar yawan masu kamuwa da cutar daga Italiya, amma duk sauran ƙasashen EU/EEA da Burtaniya sun sami karuwar masu kamuwa da COVID-19 (Tushen).
Hoto na 2 ya nuna adadin masu kamuwa da COVID-19 a cikin EU/EEA da UK idan aka kwatanta da Italiya a lokacin 31 ga Janairu zuwa 15 ga Maris 2020.
Ya nuna cewa, a ranar 15 ga Agusta da karfe 2:00 na safe, sauran ƙasashen EU/EEA da UK 15 suna da adadin adadin masu cutar da suka yi daidai da Italiya makonni 3 da suka gabata ko ƙasa da haka.
Bincikenmu ya nuna cewa yawan masu kamuwa da COVID-19 yana ƙaruwa cikin sauri a cikin EU/EEA da UK.
Yanayin da aka samu a cikin adadin masu kamuwa da COVID-19 yana nuna cewa cutar tana ƙaruwa a cikin ƙasa ɗaya.
Wannan ya kasance haka har ma da ƙasashe da ke da matakan kiwon lafiya daban-daban, da ma'auni daban-daban don tantancewa da kuma ƙididdigar ƙididdigar mutane don gwajin COVID-19, gami da ƙara yawan gwajin.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana cewa kashi 10% na masu cutar COVID-19 suna buƙatar kulawa mai tsanani kuma rahotanni sun nuna cewa asibitoci da dakunan kulawa mai tsanani a waɗannan yankuna sun cika.
Adadin marasa lafiya na COVID-19 a asibiti da / ko dakunan kulawa na gaggawa a cikin EU / EEA ya kai kashi 6% da 1% daidai da haka, (ba a nuna waɗannan bayanan ba).
Maimakon haka, ya kamata a tattara su cikin tsari mai kyau bisa ga bayanan da aka bayar game da yawan masu cutar da kuma mutuwar.
Wani bincike da aka yi a shekara ta 2010-11 ya nuna cewa akwai bambanci sosai tsakanin wuraren kula da marasa lafiya da kuma wuraren kula da marasa lafiya a Turai, inda a Jamus akwai gadaje 29.2 da kuma Portugal akwai gadaje 4.2 ga kowane mutum 100,000.
Wannan yana nufin cewa akwai wasu ƙasashe da ke da ƙarin ko ƙasa da Italiya (gadoji 12.5 na asibiti mai tsanani da na alurar riga kafi ga kowane mutum 100,000 a 201011).
Abubuwan da ke tattare da wadatar kayan aikin kiwon lafiya, dangane da kwatancen yawan marasa lafiya na COVID-19 a kowace ƙasa ta EU / EEA da UK da kuma yiwuwar buƙatar gado mai mahimmanci ya wuce kashi 90%, an bayyana a cikin rahoton ECDC na shida na saurin haɗarin haɗari kan COVID-19.
Saboda har yanzu akwai wasu yankuna a cikin EU / EEA da UK, kuma asibitoci da dakunan jinya na gaggawa suna ba da sabis ga mutane a cikin yankuna da aka sani, za a sami bayanan marasa lafiya da gadajen jinya ta hanyar Nomenclature of territorial units for statistics 2 (NUTS-2).
Abubuwan da ke faruwa a Italiya da sauran ƙasashe sun nuna cewa cutar COVID-19 COVID-19 tana ƙaruwa cikin sauri a cikin EU/EEA da UK.
Saboda haka, asibitoci da dakunan kulawa na gaggawa suna buƙatar shirya don yanayin yaduwar SARS-CoV-2 tsakanin al'ummomin da kuma karuwar yawan masu cutar COVID-19 da ke buƙatar kulawa, musamman kulawa mai tsanani, kamar yadda yake a yankunan da ke cikin Italiya.
Kamar yadda aka nuna a cikin nazarin gaggawa na ECDC, shirye-shirye na gaggawa yana da mahimmanci don hana yaduwar SARS-COV-2, gami da sauyawa daga hana yaduwa zuwa warkarwa, saboda saurin karuwar yawan masu cutar da ake tsammani a cikin hukumomi ba zai ba hukumomi da asibitoci isasshen lokaci don ganewa, yarda da aiwatar da matakan da suka dace ba idan ba a aiwatar da su ba.
Binciken farko na cutar ya nuna hanyoyin kiwon lafiya don magance matsalar.
Akwai ɗan takaddama game da yadda ƙasashe za su iya haɓaka ƙarfin su don rage yaduwar SARS-CoV-2 da rage matsin lamba kan kiwon lafiya.
Idan hakan ya gaza, ana sa ran cewa za a matsa wa tsarin kiwon lafiya a sauran ƙasashen EU/EEA saboda yawan marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar Coronavirus ta 2019 (COVID-19), wacce ke haifar da mummunan cututtukan numfashi (SARS) coronavirus 2 (SARS-CoV-2), ta kashe mutane sama da 3,000 kuma ta sami sama da 80,000 a China da sauran ƙasashe, wanda ya haifar da bala'in jama'a.
Kamar dai yadda yake tare da SARS-CoV, wanda ya haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya zama mai saurin kamuwa da cutar kuma yana haifar da alamun bayyanar cututtuka iri ɗaya.
Koyaya, COVID-19 ba shi da ƙarfi kamar SARS kuma yana kashe mutane kaɗan amma yana da saurin yaduwa kuma yana shafar tsofaffi da maza fiye da matasa da mata.
Dangane da yawan wallafe-wallafen da aka buga game da cutar, wannan shafin yana nufin gabatar da cikakken nazarin binciken da aka yi game da cutar.
Za mu tattauna abubuwa na asali game da cututtuka, abin da ke jawo su, ƙwayoyin cuta, ganewar asali, magani, da kuma yadda za a yi tsinkaya da kuma guje wa su.
Ko da yake akwai tambayoyi da yawa da ba a amsa ba, muna da tabbacin cewa wannan binciken zai taimaka wajen fahimtar da kuma magance wannan cuta mai tsanani.
Bikin bazara na ranar 25 ga Janairun 2020 ya zama abin tunawa ga Sinawa da aka umarce su da su zauna a gidajen su a duk lokacin hutu da kuma makonni masu zuwa saboda barkewar cutar da ba a sani ba.
Kwayar cutar ta yi kama da kwayar cutar coronavirus (CoV) wacce ta haifar da mummunan ciwon numfashi (SARS) a cikin 2003; don haka Hukumar Lafiya ta Duniya (WHO) ta ba da sunan SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma cutar da ke haifar da ita ana kiranta CoV Disease-19 (COVID-19).
Cutar ta fara ne a Wuhan, China, kuma nan da nan ta bazu zuwa duk ƙasar da kuma wasu ƙasashe kusan 50 a duniya.
A ranar 2 ga Maris, 2020, cutar ta haifar da sabbin mutane sama da 80,000 da aka tabbatar da cutar COVID-19, tare da warkewar sama da 40,000 da mutuwar sama da 3,000.
WHO ta yi gargadin cewa COVID-19 shine "Maƙiyi na 1" kuma yana iya zama mafi haɗari fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga takardu sama da 200 game da COVID-19 wanda ya haɗa da bayanai game da kwayar cutar, cututtuka, abubuwan da ke haifar da su, bincike da magani tun daga rahoton farko a ranar 7 ga Janairu, 2020 wanda ya gano tsarin kwayar cutar da aka ware daga marasa lafiya daban-daban.
Wannan binciken yana da nufin gabatar da binciken da aka yi a wannan sabon filin wasa wanda ke ci gaba da sauri.
Da farko, za mu gwada COVID-19 da SARS da wata cuta da ke haifar da CoV, ciwon numfashi na Gabas ta Tsakiya (MERS, wanda ya ɓarke a cikin 2012).
Za mu kuma tattauna abin da muka koya game da yadda za mu guji kamuwa da cutar da kuma wasu tambayoyi masu muhimmanci da ba a amsa ba.
CoVs an ɗauka cewa ƙwayoyin cuta ne masu ƙarancin haɗari ga mutane, suna haifar da kusan kashi 15% na kamuwa da cutar mura 4.
A wannan karni, mun sami CoVs guda biyu masu haɗari ga ɗan adam, wato SARS-CoV da MERS-CoV, waɗanda suka haifar da kamuwa da cutar a China a 2003 da Saudi Arabia a 2012, kuma nan da nan suka bazu zuwa wasu ƙasashe tare da cutar da kashe mutane da yawa.
Saboda haka, COVID-19 na yanzu shine CoV na uku da aka sani a tarihin ɗan adam.
Kamar yadda aka nuna a hoto.Hoto.1,1, an fara bayar da rahoton cutar tarin fuka a Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta Kasa ta kasar Sin.
Bayan kwana bakwai, an fitar da tsarin CoV.
A ranar 15 ga Janairun 2020, an samu rahoton mutum na farko da ya kamu da cutar daga Wuhan.
A wannan lokacin, cutar ta yadu cikin sauri zuwa garuruwan da ke kewaye, da ƙasashe.
A ranar 20 ga Janairu, an sanar da likitocin cutar, wanda ke nufin cewa mutane na iya kamuwa da cutar ta hanyar watsawa daga mutane.
A ranar 23 ga watan Janairu, an rufe birnin Wuhan kuma an dakatar da duk zirga-zirgar jama'a.
A ranar 24 ga Janairu, binciken farko na asibiti game da cutar ya nuna cewa, daga cikin mutane 41 da aka tabbatar da cutar, 21 ne kawai suka isa kasuwar kifin Wuhan kai tsaye inda ake tsammanin cutar ta samo asali ne daga wata dabba da ba a sani ba.
A ranar 30 ga Janairu, WHO ta ayyana cutar a matsayin gaggawa ta kiwon lafiya a duniya.
A lokacin da aka wallafa wannan rahoton, cutar ta yadu zuwa China da ƙasashe kusan 50 a duniya (Hotuna (Hotuna.2).2).
Yayin da yanayi ya canja, ba a san yadda matsalar za ta kasance ba.
A ranar 11 ga Fabrairu, 2020, binciken da aka yi a wurare daban-daban na mutane 8,866 da aka tabbatar da cutar COVID-19 4,021 ya ba da sabon ma'anar cutar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 yana kamuwa da mutane a kowane zamani, amma sama da shekaru 30-65.
Kusan rabin (47.7%) na masu cutar sun haura shekaru 50, kaɗan sun kasance ƙasa da 20, kuma kawai 14 daga cikin masu cutar sun kasance ƙasa da shekaru 10.
SARS-CoV-2 ya kasance a cikin maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya fi yawaita a cikin mutane fiye da Hubei da kewayenta.
COVID-19 ya ɗauki kwanaki 5 (2-9) daga lokacin da ya fara zuwa lokacin da aka gano shi.
Aƙalla kwanaki 4.8 ne alamun cutar suka soma bayyana.
Lokaci daga lokacin da aka gano shi zuwa lokacin da ya mutu ya kai kwanaki 9.5 (4.8-13).
Yawan masu haihuwa, R0 ya kasance 3.77 (95% CI: 3.51-4.05), yayin da ƙimar R0 da aka gyara ta kasance 2.23-4.82.
Yawan masu kamuwa da cutar ya karu kafin ranar 23 ga Janairu, 2020, saboda yawan mutanen da suka yi tafiya kafin bikin bazara na kasar Sin.
Yawan mutuwar marasa lafiya ya kasance 1.44% (95% CI: 1.10-1.86%), yayin da yawan mutuwar marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Abubuwa uku masu mahimmanci na COVID-19 sune jima'i (maza), shekaru (≥60), da cutar nimoniya mai tsanani.
Kwayoyin cutar CoVs sun kasance manyan ƙwayoyin cuta da ke kewaye da wani abu mai laushi tare da RNA guda ɗaya.
Ana iya raba shi zuwa nau'ikan jinsi huɗu, wato alpha, beta, gamma, da delta, daga cikin waɗannan alpha- da beta-CoVs an san su da cutarwa ga mutane.
Kwayar glycoprotein (S) tana da alaƙa da haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar
Ana aika da kwayar RNA ta kwayar cutar zuwa cikin kwayar halitta; bayan kwayar cutar ta kwayar halitta, kwayar RNA ta kwayar halitta ta glycoproteins da nucleocapsid sun hada da kwayar cutar, wanda ke haɗuwa da kwayar cutar don samar da kwayar cutar.
An bayyana asalin SARS-CoV-2 na farko a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV tare da kamanceceniya ta kwayoyin halitta na 99.98% a cikin samfuran 10 da aka gano a cikin asalin cutar, Kasuwar Abinci ta Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ru
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar amfani da na'urorin bincike, an gano ƙwayoyin SARS-CoV-2 a cikin hanyoyin numfashi.
An gano enzymes ACE2 a cikin SARS-CoV-2 da kuma SARS-CoV.
A gefe guda, furotin S na SARS-CoV-2 yana ɗaure da enzymes na ACE2 amma ba shi da ƙarfi kamar SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana da ƙananan haɗari ga mutane idan aka kwatanta da SARS-CoV.
SARS-CoV-2 kuma yana iya samar da wani ɗan gajeren furotin da ba a taɓa gani ba wanda ake kira orf3b da furotin mai ɓoyewa wanda ake kira orf8.
SARS-CoV-2 orf3b na iya zama mai cutarwa ga mutane kuma yana hana IFNβ bayyana; duk da haka, orf8 ba shi da wani abu mai aiki.
A ranar 18 ga Fabrairu, 2020, Zhou, da abokan aiki, sun nuna cikakken tsarin cryo-EM na enzyme ACE2 a ƙuduri na 2.9 Å a cikin amino acid B0AT1.
Sun gano cewa wannan mahaɗin, wanda ya ƙunshi atom guda biyu, an tsara shi a matsayin kwayar halitta ta atom kuma cewa mahaɗin ACE2-B0AT1 na iya haɗa sunadarai na S, yana ba da tabbacin gano CoV da mai kamuwa da cutar.
B0AT1 na iya zama maƙasudin magani don gwajin maganin rigakafin SARS-CoV-2.
Tushen da ya sa aka yi wannan
An san cewa SARS-CoV da MERS-CoV duka sun samo asali ne daga bera kuma sun bazu zuwa mutane ta hanyar ƙuda da raƙumi, a cikin wannan kwayar.
Idan aka kwatanta SARS-CoV-2 da sauran CoVs, ana ɗaukar kwari a matsayin mafi kyawun hanyar watsa SARS-CoV-2 saboda yana da kusan 96% kama da wasu CoVs masu kama da SARS guda biyu waɗanda aka gano a cikin kwari, bat-SL-CoVZX45 da bat-SL-CoVZX21.
Amma, ba a san ainihin dabbar da ta sa ta tsallake wannan shingen zuwa wurin mutane ba, kuma ba a san hanyar da ta bi ba.
Ji, da abokan aikinsa sun yi tunanin cewa macizai sun canja kwayar cutar daga kura zuwa mutane ta hanyar musayar kwayoyin S protein.
A cewar wani bincike, masu bincike a Guangzhou, China, sun nuna cewa pangolin - dabba mai cin kwari da ake amfani da ita a cikin maganin gargajiya na kasar Sin - na iya zama mai ɗaukar SARS-CoV-2 zuwa mutane bisa ga kamanceceniya ta kwayoyin halitta 99% na CoV da aka gano a cikin harshe da SARS-CoV-2.
Amma, bambancin kashi 1 cikin 100 tsakanin kwayoyin halitta biyu yana da girma sosai; saboda haka, ba a sami cikakkiyar shaida ba tukuna (Fig. 33).
Ba a san yawancin kwayoyin SARS-CoV-2 ba tukuna.
Kwayoyin SARS-CoV da MERS-CoV na iya rayuwa a cikin gilashi har tsawon awanni 48 a cikin yanayin bushewa da kwanaki 5 a cikin zafin jiki 20 °C da 40%-50%.
SARS-CoV-2 na iya samun wasu halaye.
An nuna cewa SARS-CoV-2 ba ya kamuwa da hasken rana (ultraviolet rays) da zafin jiki na 56 °C na tsawon minti 30; a cikin kashi 75%, chlorine, peracetic acid, calcium, da sauran magungunan ƙwayoyin cuta, amma ba chlorhexidine ba, suna kashe kwayar cutar sosai.
Yawancin mutane ba su da rigakafi ga SARS-CoV-2 kuma saboda haka suna iya kamuwa da cutar.
A halin yanzu, babu wani bincike da aka yi game da cutar SARS-CoV-2.
Don haka, zamu iya dogaro da binciken da aka yi a baya game da CoVs, musamman SARS-CoV da MERS-CoV (Hoto (Hoto 4).4).
Yawancin lokaci, lokacin da kwayar cuta ta kai hari kan dabba mai motsi, ana gano tsarin ƙwayar cuta ta hanyar masu karɓar ƙwayoyin cuta (PRRs) waɗanda suka haɗa da masu karɓar nau'in C-type lectin-like receptors (TLR), mai karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar
Ta hanyar hanyoyi daban-daban, kwayar cutar tana haifar da haɓakawa, haɓakar ƙwayoyin dendritic, da samar da interferons na I (IFNs) waɗanda ke hana yaduwar kwayar cutar da haɓaka ƙarfin macrophage don yaƙar kwayar cutar.
A gefe guda, furotin N na SARS-CoV na iya taimakawa wajen tserewa daga cikin ƙwayoyin cuta.
Nan da nan, tsarin rigakafi na jiki ya shiga cikin yaƙi da ƙwayoyin cuta.
Kwayoyin T lymphocytes ciki har da CD4+ da CD8+ T cells suna taka muhimmiyar rawa wajen kare kwayoyin cutar.
Kwayoyin CD4+ T suna motsa kwayoyin B don samar da ƙwayoyin cuta, kuma CD8+ T suna kashe ƙwayoyin cuta kai tsaye.
Kwayoyin T masu taimakawa suna samar da cytokines masu taimakawa wajen taimakawa wajen hana kumburi.
A maimakon haka, CoV yana iya hana ayyukan T cell ta hanyar haifar da mutuwar T cell.
Tsarin rigakafin humoral da ya hada da sunadarai kamar C3a da C5a da kuma kwayoyin rigakafi suna da matukar muhimmanci wajen yaki da cutar.
Misali, ƙwayoyin cuta da aka samo daga mai haƙuri da aka warkar sun gurgunta MERS-CoV.
A wani ɓangare kuma, ƙwayar cuta tana sa a samu ƙwayoyin cuta da yawa da ke sa huhu da sauran gabobin jiki su lalace, wasu kuma suna sa gabobin jiki su kasa aiki kuma wasu kuma su mutu.
Kwayar SARS-CoV-2, wanda aka gano a cikin mutane na farko, tana da alama tana shafar tsofaffi da ke da wasu cututtuka da mata masu ciki.
A yawancin lokaci, mutanen da ke da ƙwayoyin cuta ko kuma waɗanda ba su da ƙwayoyin cuta suna da saurin kamuwa da cuta fiye da wasu.
Lokacin bayyanar cututtuka na SARS-CoV-2 ya kasance daga kwanaki 1-14, yawanci kwanaki 3-7 bisa ga binciken da aka yi akan marasa lafiya 425 na farko a Wuhan.
Amma, binciken da aka yi kan marasa lafiya 1,099 ya nuna cewa a matsakaita, alamun cutar suna faruwa ne bayan kwana 3 kuma daga 0 zuwa 24.
Wani bincike da aka yi kwanan nan, wanda aka ambata ɗazu, ya nuna cewa yawan ciwon yana da kwanaki 4.8 (3.0-7.2) bisa ga mutane 8,866.
Yana da mahimmanci ga ma'aikatan kiwon lafiya su sanya ranakun keɓewa dangane da lokacin da cutar ke nuna alamun cutar, don hana mutane masu cutar amma ba su da alamun cutar cutar.
A al'adance, mutanen da ke cikin yanayin cutar ko kuma waɗanda ke da cutar suna bukatar su keɓe kansu na kwanaki 14.
Shin ya kamata a kara wa mutane kwanaki 24 a keɓe su?
Zazzabin zazzabi shine mafi yawan alamun farko na COVID-19, wanda zai iya kasancewa ba tare da alamun bayyanar cututtuka ba kamar bushewar hanci, wahalar numfashi, ciwon tsoka, zazzabi, ciwon kai, ciwon makogwaro, hanci, ciwon kirji, gudu, numfashi mai sauƙi, da hanci.
Wasu marasa lafiya sun sami wahalar numfashi da / ko rashin iskar oxygen a cikin mako guda bayan kamuwa da cutar.
A cikin yanayi mafi tsanani, marasa lafiya suna da saurin kamuwa da rashin ruwa a cikin huhu, rashin jini (septic shock), acidosis na metabolism, da coagulopathy.
Marasa lafiya da ke da zazzabin cizon sauro da/ko alamun da ke tattare da zazzabin zazzabin zazzabin sauro, koda kuwa ba su da wata cuta a cikin huhu, ya kamata a fara bincikar su don gano ko suna da cutar.
Binciken marasa lafiya na Disamba 2019 ya nuna cewa kashi 98% na alamun cutar sun kasance a kan kumburi, kashi 76% a kan tari mai bushe, kashi 55% a kan wahalar numfashi, da kashi 3% a kan gudu; kashi 8% na marasa lafiya suna buƙatar kayan aikin numfashi.
An gano irin wannan binciken a cikin bincike biyu da aka yi a kan marasa lafiya na iyali ɗaya da marasa lafiya da ba su da alamun cutar.
A kwatankwacin haka, binciken ɗan adam na 2012 ya nuna cewa masu cutar MERS-CoV suna da zazzabin cizon sauro (98%), tari mai zafi (47%), da wahalar numfashi (55%) a matsayin manyan alamun su.
Amma, kashi 80% na su sun buƙaci taimakon numfashi, musamman marasa lafiya na COVID-19 kuma wannan ya zo ne saboda gaskiyar cewa MERS ya fi COVID-19 haɗari.
An kuma lura da zubar da jini (26%) da kuma ciwon makogwaro (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiyar SARS, an nuna zazzabin cizon sauro (99%-100%), bushewar hanci (29%-75%), wahalar numfashi (40%-42%), gudu (20-25%), ciwon makogwaro (13-25%) sune manyan alamun bayyanar cututtuka kuma ana buƙatar kayan aikin numfashi a cikin 14%-20% na marasa lafiya.
A ranar 14 ga Fabrairu, yawan mutuwar COVID-19 ya kai kashi 2% yayin da aka tabbatar da cutar a duniya a cikin mutane 66,576.
A wani ɓangare kuma, mutuwar SARS a watan Nuwamba 2002 ya kai kashi 10 cikin ɗari na mutane 8,096 da aka yi wa gwaji.
A cikin MERS, yawan mutanen da suka mutu a watan Yuni na shekara ta 2012 ya kai kashi 37 cikin ɗari na mutane 2,494 da aka gano.
Binciken da aka yi a baya ya nuna cewa R0 na SARS-CoV-2 ya kasance mafi girma a 6.47 yayin da CI ya kasance kashi 95% a cikin 5.71-7.23, yayin da R0 na SARS-CoV ya kasance tsakanin 2 zuwa 4.
Kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamun cututtuka, yanayin cutar, da R0 an nuna su a cikin Tebur na 1.1.
Waɗannan ƙididdigar sun nuna cewa SARS-CoV-2 yana da ƙwarewar watsawa fiye da MERS-CoV da SARS-CoV, amma ba kamar sauran biyun ba.
Saboda haka, yana da wuya a rage cutar SARS-CoV-2 fiye da MERS-CoV da SARS-CoV.
Mutane da yawa da ke da cutar za su zauna a gida ɗaya ko kuma a cikin mota ɗaya.
Masu cutar sun yi tafiya daga ko sun zauna a Wuhan ko wasu wuraren da cutar ta bulla ko kuma sun kasance tare da mutanen da ke da cutar ko kuma waɗanda ke da cutar a cikin makonni biyu kafin cutar.
Koyaya, an ba da rahoton cewa mutane na iya kamuwa da cutar ba tare da nuna alamun cutar ba sama da makonni biyu kuma marasa lafiya da suka warke kuma aka sallame su daga asibiti na iya sake kamuwa da cutar, wanda ke nuna buƙatar ƙara lokacin keɓewa.
Marasa lafiya suna da ƙarancin ƙwayoyin farin jini (musamman ƙwayoyin lymphocytes) a farkon lokacin.
Misali, an gano cutar lymphopenia da ƙididdigar farin jini &lt; 4×109/L gami da ƙididdigar lymphocyte &lt; 1×109/L, tare da haɓaka aspartate aminotransferase da viremia a cikin marasa lafiya 1,099 na COVID-19.
An ƙara yawan enzymes na hanta da myoglobin a cikin jinin wasu marasa lafiya, kuma sun sami haɓakar furotin mai aiki da C da kuma erythrocyte a cikin mafi yawan marasa lafiya.
A cikin marasa lafiya masu tsanani, yawan D-dimer, wanda shine samfurin lalacewar fibrin a cikin jini, ya karu, kuma yawan lymphocytes ya ragu.
Yawancin marasa lafiya na COVID-19 suna da ciwon kirji wanda ke tattare da ciwon huhu (duhu mai launi biyu ko rashin haske na gilashin ƙasa).
Marasa lafiya suna fama da ciwon huhu, cutar huhu, da kuma ciwon numfashi mai tsanani (acute respiratory distress syndrome, ARDS).
A lokacin ARDS, akwai ciwon jini da kuma ruwa mai yawa, kuma nama yana rufe raunuka wanda ke haifar da matsalolin samun iska.
Pneumocytes na nau'in I da na II (nau'in-I da nau'in-II pneumocytes) suna rage yawan abubuwan da ke cikin farfajiya kuma suna ƙara matsa lamba a cikin iska, wanda ke rage ƙarfin numfashi don faɗaɗa kuma yana ƙara damar numfashi don kasawa.
Saboda haka, sakamakon gwajin nono mafi muni sau da yawa yana nuna yanayin cutar mafi muni.
A ranar 18 ga Fabrairu, 2020, gwajin farko na COVID-19 ya nuna haɓakar ƙwayoyin cuta, samar da ƙwayar hyaline, ƙwayoyin cuta, da ƙwayoyin cuta masu yawa a cikin huhu na mai cutar da ta mutu, wanda yayi kama da gwajin marasa lafiya da ke fama da ARDS kuma yayi kama da na SARS da MERS.
Gano RNA na SARS-CoV-2 ta hanyar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju
Amma, saboda yawan marasa lafiya da ke dauke da cutar, wanda zai iya kara yawan kamuwa da cutar, an fara amfani da alamun lafiya don gwaji (ba kawai RT-PCR ba) a China a ranar 13 ga Fabrairu, 2020.
Haka kuma an samu a gwajin SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwajin gwaji, da daukar hoto yana da mahimmanci kuma ya kamata a yi don gano cutar da kyau.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana yadda ake amfani da fasahar CRISPR-based SHERLOCK don gano SARS-CoV-2, wanda ke gano kwayoyin SARS-CoV-2 RNA a cikin 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (kwafin 10-100 a kowane microliter da aka gwada) ta amfani da dipstick a cikin ƙasa da minti 30 ba tare da buƙatar gwaji mai yawa ba.
Ana sa ran cewa wannan sabon tsarin zai taimaka wajen gano idan an cire shi daga samfuran gwaji.
Saboda rashin ilimin da aka samu game da sabon kwayar cutar CoV, likitoci sun fi dacewa da kula da marasa lafiya na COVID-19, kamar yadda suke gwada magungunan da aka riga aka yi amfani da su ko kuma waɗanda aka ba da shawarar a baya don magance wasu cututtukan CoV kamar SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Covid-2).
Wannan magani ne na zamani wanda zai iya magance ƙwayoyin cuta, rage ƙwayoyin cuta, steroids, jini (plasma) daga waɗanda aka warkar, maganin gargajiya na kasar Sin, da kuma maganin ta'aziyya.
Har plasma daga mutanen da suka warke ma an amince da shi don amfani da magani.
Kamfanonin harhada magunguna suna aiki tuƙuru don samar da ƙwayoyin cuta da alluran rigakafi.
SARS-CoV-2 yana fara kai hari ga huhu kuma yana iya kai hari ga sauran sassan jikin da ke da ACE2, gami da tsarin hanji da kodan.
Duk da haka, ciwon numfashi yana daɗa zama sanadin mutuwa.
Don haka, kayan aikin numfashi suna da mahimmanci don magance matsalolin numfashi da ceton rai kuma wannan ya haɗa da maganin oxygen gaba ɗaya, oxygen mai gudana, numfashi mara ƙarfi, da numfashi na inji mai ƙarfi dangane da yawan cutar.
Marasa lafiya da ke fama da matsalar numfashi mai tsanani suna buƙatar taimakon oxygenation na membrane na waje (ECMO), wanda shine hanyar da ake amfani da ita don magance matsalar numfashi mai tsanani wanda zai iya haifar da mutuwa.
Bugu da ƙari, kiyaye matakan lantarki, hanawa da kula da wasu ƙwayoyin cuta masu saurin yaduwa, da kiyaye manyan gabobin jiki suna aiki suna da mahimmanci a cikin marasa lafiya na SARS-CoV-2.
An san cewa hadarin cytokine yana haifar da halayen tsarin garkuwar jiki a cikin marasa lafiya na SARS da MERS.
Cytokine hadari shine amsawar jiki mai kyau ta hanyar sakin cytokines da yawa ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan kwayoyin sun sa tsarin garkuwar jiki ya samar da kwayoyin da ke da alhakin ARDS da kuma rashin aiki.
Rage ƙwayoyin cuta yana da mahimmanci wajen magance guguwar cytokine, musamman a cikin marasa lafiya masu tsanani.
An yi amfani da kwayoyin cuta da tocilizumab, wanda shine kwayar cutar IL6 monoclonal, don magance hadarin cytokine.
Sauran maganin cytokine storm don rage yawan cutar sun hada da daidaita tsarin rigakafin T-cell; hana IFN-γ, IL-1, da TNF; hana JAK; blinatumomab; mai hana siginar cytokine 4; da masu hana HDAC.
Ana amfani da steroids, wanda ake amfani da shi don rage yawan ƙwayoyin cuta, a cikin maganin SARS don rage tasirin kumburi.
Koyaya, amfani da steroids a cikin adadi mai yawa bai taimaka ba game da haɗarin cutar huhu a cikin marasa lafiya na SARS da COVID-19.
Ƙari ga haka, suna iya jawo sakamako mai tsanani, musamman cutar ƙashi, wanda hakan zai iya shafan sakamakon da ake tsammani.
Duk da haka, an ba da shawarar amfani da corticosteroids a cikin marasa lafiya masu cutar COVID-19 a cikin ƙananan allurai.
A lokacin da ake rubuta wannan labarin, babu wani magani da aka tabbatar don warkar da cutar.
Amma, an gano cewa karɓar remdesivir ta hanyar allurar, wanda shine analog na nucleotide, ya yi tasiri a cikin wani mai cutar COVID-19 na Amurka.
Remdesivir wani sabon magani ne na Gilead wanda aka fara amfani da shi don magance cutar Ebola da Marlburg.
Daga baya, an gano remdesivir a matsayin magani mai amfani ga wasu ƙwayoyin cuta na RNA guda ɗaya kamar MERS da SARS.
Bisa ga wannan, Gilead ta ba da maganin ga China don gwaji a kan mutane da ke da cutar SARS-CoV-2, kuma ana jiran sakamakon da ake tsammani.
An kuma ba da shawarar baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin a matsayin magunguna masu amfani don magance marasa lafiya da ke fama da matsalar numfashi.
Rashin nutsuwa, tashin zuciya, amai, cutar hanta, da sauran matsaloli masu tsanani na iya faruwa yayin da aka haɗa lopinavir/ritonavir da wasu magunguna.
Hadin gwiwar wannan magani da sauran magunguna a cikin marasa lafiya ya kamata a kula da su sosai.
Plasma daga marasa lafiya da suka warke da kuma aiki ne antibody
An daɗe ana amfani da ƙarin jini daga waɗanda aka warkar da su daga cutar da ake yi wa jinin domin a kula da wasu marasa lafiya da suke da irin wannan cutar ko kuma don a ceci rayayyu daga kamuwa da cutar.
Hakika, mutane da suka warke daga wata cuta suna da ƙwayar ƙwayoyin cuta da yawa a cikin jinin su.
Kwayoyin rigakafi sune kwayoyin halitta da kwayoyin B ke samarwa don magance ƙwayoyin cuta da sauran ƙwayoyin cuta da ke cikin jiki kuma suna ƙuntata kwayoyin halitta da ke cikin kwayoyin cuta.
Bisa ga wannan, an cire jini daga jinin marasa lafiya da suka warke daga COVID-19 kuma an ba da su ga marasa lafiya 10 da ke da mummunan rauni.
Yanayin su ya inganta cikin sa'o'i 24, kuma ƙwayoyin cuta sun ragu kuma yawan cutar ya ragu kuma yawan iska a cikin jini ya ragu.
Maimakon haka, dole ne a sami tabbaci da kuma fahimta don yin amfani da kowane irin tsari don amfani da mutane da yawa kafin a samar da wannan tsari.
Bugu da ƙari, domin sakamakon amfani da magani, ya kamata a yi la'akari da haɗarin da ke tattare da jini.
Alal misali, ƙwayoyin rigakafi suna iya sa ƙwayoyin cuta su ƙaru sosai kuma su sa a samu ƙwayar cuta mai haɗari.
Sau da yawa ƙwayoyin rigakafi a cikin jini ba su da yawa, kuma ana bukatar jini mai yawa don a kula da marasa lafiya.
Yana da wahala a samar da rigakafi da sauri don magance cutar ta duniya.
Saboda haka, za a iya rarrabe ƙwayoyin B daga mutanen da suka warke don gano lambobin kwayoyin cutar ko kuma don gano ƙwayoyin cuta don ƙwayoyin cuta.
Ta wannan hanyar, za mu iya ƙara yawan ƙwayoyin cuta.
An yi amfani da TCM don magance cututtuka da yawa a China tsawon dubban shekaru.
Maimakon haka, aikinsa ya dogara ne akan haɗuwa da abubuwa daban-daban a cikin magani wanda ke canzawa dangane da yanayin cutar bisa ga ka'idar TCM.
Ba a san yawancin sinadaran da ke aiki ba ko kuma ba a san su sosai ba domin yana da wuya a gano su.
A halin yanzu, saboda babu wani magani da aka sani don COVID-19, TCM shine mafi yawan magungunan da ake amfani da su don kula da marasa lafiya masu saurin bayyanar cututtuka ko waɗanda suka warke daga cutar.
Misali, an gano cewa maganin Shu Feng Jie Du da Lian Hua Qing Wen sun yi tasiri sosai wajen magance COVID-19.
Yawancin marasa lafiya sun warke daga COVID-19 a larduna da yawa a China tare da maganin TCM a kashi 87% na wuraren cutar, gami da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da a lardin Hubei, wanda ya yi amfani da TCM a kusan kashi 30% na wuraren cutar COVID-19, yawan warkewar ya kasance mafi ƙanƙanta (13%).
Amma, wannan kwatancen ba daidai bane saboda akwai wasu dalilai da yawa kamar ƙimar da yanayin marasa lafiya da za a yi la'akari da su.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga sakamakon binciken da ya kwatanta maganin gargajiya na yamma da maganin da ya haɗa da maganin gargajiya da TCM.
Sun gano cewa lokacin da ake buƙata don dawo da zafin jiki, bayyanar cututtuka, da kwanciya a gado sun fi guntu a cikin ƙungiyar maganin TCM + na baki fiye da ƙungiyar maganin baki kawai.
Abin sha'awa, rashin lafiyar (daga rashin ƙarfi zuwa tsanani) ya kasance ƙasa da ƙananan a cikin ƙungiyar maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin
Ko da yake, inganci da ingancin TCM har yanzu suna buƙatar ƙarin gwaji tare da ƙarin marasa lafiya da kuma wurare.
Zai kuma zama da ban sha'awa don bayyana ayyukan da kuma fadakarwa game da hanyoyin TCM na magani ko kuma yadda ake yin su idan ya yiwu.
Masu fama da cutar COVID-19 ko waɗanda ake zargi da cutar sau da yawa suna jin tsoron wannan cuta mai saurin yaduwa da haɗari, kuma mutanen da aka keɓe suna jin kaɗaici, rashin kwanciyar hankali, da fushi.
Ƙari ga haka, alamun rashin lafiya kamar zazzabi, rashin numfashi, tari da kuma rashin barci mai tsanani da magunguna suke jawowa suna iya sa mutum ya ƙara damuwa da kuma ciwon kai.
A farkon lokacin barkewar cutar SARS, akwai cututtukan da ke tattare da ciwon kai da yawa da suka haɗa da damuwa, damuwa, tsoro, damuwa, rashin tunani, rashin kulawa, da kashe kansa.
Binciken da ake buƙata na masu cutar da ke cikin keɓewa, a matsayin ɓangare na aikin COVID-19, na iya haifar da ƙarin damuwa da laifi game da tasirin cutar, keɓewa, da nuna bambanci daga dangi da abokai.
Saboda haka, ya kamata a ba da kulawa ta hankali ga marasa lafiya na COVID-19, waɗanda ake zargi da cutar, da waɗanda ke zaune kusa da su da duk waɗanda ke buƙatar ta.
Kula da lafiyar kwakwalwa ya kamata ya haɗa da samar da ƙungiyoyin likita don abubuwan da suka shafi ƙwaƙwalwa, sanarwar SARS-CoV-2 a kan lokaci da kuma yadda ya kamata da kuma tsarin kulawa da amfani da na'urorin ƙarancin kusanci.
Magungunan rigakafi suna da amfani wajen hana kwayar cutar daga dabbobi da ke cikin su zuwa mutane masu cutarwa zuwa abubuwa masu motsi kuma galibi suna aiki tare da maganin rigakafi don magance cututtukan da ƙwayoyin cuta ke haifarwa.
An yi ƙoƙari don haɓaka allurar rigakafi ta S-protein don samar da ƙwararrun ƙwayoyin cuta masu ƙarfi da ƙarfi da kuma / ko ƙwayoyin cuta masu ƙarfi da ke hana SARS-CoV.
An yi amfani da maganin rigakafi na SARS a cikin dabbobi.
Koyaya, aikin rigakafin a cikin manya da samfuran ƙalubalen kisa da kuma tsarin rigakafin cutar a cikin dabbobi har yanzu ba a tabbatar da su ba kafin a gudanar da binciken asibiti.
Wannan yana iya kasancewa domin SARS ya mutu shekaru 17 da suka shige kuma ba a sake gano shi ba tun daga lokacin.
Akasin haka, akwai wasu mutane da ke fama da cutar MERS a Gabas ta Tsakiya kuma ta yadu zuwa wasu yankuna ta hanyar dabbobi da ke zaune a waɗannan yankuna.
An samar da allurar rigakafin MERS ta amfani da kwayar cutar da aka lalata, DNA plasmids, masu ɗaukar hoto, nanoparticles, ƙwayoyin cuta masu kama da kwayar cuta da ƙwayoyin cuta masu haɗuwa kuma an gwada su akan dabbobi.
Ana buƙatar ci gaban maganin rigakafin SARS-CoV-2 a cikin ƙananan ƙwayoyin cuta don magance cutar.
Koyaya, yana da ƙalubale don shawo kan wannan matsalar saboda tsayin lokaci mai tsawo (kimanin watanni 18) da ake buƙata don haɓakawa da juyin halitta na CoVs.
A matsayin sabon kamuwa da cuta, halin COVID-19 ya fara bayyana a cikin dubban marasa lafiya.
A yawancin lokaci, marasa lafiya suna warkewa a hankali ba tare da alamun cutar ba.
Amma, kamar yadda yake a cikin SARS da MERS, marasa lafiya na COVID-19 suna da rashin lafiya da mutuwa.
Saboda haka, sanin haɗarin da zai iya tasowa yana da muhimmanci ga ma'aikatan kiwon lafiya su shirya hidimarsu, musamman a wuraren da ba a yawan yin hidima.
Dangane da binciken asibiti, waɗannan batutuwan na iya zama masu alaƙa da haɗarin haɗari ga marasa lafiya na COVID-19 (Matsayi (33)):
Muhimmanci: Muhimmanci shine mafi mahimmancin ma'auni don kimanta haɗarin cutar SARS, kuma wannan gaskiya ne ga COVID-19.
COVID-19 ya fi shafar mutanen da ke tsakanin shekaru 30-65 tare da kashi 47.7% na masu cutar sama da shekaru 50 a cikin binciken mutane 8,866 kamar yadda aka nuna a sama.
Marasa lafiya da ke buƙatar kulawa mai tsanani sun kasance da wasu cututtuka kuma sun fi tsofaffi fiye da waɗanda ba su da (a matsakaita na shekaru 66 da 51), wanda ke nufin cewa shekaru yana da mahimmanci wajen tantance haɗarin COVID-19.
Jima'i: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 da 0.27/100,000), kamar yadda aka nuna a sama.
Cutar cututtuka da cututtuka: Marasa lafiya na COVID-19 waɗanda ke buƙatar kulawa mai tsanani suna da haɗarin kamuwa da rauni na zuciya da arrhythmia.
Cutar zuciya ita ce kuma babbar hanyar mutuwa a cikin marasa lafiyar SARS.
An gano cewa SARS-CoV-2 na iya haɗuwa da kwayoyin cutar ACE2-positive, wanda zai iya haifar da cutar hanta a cikin marasa lafiya na COVID-19.
Yana da kyau mu tuna cewa tsufa da kuma wasu cututtuka suna da nasaba sosai kuma kowannensu yana shafan ɗayan.
Sakamakon gwaje-gwaje na yau da kullun: Matsayin C-reactive protein (CRP) a cikin jini yana nuna tsananin ciwon tsoka ko lalacewar nama kuma an bayyana shi azaman haɗarin haɗari, sakamakon magani, da kuma warkewa.
An kuma tattauna alaƙar da ke tsakanin ƙimar CRP da hawan jini da haɗarin kamuwa da cutar COVID-19.
Bugu da ƙari, ƙaruwa na lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Ana samun waɗannan enzymes a wurare dabam dabam, musamman a zuciya da hanta, kuma ana fitar da su idan aka ji rauni.
Saboda haka, yawanci suna nuna ciwon zuciya ko kuma hanta.
Alamun asibiti masu mahimmanci: Ana buƙatar ɗaukar hoto na kirji da lura da alamun lokaci tare da wasu dalilai don hango haɗarin COVID-19.
Yin amfani da steroids: Kamar yadda aka ambata a sama, steroids suna da tasiri a kan ƙwayar cuta kuma ana amfani da su sosai don taimakawa wajen magance cututtukan da ke haifar da ciwon ƙwayar cuta.
Saboda yawan amfani da maganin corticosteroids a cikin marasa lafiya na SARS, yawancin marasa lafiya da suka warke sun kamu da cutar osteonecrosis na jijiyoyin jiki wanda ya haifar da nakasa na dogon lokaci da rashin ingancin rayuwa.
Don haka, idan ya cancanta, ya kamata a yi amfani da steroids a ƙananan allurai kuma na ɗan gajeren lokaci a cikin marasa lafiya na COVID-19.
Rashin hankali: Kamar yadda aka ambata a sama, a lokacin barkewar COVID-19, yawancin marasa lafiya suna fama da matsanancin damuwa saboda yawan lokacin da suke keɓewa da rashin sanin abin da zai faru kuma sun ga danginsu da abokan aikin su sun mutu.
Irin waɗannan marasa lafiya suna bukatar ta'aziyya da taimako na ɗan lokaci don su iya jimre wa wannan matsi kuma su koma rayuwa ta yau da kullum.
Dangane da binciken alƙaluma, COVID-19 yana da alamun bayyanar cututtuka daban da SARS.
Baya ga kasancewa a cikin ƙananan ƙwayar cuta, SARS-CoV-2 yana iya zama a cikin ƙananan ƙwayar cuta ba tare da nuna alamun bayyanar cututtuka ba, kamar yadda yake a cikin sauran CoVs da ke haifar da mura.
Don haka, marasa lafiya a farkon lokacin ko lokacin da cutar ba ta bayyana ba na iya fitar da ƙwayoyin cuta da yawa a cikin ayyukansu na yau da kullun, yana wahalar da aikin rigakafin cutar.
Duk da haka, ana tsammanin yaduwar SARS-CoV ya faru ne a lokacin da akwai ƙarancin masu cutar, kuma yaduwar ba ta da yawa a farkon lokacin.
Saboda haka, annobar COVID-19 ta yanzu ta fi rikitarwa da kuma wahalar shawo kanta fiye da cutar SARS.
Ana ci gaba da yin gwagwarmaya a China ciki har da rufe Wuhan da biranen da ke kewaye da shi da kuma keɓewar kusan dukkanin jama'a don hana yaduwar SARS-CoV-2.
Duk da irin wannan tasirin tattalin arziki da sauran cibiyoyin, yawan sabbin masu cutar yana raguwa, wanda ke nuna cewa matsalar tana raguwa.
Mafi kyawun hasashen shine cewa matsalar za ta ƙare a ranar Laraba kuma raguwar za ta ɗauki watanni 3-4.
Amma, wasu masana ba su da wannan begen.
Paul Hunter, da abokan aikinsa, sun yi hasashen cewa COVID-19, wanda ya fi SARS yaduwa, ba zai ƙare a shekarar 2020 ba.
Ira Longini, da abokan aikinsa, sun gano hanyar da za ta hango sakamakon cutar kuma sun kiyasta cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wani rukunin Kanada ya nuna cewa an gano SARS-CoV-2 a cikin marasa lafiya da suka warke daga asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar na iya sake dawowa kamar mura.
A maimakon haka, an ga alamun bege a China dangane da raguwar sabbin masu cutar, wanda ke nuna cewa matakan da ake da su na iya yin tasiri.
A dā an yi hasashen cewa cutar Ebola za ta kamu da mutane miliyan ɗaya kuma ta kashe mutane miliyan hamsin.
Amma, saboda bin ƙa'idodin keɓewa da keɓewa, an sami nasarar magance cutar.
Zai yiwu, kamar yadda ya faru da SARS-CoV, cewa kwayar cutar SARS-CoV-2 za ta iya zama mai rauni a cikin yanayin mutum kuma daga baya ta ɓace ko ta zama mai rauni kuma ta rayu cikin mutane.
Kwatanta cutar COVID-19 da SARS da MERS an nuna su a ƙasa (Hoto. (Hoto.55).
SARS-CoV-2 ana yaduwa ne ta hanyar tari ko hancin mutum, kuma mai yiwuwa ta hanyar taɓa abubuwa masu cutar.
An kuma gano cutar a cikin kwayar cutar, wanda ke nuna cewa yana yiwuwa kuma yana yiwuwa a kamu da cutar ta hanyar rashin abinci mai gina jiki.
Wani bincike da aka yi kwanan nan kan marasa lafiya 138 ya nuna cewa kashi 41 cikin 100 na marasa lafiya sun warke daga cutar, ciki har da marasa lafiya 17 da ke da wasu cututtuka da kuma likitoci 40.
Saboda haka, ana bukatar a yi hankali sosai don a ceci mutane, musamman ma likitoci, masu ba da taimako, waɗanda suke kula da gida, ma'aikata, da kuma waɗanda suke tsaye kusa da marasa lafiya ko waɗanda ke da cutar.
Hanya ta farko da za a iya amfani da ita don rage haɗarin kamuwa da cutar ita ce sanya abin rufe fuska; amfani da abin rufe fuska na tsabta da N95 (jerin # 1860s) duka suna taimakawa wajen rage yaduwar kwayar cutar.
Magungunan da ake amfani da su wajen tsabtace jiki suna hana abubuwa kamar su kumfa daga yin yawo a cikin iska ko kuma su kasance a kan wasu abubuwa.
Koyaya, kawai N95 (jerin # 1860s) yana da ƙarfin hana ƙwayoyin cuta 10 a cikin 80 nm, tare da ƙwayoyin cuta 5% kawai ke iya wucewa gaba ɗaya; SARS-CoV-2 yayi daidai da SARS-CoV a girma kuma duka suna da 85 nm.
Saboda kwayar cutar na iya shiga cikin abin rufe fuska na tiyata guda biyar a hade, likitocin da ke kusa da marasa lafiya dole ne su sa abin rufe fuska na N95 (jerin # 1860s) maimakon na tiyata.
Baya ga cutar sankara, likitoci suna buƙatar sanya rigakafi don rage haɗuwa da ƙwayoyin cuta.
Ƙari ga haka, ƙwayoyin cuta suna iya kamuwa da mutum ta hanyar wucewa.
A ranar 22 ga Janairun 2020, likitan ya kamu da SARS-CoV-2 duk da cewa yana sanye da kwayar cutar N95; ƙila kwayar cutar ta shiga jikinsa ta hanyar idanunsa da aka rufe.
Saboda haka, likitoci suna bukatar su saka abin rufe fuska ko kuma tabarau sa'ad da suke aiki da marasa lafiya.
Ga mutanen da ke cikin yankuna masu cutar ko kuma waɗanda za su iya kamuwa da cutar, zai zama da kyau kowa ya wanke hannayensu da sabulu sau da yawa fiye da yadda suke yi, ƙoƙarin kasancewa a cikin gida yayin keɓewa da rage hulɗa da mutanen da za su iya kamuwa da cutar.
Ana ganin cewa mutum zai iya yin barci a nisan kafa uku.
Wadannan ayyuka suna da tasiri wajen rage damar kamuwa da cutar da kuma yada ta.
Kodayake SARS-CoV-2 ya zo ne a matsayin sabon kwayar cutar a cikin mutane, kamanceceniya da SARS-CoV kamar yadda aka nuna a ranar 7 ga Janairu 2020 zai ba China darasi mai mahimmanci dangane da abubuwan da suka faru a lokacin barkewar cutar SARS a 2003.
Koyaya, har zuwa 19 ga Janairun 2020 shugaban Cibiyar Kula da Cututtuka ta Wuhan ya tabbatar wa jama'a cewa sabon kwayar cutar ba ta da yawa kuma ba ta yaduwa daga mutum zuwa mutum kuma cutar ba ta da wahalar hanawa da sarrafawa.
Wannan labarin ya sa mutane sun yi shiru, musamman a lokacin da kasar ke shirin bikin bazara, kuma lokacin da ya dace don magance cutar ya yi nisa a Wuhan.
Hukumomin yaki da cututtuka na kasar Sin na iya amfani da wannan darasi don yin rigakafi na gaba.
Misali, waɗannan hukumomin za su (1) yi taka tsantsan wajen sanar da jama'a saboda kowane kalma tana da ma'ana ga al'umma kuma tana iya canza ra'ayi da yanke shawara; (2) su kasance masu kulawa da amsawa ga bayanan da ba na al'ada ba daga asibitoci maimakon jiran rahotanni na hukuma daga likitoci ko hukumomi; (3) ƙara ƙarfin gwiwa don magance cutar da ke iya zama mai haɗari a farkon fashewar ta ƙoƙarin kwantar da hankalin jama'a; da (4) yin gwaji akai-akai ta hanyar ƙara wayar da kan jama'a game da cutar da gwaji da haɓaka yadda al'ummomin ke magance duk lamura a kowane lokaci.
Cutar COVID-19 ta hanyar sabon kwayar cutar SARS-CoV-2 ta fara ne a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, ya bazu ko'ina cikin China da kusan ƙasashe 50 a duniya a lokacin rubuta wannan.
Saboda kamawar cutar da SARS-CoV da alamun bayyanar cututtuka tsakanin COVID-19 da SARS, cutar COVID-19 ta sa mutane su yi tunanin cewa SARS ya dawo.
Amma, waɗannan sune manyan bambance-bambance tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don magance cutar da kuma kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa da maza fiye da mata, kuma yana da saurin kamuwa da cutar da kuma mutuwa a cikin tsofaffi fiye da matasa.
SARS ya fi COVID-19 kisa (10.91% idan aka kwatanta da 1.44%).
Marasa lafiya na COVID-19 suna kamuwa da cutar koda kuwa basu nuna alamun cutar ba kamar yadda marasa lafiya na SARS ke kamuwa da cutar idan suna cikin mawuyacin hali, wanda hakan ya sa ya zama da wahala a hana yaduwar COVID-19 fiye da SARS.
Wannan shine ɗaya daga cikin dalilan da yasa SARS-CoV-2 ke tafiya da sauri kuma ya isa nesa fiye da SARS-CoV.
Gwajin SARS-CoV-2 da RNA na iya tabbatar da rashin cutar a cikin wasu marasa lafiya na COVID-19.
Ƙari ga haka, waɗanda suka warke daga cutar suna iya sake kamuwa da cutar.
Waɗannan binciken sun sa an samu ƙarin damar yaduwar ƙwayoyin cuta.
Duk da gaggawa da aka samu a cikin binciken COVID-19, an ci gaba da magance wasu mahimman batutuwa, kamar:
Daga ina ne SARS-CoV-2 ya fito?
Duk da cewa akwai kamanceceniya ta kwayoyin halitta na 96% tsakanin SARS-CoV-2 da kwayar cutar Covid-19 mai kama da SARS, har yanzu ba mu iya tabbatar da cewa SARS-CoV-2 ta samo asali ne daga ƙuda ba.
Wane dabba ne a lokacin da ya fito daga dabba ta farko, kamar su ƙuda, kuma ya kawo cutar ga mutane?
Idan ba mu san amsoshin tambayoyi na 1 da 2 ba, ba za mu iya hana yaduwar cutar ba, kuma cutar za ta iya sake tashi a kowane lokaci.
Duk da cewa tsarin samfurin kwayoyin halitta da gwaje-gwajen ilimin halittu sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, ta yaya kwayar cutar ke shiga cikin ƙwayoyin iska kuma ke haifar da cuta?
Shin kwayar cutar tana shafar kwayar cutar ACE2 a wasu sassan jiki?
Idan ba mu da amsoshi masu kyau ga waɗannan tambayoyin, ba za mu iya bincika cutar da sauri ba kuma ba za mu iya samun magani mai kyau ba.
Har yaushe ne za a daina wannan ciwon?
Ta yaya kwayoyin halitta suke canjawa yayin da suke yaduwa?
Shin zai zama matsalar duniya, zai ƙare kamar SARS ko zai sake dawowa a matsayin mura?
Yana da muhimmanci mu bincika amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Maimakon haka, ko da menene ya kamata a yi, babu abin da za mu yi sai dai mu kawar da cutar da wuri-wuri kuma mu koma rayuwa ta yau da kullum.
Kwayar cutar corona ta samo asali ne daga dabbobi
Juyin halittar kwayoyin halitta ya haifar da canjin kwayoyin coronaviruses (CoVs) da kuma na dabbobi, gami da mutane, a cikin dubunnan shekaru.
Kafin 2003, an san cewa kwayoyin cutar CoVs na mutum (HCoVs) suna haifar da cututtuka masu saurin kamuwa da cuta, kamar mura.
Fashewar cutar cututtukan numfashi mai tsanani (SARS) da cututtukan numfashi na Gabas ta Tsakiya (MERS) sun canza yanayin kuma sun nuna yadda cutar HCoV ke da haɗari da kisa.
Barkewar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake dawo da CoVs a cikin ɗakin ajiya kuma ya ba mu mamaki yadda yake saurin yaduwa da rashin lafiya idan aka kwatanta da SARS-CoV.
HCoVs sun samo asali ne daga dabbobi kuma fahimtar asalin HCoVs na dabbobi yana da amfani sosai.
Yawancin HCoVs suna fitowa ne daga ƙwari kuma ba sa cutarwa.
An kuma gano wasu dabbobin da HCoVs ke fara kamuwa da su kafin su shiga cikin mutane.
Sanin dabbobin da ke kamuwa da cutar yana da amfani wajen hana cutar.
Binciken alaƙar da ke tsakanin dabbobi da ke dauke da CoV na iya taimakawa wajen gano cutar CoV a cikin mutane.
A cikin wannan bita, mun taƙaita abubuwan da aka gano kwanan nan game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su da asalin su a cikin dabbobi da kuma yadda suka bazu tsakanin dabbobi daban-daban.
Mafi mahimmanci, mun gano kamanceceniya da bambance-bambance tsakanin HCoVs daban-daban ta hanyar nazarin juyin halitta na kwayar cuta da sake haɗuwa da kwayoyin halitta.
Ana magana ne game da cutar CoV 2019 (COVID-19) a halin yanzu.
An kuma tattauna yadda kwayoyin halitta da ke dauke da cutar ke canzawa da kuma yadda cutar ke sa mutane su kamu da cutar.
Kwayar cutar corona (CoVs) ta kasance cikin dangin Coronaviridae, wanda ke da tarin ƙwayoyin cuta masu ɗauke da ƙwayoyin cuta, kowannensu yana da ƙwayoyin cuta masu ɗauke da ƙwayoyin cuta, kuma suna da RNA guda ɗaya.
Wannan kwayar cuta tare da mafi girman kwayoyin halitta na 26 na 32 kilobases a cikin RNA an kira shi CoVs saboda siffar kambi da aka gani a cikin yisti.
A cikin tsari, CoVs suna da kwayoyin halitta da ba a rarraba su ba kuma suna tare.
Kimanin kashi biyu bisa uku na kwayoyin halitta suna da manyan filayen biyu (ORF1a da ORF1b), wanda ke haifar da pp1a da pp1ab polyproteins.
Bayan haka, sai a haɗa su zuwa sunaye 16 da ake kira nsp1~16.
Sauran ɓangaren kwayoyin halitta yana da ORFs a kan sunadarai masu gina jiki, ciki har da spike (S), envelope (E), membrane (M) da nucleoprotein (N).
Ana kuma sanya sunadarai masu yawa na asali a cikin layin CoV.
Dangane da bambance-bambance a cikin tsarin furotin, ana rarraba CoVs zuwa manyan rukuni huɗu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), wanda beta-CoV shine mafi yawan HCoVs kuma an rarraba shi zuwa layi huɗu (A, B, C da D).
Sakamakon bincike ya nuna cewa kwari da sauro sune tushen alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune tushen gamma-CoVs da delta-CoVs.
A cikin dubban shekaru, CoVs sun samo asali ne daga dabbobi kuma wasu sun zama tushen cutar ɗan adam.
Ya zuwa yanzu, an gano mutane bakwai da ke dauke da kwayar cutar HCoV.
A cikin waɗannan HCoVs HCoV-229E da HCoV-NL63 sune nau'in alpha-CoVs.
Sauran beta-CoVs guda biyar sun haɗa da HCoV-OC43, HCoV-HKU1, coronavirus mai ciwo mai tsanani (SARS-CoV), coronavirus mai ciwon numfashi na Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 suna haifar da ƙananan cututtuka, kamar mura da / ko tari.
Akasin haka, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 suna da cutarwa sosai, suna shafar ƙananan ƙwayar cuta a cikin yawancin marasa lafiya kuma suna da haɗarin kamuwa da cututtukan numfashi mai tsanani (ARDS) da bayyanar cututtuka na waje.
An gano asalin HCoV-229E, B814, a cikin hanjin marasa lafiya na mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin bincike ta hanyar bincike mai zurfi game da HCoV-229E da HCoV-OC43, dukansu suna haifar da alamun cutar kai tsaye.
A zahiri, an yarda da shi cewa kamuwa da HCoVs gabaɗaya ba shi da haɗari har zuwa barkewar SARS.
Cutar SARS ta barke a shekara ta 2003 kuma ta kasance ɗaya daga cikin bala'i mafi muni a tarihin kwanan nan, tare da kamuwa da mutane fiye da 8,000 da kashi 10% na mutuwar da ake tsammani.
Shekaru goma bayan haka, cutar murhun numfashi ta Gabas ta Tsakiya (MERS) ta haifar da annoba a yankin Gulf da ke yaduwa zuwa sauran sassan duniya.
2019 sabon HCoV (2019-nCoV), wanda daga baya aka kira SARS-CoV-2, shine ke haifar da cutar coronavirus ta 2019 (COVID-19), wanda ya kashe mutane sama da 3,120 kuma ya kamu da mutane sama da 91,000 har zuwa 3 ga Maris 2020.
An yi kararrawa kuma dole ne duniya ta shirya don cutar SARS-CoV-2 ta duniya.
Dukkanin HCoVs guda bakwai sun samo asali ne daga kwari, beraye ko dabbobin gida.
Yawancin shaidu sun tabbatar da cewa dukkanin HCoVs sun samo asali ne daga ƙuda, inda ƙwayoyin cuta ke rayuwa cikin aminci kuma ba su da cutarwa amma suna da tsarin kwayoyin halitta daban-daban.
Cutar COVID-19 ta haifar da manyan kalubale na kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Binciken asalin HCoVs a cikin dabbobi yana ba mu damar fahimtar tarihin, abubuwan da ke hanawa da hana ƙwayoyin cuta daga dabbobi zuwa wasu.
Wannan zai iya haifar da hanzarta gano kwayoyin SARS-CoV-2 daga dabbobi zuwa mutane, wanda ke da mahimmancin gaske don hana barkewar cutar a nan gaba.
A cikin wannan binciken mun bayyana asalin HCoVs a cikin dabbobi, yadda suke yaduwa a cikin dabbobi daban-daban da kuma cutar da suke haifarwa.
Musamman, muna ba da shawara da kuma tattauna batun cewa kwayoyin HCoVs ba su da lahani a cikin dabba amma suna zama masu cutarwa idan sun canza zuwa wani dabba.
Mun kuma bincika yadda kwayar cutar HCoV ke canzawa yayin da take ƙara yin fure kuma sau da yawa tana rage haɗarin kamuwa da cuta.
Hakanan an yi la'akari da tasirin barkewar cutar SARS-CoV-2 a halin yanzu.
An san CoVs a cikin dabbobi tun daga ƙarshen 1930s.
Kafin a ware HCoV-229E mai suna B814 daga ƙwayoyin cuta na marasa lafiya na mura, an riga an ware yawancin CoVs daga dabbobi masu cutarwa, gami da koko, beraye, shanu, aladu, kuliyoyi da karnuka.
A cikin ƙarni da suka gabata, an gano nau'ikan HCoVs guda bakwai.
Wani ɗan gajeren tarihin gano HCoV a cikin zuriyarsa (Table 1) zai ba da darasi.
An gano kwayar HCoV-229E a cikin ƙwayar cuta ta marasa lafiya da ke fama da rauni a cikin farfajiyar sama a cikin 1966, kuma an gano ta a cikin kwayoyin halitta na WI-38.
Marasa lafiya da ke dauke da HCoV-229E suna da alamun cutar mura, gami da ciwon kai, hancinsa, ciwon makogwaro, zazzabi da tari a cikin kashi 10~20% na marasa lafiya.
Daga baya a cikin 1967, an gano HCoV-OC43 a cikin al'adun kwayoyin halitta kuma daga baya a cikin hanyar wucewa ta hanyar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar
Alamun asibiti da HCoV-OC43 ke haifarwa suna kama da na HCoV-229E, tare da alamun bayyanar cututtuka da ba su bambanta da na sauran ƙwayoyin cuta kamar su mura A da rhinoviruses ba.
HCoV-229E da HCoV-OC43 duka suna tafiya a duniya, kuma galibi suna tafiya a lokacin hunturu a cikin yanayin zafi.
A yawancin lokaci, cututtukan biyu ba sa wuce mako guda kafin su nuna alamun cutar, bayan haka, cutar tana ci gaba har tsawon mako biyu.
Dangane da binciken da aka yi a kan masu sa kai, mutanen da ke da rai da ke dauke da HCoV-229E sun kamu da mura mai sauƙi.
Wasu marasa lafiya da ke da ƙananan ƙwayoyin cuta sun sami mummunan rauni a cikin ƙananan ƙwayoyin cuta.
SARS, wanda aka fi sani da atypical pneumonia, shine farkon cutar da aka rubuta ta hanyar HCoV a cikin tarihin ɗan adam kuma ana haifar da SARS-CoV, nau'in HCoV na uku da aka gano.
An fara samun mutum na farko da ya kamu da cutar SARS a karshen shekarar 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta kamu da mutane 8,096 da aka sani kuma ta kashe mutane 774, wanda ya shafi ƙasashe da nahiyoyi da yawa.
Baya ga sanannun cututtukan, an kiyasta cewa kowane mai cutar zai iya kamuwa da wasu mutane biyu, tare da bayyanar cututtuka a cikin kwanaki 4 zuwa 7 yayin da yawan adadin kwayar cutar ya kai ranar 10 na cutar.
Marasa lafiya da ke dauke da SARS-CoV da farko suna fama da ciwon tsoka, ciwon kai, zazzabi, zazzabi da tari, sannan kuma suna fama da wahalar numfashi, tari da kuma samun ruwa daga huhu.
Lymphopenia, gwajin aikin hanta, da haɓaka creatine kinase sune wasu daga cikin cututtukan SARS da aka lura da su a cikin gwajin gwaji.
Hakanan an lura da cutar huhu (lalacewar alveolar), haɓakar ƙwayoyin epithelial da haɓakar ƙwayoyin cuta ta hanyar macrophages a cikin marasa lafiya na SARS.
Kimanin kashi 20-30% na marasa lafiya suna buƙatar kulawa mai tsanani da na'urar numfashi ta lantarki.
Baya ga ƙananan ƙwayoyin cuta, yawancin sassan ciki da na hanji, hanta da koda suma suna iya lalacewa a cikin waɗannan yanayi masu tsanani, sau da yawa tare da guguwar cytokine, wanda zai iya haifar da mutuwa musamman ga marasa lafiya da ƙananan ƙwayoyin cuta.
An fara gano cutar a cikin naman da aka samo daga huhu na dangin mutum na farko da aka gano wanda ya isa Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an yi ƙoƙari sosai don bincika HCoV.
An gano HCoV-NL63 a cikin jariri ɗan wata 7 daga Netherlands a ƙarshen 2004.
A baya an gano cewa ya fi yawa a cikin yara, tsofaffi da marasa lafiya da ke da ƙananan ƙwayoyin cuta da kuma cututtukan da ke tattare da ciwon sukari.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Wani bincike kuma ya nuna cewa an gano kwayar cutar a cikin hancin wani yaro mai wata takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a Netherlands, amma ya yaɗu a dukan duniya.
An kiyasta cewa HCoV-NL63 yana haifar da kusan kashi 4.7% na cututtukan numfashi na yau da kullun, kuma yana da haɗari a farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da cutar laryngitis mai hanawa, ko croup.
A wannan shekarar, an gano HCoV-HKU1 a cikin wani mutum mai shekaru 71 da haihuwa wanda aka kwantar da shi a asibiti saboda cutar huhu da kuma ciwon huhu a Hong Kong.
Baya ga ciwon huhu da ciwon huhu, an kuma gano HCoV-HKU1 yana da alaƙa da matsanancin ciwon asma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an gano HCoV-HKU1 a duk faɗin duniya, wanda ke haifar da rashin lafiya na numfashi.
Dukkanin HCoVs huɗu an san su sosai kuma ba a tsammanin za su haifar da mummunan cuta, duk da cewa an sami wasu haɗari saboda dalilai da ba a sani ba kamar cutar HCoV-NL63, wanda aka gano kwanan nan ya haifar da mummunan rauni a yankin yankin China.
A cikin yanayin, waɗannan HCoVs suna da ikon yin tafiya cikin sauƙi da kuma rayuwa cikin mutane, kuma suna da ƙarancin haɗari.
An fara gano MERS-CoV a cikin 2012 a cikin huhu na wani mai shekaru 60 da haihuwa wanda ke fama da cutar nimoniya da ciwon koda a Saudi Arabia.
Kodayake duk masu cutar sun fito ne daga Gabas ta Tsakiya, an gano wasu masu cutar daga kasashen waje daga wasu kasashen Turai da Tunisia.
A shekarar 2015 ne aka samu bullar cutar a Koriya ta Kudu inda aka samu mutum 186.
Alamun asibiti na MERS sun yi kama da na SARS, tare da ciwon huhu mai tsanani.
Ba kamar SARS ba, yawancin marasa lafiya na MERS sun sami ciwon koda, wanda a halin yanzu shine MERS kawai a cikin cututtukan da HCoV ke haifarwa.
Fiye da kashi 30% na marasa lafiya suna fama da matsalolin hanji, kamar zawo da hancin numfashi.
A ranar 14 ga Fabrairu, 2020, sama da marasa lafiya 2500 da aka tabbatar a cikin gwaji suna da yawan mutuwar 34.4%, wanda ya sa MERS-CoV ya zama ɗayan ƙwayoyin cuta masu haɗari ga ɗan adam.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano wasu marasa lafiyar tarin fuka da aka sani da cutar SARS-CoV-2 a Wuhan, Lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana cutar SARS-CoV-2 a matsayin gaggawa ta kiwon lafiya ta duniya da ake kira COVID-19.
A ranar 3 ga Maris, 2020, an samu kararraki 90,053 a duk duniya, tare da mutuwar kashi 3.4%.
Yana da mahimmanci a lura, mutuwar marasa lafiya a Hubei, China ya kai kashi 4.2%, yayin da a waje da shi ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da mummunan rauni a cikin jijiyoyin jiki kamar SARS-CoV da MERS-CoV, wanda ke haifar da zazzabi, tari da wahalar numfashi.
Ana samun ƙwari a wasu marasa lafiya.
Ciwon huhu yana ɗaya daga cikin alamun da ke sa mutum ya yi ciwo sosai kuma yana iya sa ya yi saurin ciwo.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya ta hanyar daidaiton jerin kwayoyin halittar nucleotide mai girma na 82%, sun kasance a cikin rassan daban-daban na itacen asali.
SARS-CoV-2 ba shi da haɗari amma yana da saurin yaduwa idan aka kwatanta da SARS-CoV da MERS-CoV.
An gano marasa lafiya marasa alamun SARS-CoV-2 kuma suna iya taimakawa wajen hanzarta yaduwar ta a duniya.
Kwatanta SARS-CoV-2 da sauran HCoVs guda shida sun nuna kamanceceniya da suka dace.
Na farko, lokacin bayyanar cututtuka da tsawon lokacin kamuwa da cutar HCoV sun yi kama sosai.
A wannan yanayin, SARS-CoV-2 yana kwaikwayon halayen hali na sauran HCoVs guda shida.
Na biyu, tsananin alamun COVID-19 ya bambanta tsakanin SARS-CoV da HCoVs huɗu (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, mutum mai dauke da SARS-CoV-2 yana da alamun da ake samu a cikin HCoVs, wanda ya ƙunshi alamun da ba a san su ba, marasa ƙarfi ko babu alamun.
A gefe guda, ƙananan masu cutar COVID-19 a cikin lokaci na iya zama kamar yadda yake a cikin mutane tare da SARS-CoV, kodayake ƙananan ƙananan ƙananan.
Na uku, yaduwar SARS-CoV-2 kuma tana nuna yanayin da aka samo a cikin yaduwar HCoVs da SARS-CoV.
A gefe guda, yaduwar SARS-CoV-2 tana da ƙarfi kamar yadda yake tare da HCoVs.
A gefe guda, ba a san ko yaduwar SARS-CoV-2 ta ragu ba bayan yaduwar mutum kamar yadda yake tare da SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, SARS-CoV-2 na iya bayyana a cikin samfurori masu cutarwa.
Ko mutum zai iya kamuwa da SARS-CoV-2 a cikin yanayin rashin lafiya kamar SARS-CoV a wasu lokuta ya kamata a tabbatar da shi a cikin binciken gaba.
Hakanan yana da mahimmanci a gano ko SARS-CoV-2 na iya samun lokacin da zai iya zama kamar HCoVs.
Ko da yake, yanayin SARS-CoV-2 wanda ya haɗa da kamuwa da cuta, rashin lafiyar da ke tattare da shi da kuma ci gaba da kamuwa da cutar ta hanyar ɗan adam zai zama mai mahimmanci ga sakamakon cutar COVID-19 na yanzu.
Duk wani alamar rashin lafiya da HCoVs ke haifarwa an jure ta da kyau.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun sami nasarar hana HCoVs.
A wasu kalmomin, duka biyu na iya zama masu tsira daga cutar HCoV mai haɗari a baya.
Kwayoyin HCoVs da ke haifar da cututtukan mutane da kuma cututtukan HCoVs masu tsanani sun mutu.
Don wannan ya faru, HCoVs dole ne su ninka a cikin mutane sau da yawa don samar da adadin da zai iya jurewa da tasirin mutum ko yanayin da yake ciki.
Don haka, yayin da SARS-CoV-2 ke da ƙarancin ƙarfi da kuma yawan kamuwa da cuta, damar sa ta daidaita da mutane tana ƙaruwa.
Idan an daidaita shi, zai yi wuya a hana yaduwar cutar ta hanyar kulle ko wasu hanyoyin hana yaduwar cutar.
A cikin shekaru da yawa, nau'ikan CoVs guda huɗu sun bazu cikin mutane suna haifar da mura a cikin mutane masu lafiya.
Ba sa bukatar su ɓoye kansu a cikin dabbobi.
A kwatankwacin haka, ƙwayoyin cuta masu saurin kamuwa da cuta na SARS-CoV da MERS-CoV ba su da cikakkiyar fahimta kuma ba za su iya yaduwa tsakanin mutane ba.
Dole ne ya kasance a wurin kuma ya nemi zarafi ya yi amfani da waɗanda ba su da ƙarfi, wataƙila ta wurin mutum ɗaya ko fiye da haka da suke da rauni a jiki don su ƙarfafa su.
Kwayar cutar SARS-CoV-2 tana da alamun bayyanar cututtuka kamar SARS-CoV/MERS-CoV da kuma ƙwayoyin cuta huɗu na mutum da ake kira HCoVs.
Yana da yaduwa kamar HCoVs na mutum, aƙalla kamar yadda aka sani a yanzu.
Duk da haka, yana da haɗari fiye da HCoVs na ɗan adam kuma ba shi da haɗari kamar SARS-CoV ko MERS-CoV.
Har yanzu ba a san ko zai iya zama cikakke ga mutane ba kuma ya bazu daga mutum zuwa mutum ba tare da cutar ba ko kuma daga dabba zuwa dabba.
Kafin mu tattauna game da dabbobi da ke haifar da HCoVs, zai taimaka mana mu tattauna ma'anar kalmomin da alamun waɗannan kalmomin, maye gurbi, yanayin halitta, yaduwa, yanayin da ba a yadawa da kuma yanayin da ke haifar da HCoVs.
Dabbobi suna aiki a matsayin masu watsawa wanda ke haifar da HCoV idan suna da kwayar halitta mai kama da kwayar halitta ta hanyar raba kwayoyin halitta a matakin kwayar halitta.
Kwayoyin cuta da ke cikin jiki ba sa cutar da abin da suke zaune a ciki.
Hakazalika, HCoVs suna rayuwa a cikin kwayoyin halitta na tsawon lokaci.
A cikin waɗannan lokuta biyu, mai dauke da kwayar cutar yana da cutar kuma yana da kwayar HCoV ko kuma haifaffen kwayar cutar.
Akasin haka, idan an sanya kwayar cutar HCoV a cikin wani wuri mai dauke da kwayar cutar kafin ko a lokaci guda da shi, ba ta saba da yanayin da ke ciki ba kuma tana iya yada cutar.
Yanayin da kwayar cutar ke zaune zai iya zama tushen cutar ga mutane kuma ya zama wurin da kwayar cutar ke rayuwa ta hanyar hana kwayar cutar ta yaduwa da kamuwa da mutane da kuma yada cutar ga mutane.
HCoV ba zai iya yaduwa ba idan ba zai iya rayuwa a cikin wani kwayar cuta mai yaduwa ba.
A wasu kalmomi, HCoVs na iya zama a cikin wani wuri mai kama da kwayar cuta kuma su kasance masu cutarwa na dogon lokaci.
A sakamakon haka, ƙwayoyin cuta da ke cikin gida suna zama masu cutarwa.
Rahotanni game da cututtuka sun nuna cewa yaduwar SARS ya kasance yana da alaƙa da dabbobin daji.
Binciken da aka yi a rijiyar ya nuna cewa masu sayar da dabbobi suna da ƙarin ƙwayoyin rigakafin SARS-CoV IgG a jikinsu fiye da sauran mutane.
An gano cewa ƙudaje (Paguma larvata) da kuma raccoon na Asiya suna dauke da kwayar cutar SARS-CoV mai kama da SARS-CoV.
Wannan ya kara da cewa bayan an kashe dabbobin da ke cikin kasuwa, ba a sake samun kwayar SARS ba.
Amma, dabbobin daji ko dabbobin daji da ke cikin daji kafin su shiga kasuwa ba su da kwayar cutar SARS-CoV, wanda ke nufin cewa dabba za ta iya zama mai saurin kamuwa da cutar amma ba ta da wata hanyar halitta ta SARS-CoV.
Yanzu, tare da kashi 80% na dabbobi a kasuwar Guangzhou suna da rigakafin SARS-CoV, ba za a iya watsi da yiwuwar cewa ƙananan dabbobi suna iya zama masu aiki tare da kwayar cutar SARS-CoV ba.
Duk waɗannan suna kama da SARS-CoV amma ba su yaduwa.
A sakamakon haka, kwayar halitta mai dauke da kwayar cutar SARS-CoV ta nuna kamanceceniya da kwayar cutar CoV, SARS Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin kwari na kudan zuma na kasar Sin.
Wannan kwayar cutar tana da kwayoyin cuta masu karewa da SARS-CoV da kuma kwayoyin cutar BatCoV HKU3.
Wannan kwayar cutar CoV ce mai saurin kamuwa da cuta wacce ke da kashi 88-92% na kwayoyin halitta tare da SARS-CoV.
Wannan binciken ya kafa tushen sabon fahimtar cewa ƙuda tana ɗauke da sababbin cututtuka da ke shafan mutane.
An gano wasu ƙwayoyin cuta da yawa da ke kama da SARS CoVs (SL-CoVs) a cikin bera amma babu wanda aka gano a matsayin mai rai sai WIV1.
An san cewa wani abu mai suna angiotensin converting enzyme 2 (ACE2) yana da tasiri ga SARS-CoV.
An samo WIV1 daga samfurin cutar ƙwari kuma an nuna shi ta hanyar amfani da ƙwari, ƙwari da ACE2 a cikin mutane don hana kamuwa da cutar.
Abin farin ciki, ƙwayar SARS a cikin marasa lafiya masu warkewa ta iya lalata WIV1.
Ko da a nan, WIV1 yana wakiltar dangi mafi kusa ga SARS-CoV a cikin ƙuda, wanda ke raba kashi 95% na kwayoyin halitta.
Baya ga kamanceceniya tsakanin kwayoyin halitta tsakanin kwayoyin biyu, an yarda da cewa WIV1 ba shine kwayar cutar SAR-CoV da ke kusa da ita ba kuma ba kwayar cutar SARS-CoV ba ce.
Binciken kwayar halitta ya sanya MERS-CoV a cikin rukuni ɗaya tare da CoV-HKU4 da CoV-HKU5.
Kwayoyin CoV-HKU4 da MERS-CoV suna amfani da kwayar halitta guda ɗaya, dipeptidyl peptidase 4 (DPP4), don shigar da kwayar cutar.
Kwayar halittar (RNA) ta MERS-CoV ta yi kama da wanda aka gano a cikin beta-CoVs na bera da aka gano a Turai da Afirka.
Ko da a wannan yanayin, babu wani kwayar cutar MERS-CoV mai rai da za a iya ganowa a cikin ƙuda.
MERS-CoV da danginsa CoV-HKU25 suna da kashi 87% na kwayoyin halitta.
A wannan yanayin, ƙwayoyin cuta ba su da wata matsala da cutar MERS-CoV.
A gefe guda kuma, binciken da aka yi a ƙasashen Gabas ta Tsakiya ya nuna cewa raƙuma suna da ƙwayar MERS-CoV a cikin tsarin rigakafi, kamar yadda yake a raƙuma na Afirka da aka kawo daga Gabas ta Tsakiya.
Kwayar cuta mai rai ce ta MERS-CoV mai kama da kwayar cutar da aka gano a cikin mutane wanda aka ware daga ƙurar raƙumi, wanda ya nuna cewa raƙuma suna aiki kamar waɗanda ke fama da cutar MERS-CoV.
Abin lura, an gano alamun rashin lafiya a cikin raƙuman da ke dauke da MERS-CoV.
Ka lura, raƙuma masu cutarwa ba kawai suna da ƙwayoyin cuta ba ne kawai, amma ƙwayoyin cuta sune babban abin da ke haifar da cutar ta hanyar ƙwayoyin cuta.
Koyaya, tambayoyi har yanzu suna nan saboda marasa lafiyar MERS ba su da wata hanyar tuntuɓar da ta gabata tare da raƙuma kafin bayyanar cututtukan, wanda zai iya zama daga mutum zuwa mutum ko kuma hanyoyin watsawa da ba a sani ba wanda ya haɗa da nau'ikan da ba a sani ba na MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na kwayoyin halitta tare da CoV RaTG13 wanda aka ware daga ƙuda mai suna Rhinolophus affinis bats.
Kuma kamar yadda yake tare da SARS-CoV da MERS-CoV, bambancin dake tsakanin SARS-CoV-2 da RaTG13 yana da ƙarfi sosai har yana da wuya a gano dangantakar da ke tsakanin kwayoyin.
Wato, baza'a iya samun kwari da sauri don ɗaukar kwayar cutar SARS-CoV-2 ba sai dai idan an gano wasu kwayar cutar COVID-CoVs.
A cewar hasashe, dabba mai dauke da kwayar cutar da ba ta yada SARS-CoV-2 ya kamata ya kasance daya daga cikin nau'ikan da ake sayar da su a cikin daji kuma aka kashe su a kasuwar sayar da kayan abinci ta Huanan, inda a farkon cutar ta COVID-19 ta fara kamuwa da cutar ta hanyar watsawa daga dabba zuwa mutum.
Yawancin binciken da aka yi a baya da suka danganci canjin kwayoyin halitta sun nuna cewa pangolins (Manis javanica) da ke cikin haɗari na iya samun kwayoyin beta-CoVs masu kama da SARS-CoV-2.
Wannan kwayar halitta ce ta Pangolin da ba a taɓa gani ba wanda ke da tsarin CoV wanda ya raba kashi 85-92% tare da SARS-CoV-2.
Maimakon haka, yana da kusan kusan 90% na tsarin tsarin kwayoyin halitta na RaTG13.
Sun rarraba ƙananan ƙananan kwayoyin cuta guda biyu na SARS-CoV-2 a cikin sabon tsarin kwayoyin halitta wanda ɗayan ya raba aikin tare da (RBD) SARS-CoV-2, tare da 97.4% na kama da kwayoyin halitta.
A cikin kwatancen daban, ayyukan RBDs na SARS-CoV-2 da RaTG13 sun bambanta sosai amma sun bambanta ta hanyar maye gurbin kwayoyin halitta.
Binciken farko na pangolin mai cutar ya nuna cewa kwayar cutar ta kamu da cutar SARS-CoV-2.
Binciken ya yi amfani da fasahohi daban-daban da suka hada da maye gurbin kwayoyin halitta wanda ya ƙunshi kashi 86.3% na kama da kwayar cutar.
Ba za mu iya kawar da yiwuwar cewa pangolin shine mafi kyawun kwayar cutar da ba ta yada SARS-CoV-2 ba.
A halin yanzu, babu wani tabbataccen bayani game da SARS-CoV-2 na pangolin wanda ya bambanta tsakanin SARS-CoV-2 da SARS-CoV-2 beta-CoVs na pangolin .
Hakanan, tazara tsakanin SARS-CoV-2 da RaTG13 ya fi tazara tsakanin SARS-CoV-2 da SARS-CoV-2-related pangolin beta-CoVs .
Ba a san asalin SARS-CoV-2 a cikin barbashi, pangolin da sauran dabbobi masu kama da mutane ba.
Ko da yake an gano daidaiton kwayoyin halitta tsakanin RBDs da SARS-CoV-2 da pangolin, ƙwayoyin cuta masu kama da SARS-CoV-2 beta-CoVs, SARS-CoV-2 da RaTG13 suna da tsarin haɗin gwiwa.
Ana tsammanin cewa kamanceceniya tsakanin RBDs a cikin pangolin SARS-CoV-2 beta-CoVs da SARS-CoV-2 ana sarrafa su ta hanyar maye gurbi.
Wani shawarwari daban ya goyi bayan bambancin dake tsakanin kwayar cutar pangolin SARS-CoV-2 beta-CoV da RaTG13 a cikin dabbobi.
A matsayin mai motsawa don juyin halitta, rashin daidaituwa yana da yawa a cikin beta-CoVs.
Ba a yanke hukunci ba game da kwayar SARS-CoV-2.
Baya ga manyan kwayoyin cuta masu cutar HCoVs, an kuma bincika asalin HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1 na dabbobi.
Rahoton nazarin kwayoyin halitta ya nuna cewa HCoV-NL63 da HCoV-229E sun samo asali ne daga CoVs a cikin bera, yayin da aka gano asalin HCoV-OC43 da HCoV-HKU1 a cikin sauro.
An gano cewa an gano kwayar cutar CoV mai suna ARCoV.2 (Appalachian Ridge CoV) a Arewacin Amurka a cikin nau'ikan launuka uku kuma yana nuna cewa yana da alaƙa da HCoV-NL63.
A wasu kalmomin, HCoV-229E ya kasance mai kama da kwayar cuta ta CoV, Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, kuma ana tsammanin raƙuma ma suna da kwayar cutar.
Don ƙarin haske, an haɗa bayanan asalin dabbobi na HCoVs da aka sani a cikin Hoto na 1 da na 2.
Binciken juyin halitta ya kawo bayanai cewa HCoVs yana yaduwa a cikin jinsunan da ba a taɓa gani ba.
Lokacin da HCoV-OC43 ya tashi daga jinsin zuwa mutane daga dabbobin gida a cikin 1890, an gano cutar sankarar bargo.
Tarihin yaduwar bambance-bambancen HCoV-229E ba shi da tabbas.
An gano wasu ƙwayoyin cuta masu kama da alpha-CoVs waɗanda ke da alaƙa da HCoV-229E.
Daga cikin su akwai alpaca alpha-CoV.
Akwai bayanai da dama da ke nuna cewa cutar tana yaduwa daga kura zuwa mutane kai tsaye.
Na farko, mutane ba alpacas ba ne suke raba wuraren zama da su.
Maimakon haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, HCoV-229E-related bat alpha-CoVs sun bambanta kuma ba su kamu da cutar ba yayin da alpaca alpha-CoV ya haifar da cutar a cikin tsarin watsawa na dabbobi masu cutar.
A ƙarshe, ba a gano alpaca alpha-CoV a cikin dabbobin da suka koma cikin daji ba.
A halin yanzu, ba za a iya kawar da yiwuwar alpacas sun sami HCoV-229E-related alpha-CoV daga mutane ba.
A zahiri, ƙuda ita ce tushen ƙwayoyin cuta da ke yada cututtukan ɗan adam a can ciki har da cutar rabies, Ebola virus, Nipah virus da Hendra virus.
Saboda haka, ba abin mamaki ba ne cewa ƙuda za ta iya yada HCoV-229E kai tsaye ga mutane.
A wasu kalmomin, kodayake alpha-CoVs suna aiki a matsayin asalin HCoV-229E, alpacas da raƙuma na iya aiki a matsayin masu ɗaukar hoto na ƙwayoyin cuta masu saurin yaduwa ga mutane kamar yadda yake tare da MERS-CoV.
MERS-CoV ya zama misali mai kyau na yadda za a iya yadawa daga jinsin zuwa jinsin daga bera zuwa raƙuma (dromedary camels) kuma daga raƙuma (dromedary camels) zuwa mutane.
An san asalin MERS-CoV daga ƙuda tun daga farkon halitta kuma an tabbatar da wannan asalin a cikin binciken.
Hakika, ƙuda tana da ƙwayoyin cuta da yawa da suke rarrabuwa zuwa wasu ƙwayoyin cuta dabam dabam.
Tsawonsa, yawan garkensa, da kuma yadda yake tsalle-tsalle yana sa shi ya zama mai ɗauke da ƙwayoyin cuta.
A gefe guda, an sanya MERS-CoV a cikin raƙuma (dromedary camels) na dogon lokaci.
Ta yi rayuwa a cikin waɗannan raƙuman da suka zama kamar ƙwayoyin cuta.
MERS-CoV yana haifar da ƙananan cututtuka kuma yana da ɗan bambanci a cikin waɗannan dabbobi.
An yi la'akari da yaduwar mutum ta hanyar haɗari kuma mutane suna ci gaba da hulɗa da kwayar cutar MERS-CoV amma ba a iya yada ta ba saboda ba a iya hana yaduwar ta.
Idan aka kwatanta da rawar raƙuma a cikin watsa MERS-CoV, rawar pangolins, a matsayin mai zaman kansa, a cikin watsa SARS-CoV-2 ya bambanta.
Mafi mahimmanci, pangolin beta-CoVs suna haifar da cututtuka a cikin pangolins.
Zai iya zama mai dauke da kwayar cuta wanda ba ya yada SARS-CoV-2-related beta-CoVs, kamar yadda yake a cikin SARS-CoV.
Za a tabbatar ko kuma a soke yiwuwar yaduwar SARS-CoV-2 a cikin nau'ikan da ke cikin dabbobi zuwa mutane a cikin binciken da ke zuwa.
Da farko dai, ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwarƙun ƙwar ƙwar ƙwarƙun ƙwar ƙwar ƙwar ƙwar ƙwar ƙwarƙun ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar
Mutane suna iya kwatanta yadda suke rayuwa a cikin abinci da yadda suke rayuwa a cikin rami.
Na biyu, pangolins na iya zama matsugunin kwayar cutar da ke yada kwayar cutar SARS-CoV-2 da aka sanya su.
Mutane suna kamuwa da cutar ta hanyar kashe da kuma cin naman ƙuda.
Akwai yiwuwar cewa dabbobi masu kama da mutane, gami da dabbobin gida, na iya kamuwa da SARS-CoV-2.
Ana bukatar nazarin dabbobi da ke cikin gida da na daji don gano rigakafin da ke cikinsu.
Na uku, kamar yadda aka ambata a sama, rashin daidaituwa na kwayoyin halitta da kuma daidaitawa na SARS-CoV-2 na iya zama sun faɗi cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
Ana ci gaba da bincike kan asalin SARS-CoV-2 a cikin dabbobi.
Baya ga nau'in dabbobin da cutar ta kamu da su, manyan abubuwa guda uku a gefen kwayar cutar suna da mahimmanci don samar da CoVs don hana su sake komawa cikin wasu nau'ikan.
Na farko, ana ganin cewa suna da ƙwarewa sosai wajen yin amfani da kwayoyin halitta.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ana tsammanin yawan ƙwayoyin cuta na ƙwayoyin cuta suna tsakanin matsananci da mafi girma tare da matsakaicin adadin daga ~10-4 a kowace shekara a kowane wuri 2, dangane da matakin CoV na daidaitawa da kuma cutar da ba a sani ba.
Kwayoyin cutar CoVs suna da ikon sarrafawa na exoribonuclease, kuma a yayin da aka sarrafa su, suna haifar da ƙarancin ƙarfi ko rashin ƙarfi.
Abin sha'awa, ana san analogue na nucleotide Remdesivir don hana yaduwar CoV ta hanyar hana kwayar halitta ta exoribonuclease (RNA) wanda ya dogara da RNA polymerase.
Remdesivir yana cikin jerin kwayoyin cutar SARS-CoV-2 da ake gwadawa a cikin gwaji na asibiti.
Bayan haka, yawan CoVs ya fi na cutar sau miliyan.
Hakanan, yawan canjin yana da yawa idan CoVs ba su san abin da ke dauke da su ba.
Idan aka kwatanta da SARS-CoV wanda ke da yawan canji, yawan canjin SARS-CoV-2 ya yi ƙasa, wanda ke nuna cewa yanzu ya zama cikakke ga mutane.
Wataƙila ya riga ya saba da wani abu da ya yi kama da na mutane.
Baya ga SARS-CoV-2, wannan yana shafar MERS-CoV, wanda ya saba da raƙuma.
A cikin tunani, yana da alama cewa maye gurbin kwayoyin halitta na iya sa rigakafin SARS-CoV-2 ya yi aiki da sauri.
Na biyu, babban tsarin RNA a cikin CoVs yana hana sauye-sauyen kwayoyin halitta, wanda ke kara yiwuwar bambancin jinsuna, wanda ke da amfani ga asalin kwayar cutar CoV da ba a sani ba.
Wannan yana tallafawa ta hanyar tsarin karatun buɗewa na musamman da kuma amfani da furotin a ƙarshen 3′ na kwayoyin halitta.
Na uku, CoVs sau da yawa suna canzawa ta hanyar ƙwayar cuta a lokacin haifuwa ta hanyar tsarin koppa-kyunshin.
A cikin kwayar cutar da ke aiki a matsayin mai ɗaukar hoto, canji yana faruwa a lokacin kwafin CoV RNA.
RNAs masu kama da juna da kuma RNAs na subgenomic zasu iya haɗuwa don samar da wasu CoVs.
An gano kwayar halitta mai maye gurbin kwayar halitta a cikin HCoV-HKU1 da HCoV-OC43, da kuma CoVs na dabbobi kamar SL-CoV da HCoV-HKU9.
Halin da ake ciki na kamuwa da cuta
Baya ga waɗannan abubuwa uku da aka ambata a sama, haɗuwa da kwayar cutar yana da mahimmanci a cikin yaduwar cututtuka a cikin nau'ikan.
A cikin wannan takarda, an ɗauki SARS-CoV mai maye gurbin a matsayin sanannen misali wanda ke nuna alamun zaɓin mai kyau.
Dangane da nazarin bayanan da aka gano na SARS-CoVs na mutum da na dabba, ana tsammanin SARS-CoV yana da saurin daidaitawa ga yanayin kwayoyin cuta, musamman ta hanyar maye gurbin RDB a cikin furotin S.
Gabaɗaya, RBD a cikin furotin S na CoV yana da alaƙa da ƙwayoyin cuta kuma ana zaɓar shi ta hanyar rigakafi a cikin kwayar cutar.
A cikin SARS-CoV, RBD yana cikin amino acid 318 zuwa 510 a kan S1 yanki, wanda ke da alaƙa da ACE2 a cikin mutane da kuma ƙwayoyin cuta.
SARS-CoV RBD na iya hana masu karɓar ACE2 a cikin dabbobi daban-daban, gami da bera, kifi, bera da kare, yana ba da damar yaduwar kwayar cutar ta hanyar jinsuna daban-daban.
A zahiri, an gano sauran amino acid guda 6 daban da waɗanda aka ware daga ɗan adam a cikin RBD kuma 4 daga cikinsu suna cikin kwayar halitta ta hanyar hulɗa da kwayar halitta ta ACE2.
Sabon SARS-CoV yana da maye gurbin K479N da S487T RBD, wanda zai iya haɓaka haɗin haɗin furotin mai ƙaruwa tare da ACE2 wanda ke haifar da cutar a cikin mutane.
Wato, amino acid biyu da ke cikin jini suna iya zama da muhimmanci wajen daidaita ƙwayoyin cuta a cikin mutane.
Yana da mahimmanci a lura cewa SARS-CoV-2 yana da kwayar cutar da ke kama da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a matakin S1 na furotin S yana nuna cewa yana ƙarfafa dangin furotin S da ACE2 a cikin mutane na iya canzawa.
A zahiri, nazarin cryo-EM ya nuna dangantaka tsakanin 10-20 mafi ƙarfi a cikin wannan haɗin gwiwa fiye da ACE2 a cikin mutane da furotin SARS-CoV S.
Zai zama mai ban sha'awa kuma a ga ko za a buƙaci wani abu mai kama da kwayar cutar don watsa SARS-CoV-2.
Abin sha'awa, HCoV-NL63 kuma yana ƙarfafa ACE2 amma ta amfani da wani sabon S-gene.
Akwai wasu masu karɓar HCoVs da yawa, kamar aminopeptidase N akan HCoV-229E, da 9-O-acetylated sialic acid akan HCoV-OC43.
Hakanan yana iya bayyana yadda kwayar cutar CoV ta dace da mutane bayan an watsa ta zuwa wasu nau'ikan dabbobi.
Baya ga ƙwayoyin cuta, yanayin HCoV yana da tasiri a kan yanayin da ke tattare da yanayin da ke tattare da cutar.
Bambancin sunadarai tsakanin mutane da kwayoyin da ke yada HCoVs kamar su kwari, raƙuma da rodents na iya zama abin hana yaduwar cutar tsakanin jinsuna.
HCoVs suna lalata yanayin yanayin kuma suna hana ƙuntatawa na yanayin yanayin saboda ingantaccen yaduwar cutar zuwa nau'ikan daban-daban.
Saboda haka, har yanzu ana bukatar a bincika da kuma bayyana ƙwayoyin halitta a cikin wannan babban yanki na ƙwayoyin cuta.
Gwajin kwayoyin halitta na gaba ɗaya wanda ya ƙunshi ƙwayoyin cuta da ƙwayoyin cuta na SARS-CoV-2 tare da amfani da fasaha mai inganci na iya haifar da sakamako mai kyau.
An sake gano ɓarkewar HCoVs: komawa zuwa farkon
Bambancin CoVs na ƙwayar cuta yana ba da babbar dama ga haɓakar HCoVs da ba a sani ba.
A wannan yanayin, CoV na kwari yana aiki a matsayin tushen kwayoyin halittar HCoVs.
Bugu da ƙari, juyin halitta da kuma haɗuwa da kwayoyin halitta suna sarrafa haɓakar HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan juyin halitta.
Alal misali, samun ko rasa kwayar halitta da ba a sani ba na iya canja yanayin ƙwayoyin cuta.
Daga cikin furotin masu amfani da SARS-CoV, ana tsammanin ORF8 yana da mahimmanci a cikin daidaituwa na ɗan adam, yayin da SARS-CoV mai cutar ta kwayar cuta ta isolated amma an gano cewa yana da furotin ORF8 daban.
An gano alamar cirewar nucleotide 29-na SARS-CoVs a cikin ƙwayoyin cuta da aka ware a farkon farkon cutar a cikin mutane.
Wannan yaduwar ya raba ORF8 zuwa ORF8a da ORF8b kuma ana tsammanin ya zama canjin yanayin da ke haifar da canji a cikin kwayar halitta.
Bugu da ƙari, SARS-CoV yana da tarihin iyawa don haɗuwa da alpha- da gamma-CoVs, wanda aka nuna ta hanyar ƙananan ƙwayoyin RNA-da ke da alaƙa da RNA polymerase.
An gano wasu wuraren haɗuwa a cikin nsp9, mafi yawa a cikin nsp10, da kuma sassan nsp14.
Hakazalika, an nuna cewa farkon cutar MERS-CoV ta kasance cikin rikice-rikice tsakanin kwayoyin halitta, wanda ya faru a cikin raƙuma a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da yawan haɗuwa a cikin sauran HCoVs, inda HCoVs ke haɗuwa da CoVs na dabbobi a cikin kwayoyin halittarsu da ake kira kwayoyin halitta.
Ya kamata a kuma yi gargadin cewa lura da mutane na iya haifar da canje-canje da ba a taɓa gani ba a cikin kwayoyin halittar kwayar cuta, galibi sakamakon warewar ƙwayoyin cuta daga matsin lamba, kamar waɗanda ke cikin ƙwayoyin cuta.
Misali na wannan lalacewar shine asarar ORF4 mai yawa a cikin kwayar HCoV-229E, wanda ke haifar da lalacewar nucleotide sau biyu.
Duk da yake ana iya gano ORF4 wanda ba a canza ba a cikin ƙwayoyin cuta da ke fama da HCoV-229E, alpaca alpha-CoV yana nuna ƙaddamar da nucleotide, daga tsarin tsarin.
A ƙarshe amma ba mafi ƙaranci ba, ba a san yadda HCoVs ke girma ba kuma ana sarrafa su ta hanyar matsa lamba ta hanyar ƙwayoyin cuta.
An lura da rashin alamun ko ƙananan alamun cutar a cikin CoVs, wanda ke nuna bambancin da ke tsakanin CoVs da ƙwari.
Ya bayyana cewa kwari sun saba da CoVs a cikin ci gaban su (anatomically) da kuma yanayin rayuwar yau da kullun.
Misali, rashin ƙarfi a cikin tsarin ƙwayoyin cuta na ƙwayoyin cuta yana rage ƙarancin cutar da CoVs ke haifarwa.
Bugu da ƙari, mutuwar ƙwayoyin halitta a cikin ƙwayoyin ƙwayoyin cuta an ɓoye shi saboda rage ƙwayoyin ƙwayoyin cuta na NKG2/CD94 da kuma ƙananan ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
A gefe guda, nau'ikan oxygen (ROS) da ke fitowa daga tsarin abinci a cikin huhu na iya hana haɓakar CoV da kuma hana tabbatar da ƙwayoyin cuta ta hanyar exoribonuclease, wanda ke haifar da matsin lamba don samar da ƙwayoyin cuta masu saurin kamuwa da cuta idan aka sanya su a cikin wani yanki na ƙwayoyin cuta.
Sauran CoVs na iya girma ba tare da haɗuwa ba, suna haifar da sunadarai da ba a sani ba ko alamun sunadarai waɗanda ke ba da damar ƙwayoyin cuta su daidaita.
A halin yanzu, ba abin mamaki bane cewa HCoVs da ba a san su ba sun bayyana a cikin shekaru 20 da suka gabata.
CoVs ba sa haifar da cuta ko haifar da alamun bayyanar cututtuka a cikin abin da ke yadawa kamar ƙwari da raƙumi.
Yana da sauƙi kuma ba ya sa ƙwayoyin cuta su yi yawa.
Wannan shi ne asirin da ke sa ƙwayoyin cuta da ba su da alamomi su zama sanadin cututtuka masu tsanani.
Alamun cutar sun fi yawa daga ɓarkewar ƙwayoyin cuta da kuma hadarin cytokine, don haka idan ƙwayoyin cuta sun fi tsanani, cutar ta fi muni.
Idan aka kwatanta da mutanen da ba su da alamun cutar, ƙwayoyin cuta sun fi hana yaduwar CoV.
Wannan hanyar da aka yi amfani da ita don kawar da ƙwayar cuta na iya zama da amfani wajen magance SARS-CoV-2.
Tsarin interferon yana da ƙarfi sosai a cikin ƙuƙwalwa.
Don haka, yin aiki tare da nau'in I interferon aƙalla lokacin da aka gano cutar SARS-CoV-2 a cikin mutane dole ne ya zama mai tasiri.
Hakazalika, kunna NLRP3 a cikin ƙwayar cuta a cikin huhu ba shi da tasiri.
A cikin wannan mahallin, hana NLRP3 ƙwayoyin cuta tare da MCC950 na iya taimakawa wajen maganin COVID-19.
Cutar SARS-CoV-2 ta biyo bayan wata matsala ta yau da kullun tsakanin SARS-CoV da MERS-CoV.
Ko da yake an gano cewa beta-CoV yana da kashi 95% na nucleotide tare da SARS-CoV, akwai kuma kwayar cutar CoV wanda ke da kashi 96% na nucleotide tare da SARS-CoV-2.
Koyaya, an gano cewa tsuntsaye da sauran dabbobin da ake siyarwa a kasuwa suna ɓoye kwayar cutar da ta yi kama da SARS-CoV, wanda ke haifar da ƙwayoyin cuta waɗanda ba sa yaduwa kafin a gano SARS-CoV-2.
An gano kamanceceniya tsakanin pangolin beta-CoVs da SARS-CoV-2, wanda ke nuna cewa pangolins na iya zama masu ɗauke da ƙwayoyin cuta masu saurin yaduwa ko kuma pangolin beta-CoVs na iya samun kwayoyin halittar da ke haifar da cutar SARS-CoV-2.
Ko da yake har yanzu akwai tambayoyi, babu wata shaida da ta nuna cewa SARS-CoV-2 an ƙirƙira shi ne da gangan ko kuma ba da gangan ba.
An sake gano CoVs a cikin mutane saboda ɓarkewar SARS-CoV-2 da ta gabata.
Binciken CoVs a cikin barbashi da sauran dabbobi ya kawo sauyi cikin gaggawa game da mahimmancin cutar da ke tattare da HCoVs a cikin watsa cututtuka ga mutane.
Bayanai masu ƙarfi sun nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga ƙuda kuma ana yada su ga mutane ta hanyar ƙwayoyin cuta marasa yaduwa.
Tunda cutar SARS-CoV tana faruwa ne ta hanyar hulɗa tsakanin mutane da ƙwayoyin cuta a kasuwa, rufe wuraren sayar da kayan ɗanyen kaya da kashe ƙwayoyin cuta zai taimaka wajen dakatar da yaduwar SARS.
Hakanan, ya kamata a cire pangolins daga kasuwar kayan lambu don hana yaduwar cututtukan da ke tattare da dabbobi zuwa mutane, tare da nufin gano wasu nau'ikan pangolin beta-CoVs waɗanda ke da tsayayya da SARS-CoV-2.
Koyaya, ko SARS-CoV-2 yana yaduwa daga pangolins zuwa mutane da sauran dabbobi masu kama da mutane da kuma yadda yake yaduwa zai kasance a cikin binciken da ke zuwa.
A gefe guda, MERS-CoV ya kasance a cikin raƙuma na dogon lokaci.
Rakuma suna da amfani sosai wajen yin tafiya kuma suna kawo nama da madara da fata da kuma gashi ga mutane.
Ana yawan samun su a Gabas ta Tsakiya da Afirka.
Yanzu yana da matukar wahala a kashe raƙuma gaba ɗaya saboda rigakafin MERS, wanda aka yi a kasuwar dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana barkewar cutar MERS, dole ne a samar da maganin rigakafin cutar don samar da allurar rigakafin MERS-CoV mai kama da raƙumi, tare da wasu hanyoyin rigakafi.
Da yake ba za mu iya kawar da ƙwayoyin cuta ba, za su iya fitowa daga wasu ƙwayoyin cuta.
Wasu nau'ikan CoV da ke yada cututtuka daga dabbobi zuwa mutane sun bazu a cikin daji.
Musamman, CoV mai saurin yaduwa yana da damar watsa cututtuka daga beraye zuwa mutane ta hanyoyi da yawa.
Akwai yiwuwar cewa CoVs da ke yada cututtuka daga dabbobi zuwa mutane ba su haɗu ba saboda fitowar sabon CoV mai saurin yaduwa da / ko daga mutane.
Dole ne a dakatar da cin namun daji a wasu yankuna na kasar Sin don rage hulɗar da ba dole ba tsakanin mutane da dabbobi.
A yayin da muke fuskantar cutar SARS, MERS da COVID-19, ya kamata a sami shirye-shirye da shirye-shiryen magance su.
Hakika, ƙwayoyin cuta sun daɗe suna rayuwa a duniya.
Suna zama a inda suke har sai sun sami zarafi su ƙaura.
Ko da yake ƙudaje suna da ayyuka masu yawa da suke sa su iya yaɗa ƙwayoyin cuta, za a iya rage haɗarin haɗuwa da ƙudaje da sauran dabbobi idan aka gaya wa mutane su guji kusantarsu.
Ana buƙatar ci gaba da bincike a cikin kwayoyin halittar mutum don ƙarin fahimtar yanayin CoVs da kuma yanayin halittu na halitta wanda zai zama da amfani wajen hana yaduwar cututtuka daga dabba zuwa mutum da kuma cutar a nan gaba.
A ƙarshe, hanya mafi kyau ta hana ƙwayoyin cuta daga dabbobi zuwa mutane ita ce ta hana mutane daga wuraren da ƙwayoyin cuta ke watsawa daga dabbobi zuwa mutane.
Har yanzu ba a san asalin SARS-CoV-2 ba daga dabbobi zuwa mutane.
Da farko, idan kwari suna yada kwayar cutar SARS-CoV-2 a cikin pangolin, yana da kyau a bincika yanayin da kwari da pangolin ke raba su a cikin yanayin su.
Na biyu, idan ƙwari na taka rawa wajen yada cututtuka kai tsaye tsakanin mutane, to, ya kamata a yi la'akari da yadda mutane ke hulɗa da ƙwari.
Na uku, idan an ga cewa dabba mai kama da mutum tana aiki ne a matsayin mai kula da ƙwayoyin cuta, to, ya kamata a bayyana yadda ya bambanta da sauran halittu, ciki har da mutane, bats da pangolins.
A ƙarshe, saboda yawancin dabbobin gida da suka haɗa da dabbobin gida suna iya kamuwa da SARS-CoV-2, ana buƙatar yin bincike da gwaji don cutar.
Idan kwari ne, pangolin ko wani dabba mai kama da mutum, ana sa ran cewa SARS-CoV-2 ko wasu ƙwayoyin cuta masu kama da juna za a gano su a cikin yanayin da ke tattare da cutar.
Ƙarin bincike a kan wannan batun zai bayyana yanayin SARS-CoV-2 a cikin dabbobi, gami da sakamako mai mahimmanci a cikin rigakafin COVID-19 a cikin mutane.
Ana buƙatar daidaita tushen tabbatar da mai haƙuri wanda ake zargi da wanda aka tabbatar  don samun COVID-19
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta fitar da jagororin gaggawa don ganowa da kuma kula da mutanen da ke da cutar coronavirus ta 2019 (2019-nCoV), wanda ke nuna ƙwarewarmu da kuma yadda za mu magance cutar a duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, wanda iliminmu game da ita yana ƙaruwa bisa ga binciken da ake ci gaba da yi da kuma hanyoyin da ake kira magani; saboda haka, bincike da hanyoyin magani suna ci gaba da canzawa.
A cikin wannan wasikar, mun amsa tambaya guda game da manufofinmu kuma mun ba da sababbin ka'idoji don yanke shawara ƙididdigar  da  tabbatarwa  bisa ga sababbin ka'idoji na Ganowa da Kula da COVID-19 (fassarar ta bakwai)) da Kwamitin Kiwon Lafiyar Jama'ar Sin ya bayar.
A watan Disamba na 2019, sabon coronavirus na 2019 (2019-nCoV) ya haifar da cutar, yanzu ana kiranta da cutar coronavirus ta 2019 (COVID-19) kuma an sake ta da cutar ta coronavirus mai saurin numfashi 2 (SARS-CoV-2).
A ranar 11 ga watan Agusta 2020, WHO ta ayyana COVID-19 a matsayin matsalar kiwon lafiya ta duniya.
Don magance SARS-CoV-2, ƙungiyarmu ta haɓaka takaddun gaggawa waɗanda aka buga akan layi a cikin Binciken Likita na Soja a ranar 06 ga Fabrairu 2020.
An yi amfani da su sosai tun lokacin da aka wallafa su.
Ya kamata a lura cewa COVID-19 sabuwar cuta ce, kuma iliminmu game da ita yana ƙaruwa bisa ga binciken da ake ci gaba da yi da kuma hanyoyin da ake bi don magance ta; saboda haka, ana iya daidaita bincike da hanyoyin magani.
Sakamakon Bincike da Kula da COVID-19 wanda Kwamitin Kiwon Lafiya na Jama'ar Sin (http://www.nhc.gov.cn/) ya gudanar tsakanin 16 ga Janairu, 2020 zuwa 3 ga Agusta, 2020, ya fitar da rahotanni bakwai na wasu lokuta masu tsanani.
Zhou da abokan aikinsa sun ba da shawarar tsarin bincike mai sauƙi bisa ga binciken asibiti.
Aikin da suka yi ya ƙarfafa bangaskiyarmu kuma ya sa muka san cewa wannan matsalar ta shafi dukan duniya.
Muna yaba musu don aikinsu mai kyau.
Koyaya, aikin su yana buƙatar sabuntawa dangane da sababbin Ka'idojin Ganowa da Kula da COVID-19 (Sakamakon 7th) da sababbin bincike.
A cewar fitowar ta bakwai (3 ga Maris 2020), tabbatar da mai haƙuri mai haƙuri yana buƙatar haɗuwa da ɗaya daga cikin ƙa'idodin tarihin asibiti da ƙididdigar asibiti guda biyu don yanke shawara, ko kuma yana buƙatar cika ƙa'idodin asibiti guda uku idan babu tarihin asibiti mai kyau:
Tarihin kamuwa da cutar: (1) ya kasance a cikin Wuhan da kewayenta, ko kuma ya kasance a cikin wani yanki da aka gano wani mai cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar alamun cutar; (2) ya kasance a cikin kusanci da mutane masu cutar SARS-CoV-2 (a cikin gwajin kwayar nucleic acid mai kyau); (3) ya kasance a cikin kusanci da masu fama da zazzabin cizon sauro ko masu fama da cutar ta COVID-19 daga Wuhan da kewayenta, ko kuma wasu yankuna da aka gano cutar a cikin kwanaki 14 da suka gabata kafin bayyanar alamun cutar; (4) ya kasance a cikin kusanci da masu cutar da aka tabbatar (ƙananan marasa lafiya 2 da zazzabi da / ko a cikin makonni 2 a cikin wuraren da ba a san su ba, kamar gida, makaranta, ƙungiyoyi, ko cibiyoyi).
Alamun asibiti: (1) zazzabi da / ko wahalar numfashi; (2) alamun cutar COVID-19; (3) ƙarancin ƙwayoyin jini na farko ko ƙarancin ƙwayoyin lymphocyte.
Tabbatar da cutar ya kamata a yi shi ne a kan mai haƙuri mai cutar ko kuma gwajin ruwan jiki kamar yadda aka nuna a ƙasa: (1) lokacin da gwajin PCR na yau da kullun ya nuna tabbataccen cutar SARS-CoV-2; (2) lokacin da jerin kwayoyin halittar kwayar cutar suka nuna kamanceceniya da sabon coronavirus; (3) lokacin da gwajin ruwan jikin ya nuna cewa mutum yana da maganin IgM da IgG na kansa da ke hana SARS-CoV-2; ko kuma canjin maganin antibody na SARS-CoV-2 daga mara kyau zuwa tabbatacce, ko kuma titer ya tashi sau ≥4 a lokacin murmurewa fiye da na lokacin cutar.
Mun lura cewa an ƙara gwajin PCR na atomatik don gano nucleic acid a cikin jini ko jini a cikin fitowar ta biyu (18 ga Janairu 2020) da ta uku (22 ga Janairu 2020).
An ƙara binciken jini a fitowar ta huɗu (27 ga Janairu 2020) da ta biyar (8 ga Fabrairu 2020); kuma an ƙara tabbacin gwajin ruwa a fitowar ta bakwai.
Wannan canjin ya dogara ne akan ƙoƙarin masu bincike don gano wani abu wanda zai iya tabbatar da ingancin nucleic acid don saurin gwaji, da kuma samfurin daga tarin jini, wanda ya kara yawan gwajin da ake samu, kuma ya ba da damar samun kwayoyin cutar da kansu a matsayin tushen tabbatar da cutar.
Ƙari ga haka, akwai ƙarin tabbaci da ke tuna mana mu mai da hankali ga marasa lafiya da ba su da alamun cutar.
Don haka, allon Zhou da abokan aikinsa ya cancanci sake fasalin, saboda ya nuna mutumin da ba shi da alamun cutar a matsayin  low risk.
Wannan tsarin gwajin (tsarin ƙimar) yana buƙatar tabbatarwa a wasu asibitoci da kuma wasu bincike.
A taƙaice, muna fatan cewa za a sami ƙarin tabbaci kuma muna gayyatar masu karatu su yi magana game da su.
Da sanin abin da aka yi hasashensa kuma aka tabbatar da shi, mun yanke shawarar yadda za mu bi da kuma bi da dokokin da aka kafa na al'ummanku.
Ƙungiyarmu za ta sabunta abubuwan da muke bi don taimaka muku.
Bangladesh ta ba da rahoton wasu mutane biyar da suka mutu daga COVID-19, mafi yawan mutuwar yau da kullun
Jiya, Bangladesh ta tabbatar da cewa wasu mutane biyar sun mutu daga COVID-19 a ranar.
Wannan shi ne adadin mafi girma a cikin rana guda da cutar ta kashe.
A jiya, Cibiyar Kula da Cututtuka ta Bangladesh (IEDCR) ta yi rajistar mutane 114 da suka warke kuma 33 a gida.
Mutane 17 ne suka mutu.
A cikin wata sanarwa da aka fitar a shafin yanar gizo, jami'in IEDCR, Dr Meerjady Sabrina Flora, ya ce wadanda suka mutu sun hada da maza hudu da mace daya.
A cewar Dr Meerjady, biyu daga cikin wadanda suka mutu sun haura shekaru 60, biyu suna tsakanin shekaru 51 zuwa 60, ɗayan kuma yana tsakanin shekaru 41 zuwa 50.
Ya kuma ce biyu daga cikin mutanen daga Dhaka ne.
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na Anadolu Agency cewa, daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, jami'in hukumar yaki da cin hanci da rashawa ta Bengal, wanda ake kula da shi a asibitin Kuwait Maitree.
A ranar Asabar, Ministan Sufuri na Bangladesh Obaidul Quader ya sanar a cikin wani sanarwar bidiyo cewa za a dakatar da duk zirga-zirgar jiragen sama na tsawon lokaci fiye da yadda aka tsara, har zuwa Asabar mai zuwa.
An fara dakatar da zirga-zirgar jiragen sama a ranar 26 ga Maris kuma an shirya za a kawo karshen a ranar 4 ga Afrilu.
Ana ba da izinin sufuri na kayayyaki masu muhimmanci - magani, mai da abinci.
An gano mutane biyu da suka kamu da cutar COVID-19 a Bangladesh a ranar 8 ga watan Maris, wadanda suka dawo daga Italiya da matar daya daga cikin mutanen.
A ranar 19 ga Maris, dukan ukun sun warke.
SARS-CoV-2 ya yi sanadiyar kamuwa da mutane miliyan daya a duniya
A ranar Alhamis, adadin masu kamuwa da cutar coronavirus ta SARS-CoV-2 ya zarce miliyan daya a duk duniya kamar yadda aka nuna a cikin wani rahoto daga Jami'ar Johns Hopkins.
Akalla mutane dubu 52 aka ce sun mutu sakamakon COVID-19, cutar da ke haifar da coronavirus.
An cimma wannan a ranar da Malawi ta tabbatar da cutar ta farko kuma a lokaci guda Zambia ta sami mutuwar mutum daya daga coronavirus.
A ranar Alhamis, Koriya ta Arewa ta ce tana cikin ƙasashen da ba su da cutar coronavirus.
A ranar Laraba ne Hukumar Lafiya ta Duniya ta ba da rahoton sabbin kamuwa da cutar 1,051,635 da suka hada da kamuwa da cutar 79,332 a cikin sa'o'i 24 da suka gabata da karfe 4 na safe, a lokacin Turai ta Tsakiya (0800 UTC) a ranar 4 ga Afrilu.
A Amirka, an samu mutane fiye da 244,000 da suka kamu da cutar kuma aƙalla 5,900 sun mutu.
CBS News ta ambaci Jami'ar Johns Hopkins da cewa, a Amurka akwai mutane sama da 1,000 da suka mutu a ranar Laraba sakamakon cutar coronavirus.
A dukan duniya, ƙasashe sun yi shelar cewa za a ɗauki matakai don hana yaduwar cututtuka.
A ranar Alhamis, magajin garin Moscow Sergei Sobyanin, ya tsawaita dokar hana fita ta birnin har zuwa ranar 1 ga Mayu.
A duk fadin kasar, Shugaba Vladimir Putin ya sanar da cewa za a biya 'yan Rasha duk da cewa ba za su dawo bakin aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar kara wa'adin kwanaki 15 na zaman majalisar; mafi yawan mutane 215 sun goyi bayanta, 10 sun ki amincewa da shi kuma daya bai goyi bayansa ba.
Saudiyya ta tsawaita lokacin shan kofi a biranen alfarma na Makka da Madina zuwa rana ɗaya; a baya, ana shan kofi daga karfe 9 na yamma zuwa 12 na safe.
Thailand ta shirya kofi tsakanin karfe 4 na dare da karfe 10 na dare.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa ranar 1 ga Mayu.
Kasuwancin Australiya suna da iyaka kan yawan kayan da mutum zai iya saya a lokaci ɗaya
A ranar Lahadi da Asabar da yamma, manyan kantunan sayar da kayayyaki na Woolworths da Coles na Australiya da ke fadin kasar suna sanya iyakar sayen kayan kwalliya a kan mutum ya sayi guda biyu ko kuma kowanne daga cikin shagunan biyu.
ALDI kuma ta kafa iyaka ga wata 'yar'uwa a ranar Litinin.
An nuna wannan haramcin a matsayin saƙo ga jama'a a kan shafukan Facebook na kamfanonin.
An umarci masu sayayya da su kasance cikin shiri saboda tsoron COVID-19 yayin da mutane ke buƙatar keɓewa.
A ranar Laraba, Woolworths ta rage yawan kayan da ake sayarwa da kuma aikawa gida a matsayin guda a rana.
Waɗannan canje-canjen sun biyo bayan ƙuntatawa na farko na farashin kaya na farko da Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris a cikin kamfanonin biyu a cikin jerin.
A cikin wasiƙar Coles ta 8 ga Maris, ya bayyana cewa an dakatar da haramcin, "shaguna da yawa sun ƙare a cikin awa ɗaya bayan kawo su", kuma ya ce bukatar ba ta taɓa faruwa ba, yayin da ALDI, wanda ya rubuta a Facebook a ranar Talata ya ce "ba zato ba tsammani".
Sayarwa ta "yi tashin gwauron zabi" a makon da ya gabata a cewar wani mai magana da yawun Woolworths.
Wani babban kanti na Costco a Canberra ya kuma sanya iyaka kan farashin da aka yarda da shi a kan wasu kayan kwalliya biyu a makon da ya gabata.
Don rage ƙarancin, Coles ya ba da ƙarin aiki kuma ya ƙara yawan aiki, Woolworths ya ba da ƙarin aiki, kuma ALDI ta kawo ƙarin kamar yadda aka shirya a ranar Laraba ta musamman.
Russell Zimmerman, shugaban kungiyar masu sayar da kayayyaki ta Australiya, ya ce masu sayar da kayayyaki suna kokarin kara yawan kayayyakin da suke sayar da su amma takunkumin da hukumomi suka sanya kan yawan motocin da ke kawo su ya kawo matsala.
Yana sa ran samun ƙarin kuɗi, yayin da ma'aikata suke ƙoƙarin biyan bukatun da ake da su kuma suna da kwanakin hutu kaɗan.
A ranar Talata, ALDI ta sanar da cewa bayan fitar da kayan da aka saita don sayarwa da sauri, wasu shagunan ba za su iya yin wani abu daban ba a ranar Laraba.
A wani rahoto da News.com.au ta bayar, Dokta Gary Mortimer, masanin sayar da kayan gargajiya daga Jami'ar Fasaha ta Queensland, ya ce kasuwanni suna kawo sayarwa a kowane dare.
Ya ce, ƙwai suna da girma sosai, kuma hakan yana sa a rage yawan kayayyakin da ake sayarwa, har sa'ad da aka sayar da su, sai su zama da yawa kuma su zama kamar sun ƙare.
Russell Zimmerman ya rubuta a ABC News cewa "Coles da Woolworths sun yi tunanin cewa idan aka samu kayayyaki da yawa, kamar su kayan wanki da kuma wanke hannu, za a iya rage yawan kayan da ake amfani da su".
Wani mai aikin kwalliya da ke kiwon tumaki ya ce a ranar Laraba, ba a sami kwalliya ba.
Kimberly-Clark, mai kera takarda, da Solaris Paper mai kera Sorbent, sun tabbatar da cewa suna aiki 24/7 don ci gaba da biyan bukatun, a cewar rahoton News.com.au.
Shafin yanar gizo na Domain.com, wanda ke sayar da ƙasa da ƙasa ya ba da rahoton cewa akwai masu siyarwa da ke ba da kayan kwalliya kyauta ga wanda ya ci hammer a Melbourne, tare da ƙananan tallace-tallace saboda masu siye sun sami hutu a ƙarshen mako mai tsawo wanda ya haɗa da Ranar Ma'aikata.
A cikin wata sanarwa a ranar Alhamis a NT News, wata jarida ta yau da kullum a Darwin, an nuna wani littafi mai layi takwas da za a cire don amfani da shi a matsayin kayan aiki.
Da farko, shagunan sun ƙi ƙuntatawa, a cewar rahoton ABC Australia a ranar 3 ga Maris inda suka ce ba su da niyyar ƙuntatawa.
Russell Zimmerman ya daɗa cewa kayayyaki da aka sayar a kasuwa sun haɗa da abin rufe fuska, kayan wanke hannu, abinci mai ƙanshi, sabulu da kuma man shanu.
Hakazalika, a waje da Ostiraliya, a ranar Lahadi da yamma an ga kantin sayar da kayan kwalliya na Ocado yana hana sayen kayan kwalliyar Andres ta hanyar sayen tsakanin 2 da 12 na 'yan uwa.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin cutar ta duniya
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19  cutar da kwayar cutar coronavirus SARS-CoV-2  ta haifar a matsayin bala'in duniya.
Duk da cewa kalmar "matsanancin duniya" tana nufin yadda cutar ta yadu, ba yadda wasu cututtukan ke da haɗari ba, WHO ta ba da shawarar cewa gwamnatoci su ɗauki mataki:
"Dukan ƙasashe za su iya canja yadda wannan matsalar ta duniya take yaduwa.
Idan ƙasashe suka yi hankali, bincika, bi da, rarrabewa, sa ido da kuma tattara mutane kan wannan batun", in ji Babban Jami'in WHO, Tedros Adhanom Ghebreyesus.
"Muna matukar damuwa da yadda cutar ke yaduwa da kuma yadda take da hatsari da kuma rashin kulawa".
A cewar Dokta Tom Frieden, tsohon darektan Cibiyar Kula da Cututtuka ta Amurka (CDC), cutar "ba zato ba tsammani".
Ya ce, a cikin wata sanarwa da aka buga a CNN a watan Fabrairu, "sai dai wannan, babu wani kwayar cutar da ta shafi hanyar numfashi da aka gano tun lokacin da ta bulla har zuwa yanzu".
Ghebreyesus ya ba da irin wannan ra'ayi, yana cewa "ba mu taɓa ganin annobar coronavirus a duniya ba".
Ya daɗa cewa: "Ba mu ga cewa matsalar ta shafi dukan duniya ba".
Sabuwar matakin matsalar ta duniya ya zo ne bayan Hukumar Lafiya ta Duniya ta yanke shawarar a watan Janairu ta ayyana barkewar cutar a matsayin babbar matsalar lafiyar jama'a ta duniya.
Shugaban Cibiyar Kula da Cututtuka da Cututtuka ta Amurka, Dr. Anthony Fauci, ya ce wannan fashewar "ba za ta yiwu ba".
A ranar Alhamis, Associated Press ta ba da rahoton cewa akwai aƙalla mutane 126,000 da ke fama da COVID-19 a duk duniya, daga cikinsu 4,600 sun mutu.
Cutar annobar coronavirus ta 2019/20 ta duniya cuta ce mai yaduwa ta cutar 2019 (COVID-19), wacce kwayar cutar ta kamu da cutar coronavirus mai saurin numfashi mai saurin kamuwa da cutar 2 (SARS-CoV-2).
An gano cutar a Wuhan, China, a watan Disamba na 2019, kuma an ayyana ta a matsayin matsalar rashin lafiyar jama'a a ranar 30 ga Janairu, 2020, sannan a matsayin gaggawa ta duniya a ranar 11 ga Agusta, 2020.
A ranar 10 ga Afrilu 2020, an bayar da rahoton kusan mutane miliyan 1.61 da suka kamu da COVID-19 a cikin ƙasashe 210 da yankuna kuma kusan mutane 97,000 sun mutu.
Mutane 364,000 ne suka tsira.
An kiyasta yawan mutuwar a kasar Sin ya kai kashi 4%, yayin da a duniya ya kai kashi 13.04% a Algeria da .08% a New Zealand.
Alamun da ake gani a fili su ne zazzabi, tari, da kuma numfashi.
Matsalolin cutar na iya haɗawa da ciwon huhu da kuma ciwon numfashi mai tsanani.
Lokaci daga kamuwa da cutar zuwa bayyanar cututtuka shine kimanin kwanaki biyar amma yana iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Babu wani maganin rigakafi ko magani da aka sani don cutar.
Maganin farko yana magance alamun cutar da kuma taimakawa da ƙananan taimako. Shawarwarin da aka ba da shawarar don hana cutar sun haɗa da wanke hannu, rufe baki lokacin da kake bayyana, nisanta kanka daga wasu, saka idanu da kuma ware kanka idan kana da wata shakka game da cutar.
Hukumomi a duk faɗin duniya sun amsa ta hanyar sanya takunkumin tafiya, keɓewa, kafe, kiyaye aiki da rufe wasu wurare.
Wannan ya haifar da rashin daidaituwa a cikin tattalin arziki da zamantakewar duniya, yana haɓaka ko dakatar da wasanni, bukukuwan addini, siyasa da al'adu, da kuma haifar da ƙarancin kayayyaki da ke haifar da yawan cin kasuwa.
An rufe makarantu da jami'o'i a ƙasashe ko yankuna a ƙasashe 193, wanda ya shafi kusan kashi 99.4 na ɗalibai a duniya.
Labaran karya game da cutar sun bazu a kan intanet kuma an sami wasu lokuta na ƙiyayya da nuna bambanci ga Sinawa, wasu mutanen da ke fitowa daga Gabas da kudu maso gabashin Asiya ko kuma masu launin fata daga yankunan da cutar ta fi yaduwa.
Saboda rufe hanyoyin sufuri da manyan masana'antu, an rage gurɓataccen yanayi da fitar da iskar carbon.
Ma'aikatar lafiya a Wuhan, China (babban birnin lardin Hubei) ta ba da rahoton cewa akwai wasu ƙananan mutane da ba a san su ba tun daga ranar 31 ga Disamba, 2019, kuma an fara binciken a farkon Janairu, 2020.
An gano masu cutar a cikin alaƙar abincin teku a Huanan (Kasuwancin Kasuwancin Abinci na teku) kuma ana tsammanin cutar ta samo asali ne daga dabbobi zuwa mutane.
Kwayar cutar da ke haifar da cutar ta SARS-CoV-2, sabuwar kwayar cuta ce da aka gano wacce take kama da coronaviruses na bat, pangolin coronaviruses, da SARS-CoV. An gano mutum na farko da ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma ba a gano cewa yana da alaƙa da kasuwar kayan lambu ba.
Daga cikin marasa lafiya da aka fara bayar da rahoto a watan Disamba na 2019, kashi biyu bisa uku na su sun kamu da cutar.
A ranar 13 ga watan Agusta, 2020, wani rahoto da ba a bayyana shi ba daga jaridar South China Morning Post ya ba da rahoton cewa mai yiwuwa mutum 55 ne ya kamu da cutar a ranar 17 ga Nuwamba, 2019, daga lardin Hubei. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa yayin da sabbin cututtukan suka ragu a China amma suka karu da sauri a Italiya, Iran, da Koriya ta Kudu, yawan sabbin cututtukan da ke wajen China ya fi na farko a cikin kasar Sin.
Wataƙila ba a ba da cikakken adadin masu cutar ba musamman waɗanda ke da alamun rashin lafiya.
A ranar 26 ga watan Fabrairu, an samu rahotanni kaɗan na kamuwa da cutar a cikin matasa masu shekaru 19 zuwa ƙasa da kashi 2.4% na kamuwa da cutar a duniya.Babban mai ba da shawara kan kimiyya a Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya na iya kamuwa da cutar kafin a gano cutar a cikin jama'a.
Cutar ta shafi yawan mutanen da aka gwada su don COVID-19, kuma gwajin ya nuna tabbatacce ga cutar bisa ga bayanan hukuma.
A ranar 23 ga Maris, babu wata ƙasa da ta sami kashi 3 cikin ɗari na yawanta, kuma ƙasashe da yawa ba su gwada waɗanda ke da alamun rashin lafiya ba, kamar Italiya, Netherlands, Spain, da Switzerland.
Binciken da aka fitar a ranar 16 ga watan Maris ya nuna cewa a kasar Sin, har zuwa ranar 23 ga watan Janairu, kusan kashi 86 cikin dari na marasa lafiya ba a yi musu allurar rigakafi ba, kuma kashi 79 cikin dari na marasa lafiya da ba a yi musu allurar rigakafi ba ne ke yin allurar rigakafi.
Wani bincike da aka fitar a ranar 30 ga Maris ya nuna cewa adadin masu cutar a Italiya ya fi yadda aka yi hasashen.
Hasashen farko na ƙididdigar ƙwayoyin cuta na farko (R0) na COVID-19 ya kasance 1.4 zuwa 2.4.
Cibiyar Kula da Cututtuka da Cututtuka ta Amirka ta ce adadin zai iya zama 5.7.
Yawancin mutanen da ke fama da COVID-19 suna warkewa.
Ga waɗanda ba su warke ba, lokaci daga bayyanar cututtuka zuwa mutuwa yana tsakanin kwanaki 6 zuwa 41 amma mafi yawan mutane 14 ne.
A ranar 10 ga Afrilu 2020, an bayar da rahoton mutuwar mutane 97,000 daga COVID-19.
A China, kusan kashi 80% na mutanen da suka mutu a ranar 5 ga Fabrairu sun kasance sama da shekaru 60, kuma kashi 75% suna da wasu cututtuka na yau da kullun, gami da cututtukan zuciya da ciwon sukari.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma saboda ba za a iya samun mutuwar da ba a gwada su ba - a gida, a gidajen kula da tsofaffi, da sauransu.
Rahotanni na yanki daga Italiya sun gano cewa yawan mutuwar a lokacin kamuwa da cutar ya ninka na COVID da aka bayar sau 4-5.
Wata mai magana da yawun Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta yarda cewa "Mun san cewa [ƙididdigar mutuwar] ba daidai ba ne", kuma mun tabbatar da hakan ta hanyar ba da shawara ga jama'a a Amurka.
Mutum na farko da ya mutu a wajen kasar Sin ya mutu a ranar 1 ga watan Fabrairu a kasar Philippines, kuma na farko da ya mutu a wajen Asiya ya mutu a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, a waje da kasar Sin, mutane fiye da 12 ne suka mutu a kowace daga cikin wadannan kasashe, Iran, Koriya ta Kudu, da Italiya.
A ranar 13 ga watan Maris, kasashe da yankuna sama da arba'in sun ba da rahoton mutuwar kusan kowace nahiya sai Antarctica.
Wadannan ƙididdiga suna canzawa daga yanki zuwa yanki da kuma lokaci daban-daban kuma sun bambanta dangane da yawan gwaje-gwaje, ingancin magani, magani da ake samu, tsawon lokacin da cutar ta fara, da yanayin al'umma kamar shekaru, jinsi, da lafiyar gaba ɗaya.
Dangane da ƙididdigar Jami'ar Johns Hopkins, yawan mutuwar da aka samu ya kai kashi 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu 2020.
Adadin yana dabam dabam daga yanki zuwa yanki.
A China, yawan mace-macen da aka kiyasta ya ragu daga kashi 17.3% (a cikin wadanda suka fara nuna alamun cutar a ranar 1 ga Janairu, 2020) zuwa kashi 0.7% (a cikin wadanda suka fara nuna alamun cutar bayan ranar 1 ga Fabrairu, 2020).
Waɗannan ƙididdigar ba su da iyaka kuma suna bin wasu mutane daga lokacin da suka kamu da cutar har zuwa lokacin da aka yi wa mai haƙuri magani.
Masu bincike da yawa sun yi ƙoƙari su ƙididdige yawan mutanen da suka mutu.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta yawan kamuwa da cutar ta farko tsakanin kashi 0.1% zuwa 0.39%.
Wannan ƙididdigar da aka yi a cikin wannan ƙimar ta tabbatar da sakamakon gwajin farko na COVID-19 a Jamus, kuma ƙididdigar binciken gwajin gwaji yana ba da hasashen mutuwar.
WHO ta yi hasashen cewa za a iya hana wannan matsalar ta duniya.
Ba a san lokacin da cutar ta fara ba kuma tsawon lokacin da za ta iya wucewa kuma zai iya bambanta daga wuri zuwa wuri.
Maciej Boni na Jami'ar Jihar Penn ya ce: "Idan ba a hana cutar ba, za ta iya ci gaba da ƙaruwa.
Amma ba zai yiwu a yi annabci a yanzu ba game da lokacin da hakan zai faru".
Babban mai ba da shawara ga gwamnatin kasar Sin Zhong Nanshan ya ce "za a iya kawar da cutar a karshen Asabar" idan aka karfafawa dukkan kasashen duniya gwiwa su bi shawarwarin WHO don dakile yaduwar cutar.
A ranar 17 ga watan Maris, Adam Kucharski na Makarantar Kiwon Lafiya da Magungunan Yanayi ta London ya ce SARS-CoV-2 "za ta iya zama mai yaduwa, mai yiwuwa na shekara ɗaya ko biyu".
Bisa ga wani bincike da kwalejin Imperial ta yi da Neil Ferguson ya yi, za a bukaci a yi jinkiri da kuma wasu abubuwa "har sai an samu maganin (wataƙila watanni 18 ko fiye)".
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina tsammanin cewa cutar coronavirus za ta iya zama cuta ta wucin gadi ta hanyar sake dawowa a kowace shekara".
Halin da zai kasance a lokacin da ya dawo zai dangana ne a kan yanayin da ya fito da shi.
Alamun COVID-19 na iya zama masu rikitarwa kuma masu cutar ba za su iya nuna alamun cutar ba.
Alamomin biyu da aka fi sani da su sune zazzabi (88%) da bushewar kirji (68%).
Alamomin da ba safai ba sun haɗa da ƙishirwa, yawan haushi, rashin jin ƙamshi, rashin barci, ciwon tsoka, ciwon makogwaro, ciwon kai, jin ƙishirwa, tari, zubar jini, gudu, ko kuma cyanosis.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun bayyana alamun gaggawa kamar numfashi mai zafi, ciwon kirji mai tsanani, jin zafi, wahalar tafiya, da kuma fuska ko baki; ana buƙatar gaggawa don kula da gaggawa idan waɗannan alamun sun bayyana.
Wasu marasa lafiya ba za su iya nuna alamun cutar ba, amma idan an tabbatar da cutar, masu bincike sun ba da shawarar cewa waɗanda suka taɓa saduwa da waɗanda aka tabbatar da cutar su kula da su sosai don tabbatar da cewa ba su da cutar.
Gwamnatin kasar Sin ta kiyasta yawan alamun cutar a tsakanin matasa da kashi 44 cikin dari.
Lokacin bayyanar cututtuka (lokacin da mutum ya kamu da cutar zuwa bayyanar cututtuka) yawanci daga kwana ɗaya zuwa 14; yawanci kwanaki biyar ne. A cikin misali mai ban mamaki, ƙididdigar yawan mutanen da ke fama da COVID-19 da ba za su iya yin allurar rigakafi ba ya fara daga 30% zuwa ƙasa zuwa 15%.
Ba a san yadda cututtuka suke yaduwa ba tukuna.
Ana zaton ana yada cutar ne ta hanyar tuntuɓar mutane da kuma taɓawa da ƙwayoyin cuta da ke yaduwa ta hanyar tari, hancin mutum ko magana; kuma ana iya samun kamuwa da cutar tsakanin mita 1 zuwa 2.
Bincike ya nuna cewa yin tari ba tare da rufe baki ba yana sa ruwa ya yi tsayi daga mita 4.5 zuwa 8.2.
Wasu sun ce ana iya yaduwar kwayar ta hanyar iska mai tsawo, wadda za a iya fitarwa ta hanyar magana.
Ana iya samun ƙwayoyin cuta a cikin baki ko hanci ko kuma a cikin huhu.
Wasu hanyoyin magani kamar su tiyata da kuma CPR suna iya sa jijiyoyin jiki su fita daga cikin jiki kuma hakan yana sa cutar ta yadu ta iska.
Ana kuma iya yaduwa ta wurin taɓa wani abu da ke ɗauke da cutar ko kuma ta wurin taɓa fuska ko baki.
Hakika, akwai tsoron cewa cutar za ta iya yaɗuwa cikin mugunta, ana ganin ƙiyayya ba ta da yawa.
Gwamnatin kasar Sin ta musanta yiwuwar yaduwar SARS-CoV-2. Kwayar cutar tana yaduwa a cikin kwanaki uku na farko na bayyanar cututtuka, kodayake ana iya samun yaduwa kafin bayyanar cututtuka da kuma a ƙarshen lokacin kamuwa da cutar.
Ana gano mutane da cutar kwanaki uku kafin a nuna alamun cutar, wanda ke nuna yiwuwar yaduwar cutar ko da ba a nuna alamun cutar ba.
Rahotanni kaɗan ne game da wasu marasa lafiya da aka tabbatar ba tare da alamun cutar ba, amma an gano yaduwar cutar daga marasa alamun cutar a wasu ƙasashe don lura da hulɗar mutum da wasu mutane.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ba a san yadda cutar ke yaduwa ba, amma yawanci mutum ɗaya yana kamuwa da mutum biyu zuwa uku.
An gano cewa kwayar cutar ta kasance a kan filastik na kwana uku da kuma takardar 304 na digiri, kwana ɗaya a kan kwali da kuma sa'o'i hudu a kan takarda.
Koyaya, wannan ya bambanta dangane da yanayin iska da yanayin zafi. An kuma gwada dabbobin gida da dabbobin gida don COVID-19.
Babu wata shaida da ta nuna cewa dabbobi suna iya cutar da mutane, duk da cewa hukumomi a Birtaniya sun ba da shawarar cewa mutane su wanke hannayensu bayan sun taɓa dabbobi, kamar su abubuwan da wasu mutane suka taɓa.
Cutar coronavirus mai saurin kamuwa da cutar 2 (SARS-CoV-2) cuta ce da ba a gano ba, wanda aka fara ganowa a cikin mutane uku da ke fama da cutar rigakafin cutar da aka gano a Wuhan.
Dukkanin alamun cutar SARS-CoV-2 da ba a sani ba suna cikin kwayar cutar coronavirus mai kama da ruwan sama. A waje da jikin mutum ana kashe kwayar cutar ta sabulu na gida, sabulu yana kashe ƙwayoyin cuta na gida. SARS-CoV-2 yayi kama da kwayar SARS-CoV da aka gano da farko.
Ana ganin cewa ya fito ne daga dabbobi kuma ya shiga cikin mutane.
Binciken kwayoyin halitta ya nuna cewa coronavirus a cikin tsarin kwayoyin halitta yana kama da betacoronavirus, a cikin Sarbecovirus (layin B) da kuma nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
Yana da kusan kashi 96% na daidaituwa a cikin tsarin kwayoyin halitta tare da sauran ƙwayoyin cuta masu ƙarancin ƙwayoyin cuta a cikin samfurori (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai amino acid guda daya a wasu sassan tsarin kwayoyin halitta tsakanin kwayoyin halitta daga pangolins da kuma na mutum.
Zuwa yau, mafi girman kwatancen kwayoyin halitta ya gano cewa kashi 92% na kwayoyin halitta sun kasance tsakanin pangolin coronavirus da SARS-CoV-2, wanda bai tabbatar da pangolin ba a matsayin kwayar cuta mai saurin yaduwa.
Ana iya gano kamuwa da cutar ta hanyar alamun farko, amma ana tabbatar da ita ta hanyar jujjuyawar jujjuyawar polymerase chain reaction (rRT-PCR) a cikin ƙwayoyin da suka lalace ko ta hanyar CT.
Nazarin da aka yi a Wuhan wanda ya kwatanta PCR da CT ya nuna cewa amfani da CT ya fi tsaro fiye da PCR, kodayake ba shi da tabbaci, kuma yana haifar da ɓarnar hoto a cikin wasu cututtuka.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "a yi amfani da CT don tantancewa ko amfani dashi azaman gwaji na farko don gano COVID-19".
WHO ta fitar da ka'idojin gwajin RNA don SARS-CoV-2, wanda aka fara fitarwa a ranar 17 ga Janairu.
Gwajin yana amfani da ainihin lokacin juyawa na juyawa na polymerase (rRT-PCR).
Ana iya yin gwajin daga samfurin jini ko jini.
Ana ganin sakamako a cikin sa'o'i da yawa zuwa kwanaki.
Yawancin lokaci, ana yin gwajin ne akan swab na nasopharyngeal kodayake ana iya amfani da swab na hanji. Yawancin gwaje-gwaje da kamfanoni suna haɓaka gwajin jini don tantance ƙwayoyin cuta.
Har zuwa 6 ga Afrilu 2020, babu ɗayan waɗannan da aka tabbatar da inganci na kimiyya don tabbatar da amfani da su a ko'ina.
A Amurka an amince da gwajin jini wanda aka haɓaka ta Cellex don amfani da gaggawa a cikin gwaji kawai.
Alamun hoto a kan radiographs da CT na mutanen da ke da alamun sun hada da asymmetrical peripheral ground glass opacities da kuma rashin pleural effusions.
Ƙungiyar Radiology ta Italiya tana aiki don ƙirƙirar tarin hotuna na kan layi na mutane da aka tabbatar da cutar.
Saboda haɗuwa da wasu cututtuka kamar adenovirus, hotuna ba tare da tabbacin PCR ba zai iya tabbatar da tabbacin gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa yayin da hoton ba zai iya tabbatar da cutar ba, yana nuna cewa yana buƙatar kulawa kamar yadda ake amfani da shi don gano wuraren da cutar ta kamu.
An tsara hanyoyin sadarwar kwakwalwa na Artificial Intelligence-based convolutional neural networks don yin amfani da hotuna na hoto na hoto ta hanyar amfani da radiographs da CT.
Matakan hana yaduwar cutar sun hada da tsabtace jiki, wanke hannu, kauce wa taɓa fuska, hanci, ko lebe ba tare da wanke hannu ba, tari ko hancin da aka yi da zane ko takarda da kuma sanya shi kai tsaye a cikin shara.
An shawarci waɗanda ke da rashin lafiya su sanya abin rufe fuska idan sun fita daga gida.
Gwamnatoci da yawa sun hana ko kuma sun ba da shawarar cewa mutane su guji tafiya sai dai idan ba shi da kyau su je ko su bar wuraren da cutar ta shafa.
Maimakon haka, cutar ta kai ga yaduwar ta a cikin yankuna da yawa a duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'umma, kuma wasu mutane a cikin al'umma ba su san inda ko yadda cutar ta shafa ba. Ana ba da shawarar likitoci / likitocin da ke kula da mai cutar su kasance masu hankali, tuntuɓar mutum da hankali, da rufe fuska.
Amfani da gwamnati ta hanyar amfani da bayanan wurin mutum daga wayoyin salula don wannan dalili ya haifar da ƙalubalen sirri yayin da Amnesty International da wasu ƙungiyoyi sama da 100 suka ba da takardu don hana irin wannan sa ido.
An yi amfani da aikace-aikacen wayoyin hannu da yawa ko kuma an tsara su don amfani da su ta hanyar son rai, kuma tun daga 7 ga Afrilu 2020, sama da ƙungiyoyin fasaha 20 suna ba da shawara kan batutuwan sirri kamar amfani da Bluetooth don haɗa mai amfani da wayar zuwa wasu wayoyin hannu.
Masu amfani suna karɓar saƙonni idan sun kasance kusa da mutumin da aka gwada don COVID-19. ana samun saƙonni masu ɓatarwa a duk faɗin hanyoyin rigakafin cutar; misali, wanke hanci da ruwan baki amma ba duka bane.
Babu maganin rigakafin COVID-19, duk da cewa yawancin kamfanoni suna aiki tuƙuru don samar da shi.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa aƙalla na minti 20 a kowane lokaci, musamman bayan sun je bayan gida ko idan hannayensu suna da ƙazanta sosai; kafin cin abinci; da kuma bayan wani ya yi atishawa, tari ko hancinsa.
Wannan shi ne saboda a waje da jikin mutum, sabulu da ake amfani da shi a gida yana kashe ƙwayoyin cuta.
CDC ta ba da shawarar yin amfani da ruwa mai ƙarancin giya da kashi 60% na barasa idan sabulu da ruwa ba su samuwa.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa kada mutane su taɓa fuska, hanci, ko lebe da hannayensu ba tare da wankewa ba.
Ana iya kashe kwayoyin cuta ta hanyar amfani da ruwa mai tsabta (a cikin minti daya idan an yi shi da karfe kuma mai haƙuri ya taɓa shi), wanda ya ƙunshi 6271% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Wasu magungunan ruwa, kamar su benzalkonium chloride da chrohexidine gluconate, ba sa aiki sosai.
CDC ta ba da shawarar cewa idan an yi zargin ko tabbatar da cutar COVID a wani wuri kamar ofis ko cibiyar kula da yara, duk wuraren da aka yi amfani da su kamar ofisoshi, dakunan wanka, wuraren da ake amfani da su, kayan lantarki da aka raba kamar su kwamfutar hannu, allon taɓawa, tebur, limousine, da ATM da aka yi amfani da su a cikin wani wuri mai cutar, ya kamata a kashe su.
Hukumomin kiwon lafiya sun ba da shawarar rufe baki da hanci da hannu ko kuma tawul nan da nan.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda ke da rashin lafiya, domin saka abin rufe fuska zai iya hana mutum yin yawan hawaye yayin da yake magana, tari da tari.
WHO ta ba da umarni kan lokacin da kuma yadda za a yi amfani da allurar rigakafi.
A cewar Stephen Griffin, masanin ilimin halittu a Jami'ar Leeds, "Sanya abin rufe fuska zai iya rage yiwuwar kamuwa da cutar a fuska kuma ya fi zama tushen kamuwa da cuta fiye da wanke hannu.
WHO ta ba da shawarar cewa mutane masu lafiya su sanya abin rufe fuska a lokacin haɗari kamar kula da mai cutar COVID-19, duk da cewa sun yi imanin cewa sanya abin rufe fuska na iya taimakawa mutane su guji kamuwa da cutar.
Ƙasashe da yawa sun soma ƙarfafa mutane su riƙa saka abin rufe fuska.
A Amurka, CDC ta ba da shawarar mutane su sa abin rufe fuska na roba wanda ba na likita ba. China ta ba da shawarar yin amfani da abin rufe fuska na likita wanda za a iya amfani da shi sau ɗaya, musamman idan mutum zai kusanci mutane (mita 1 (ƙafa 3) ko ƙasa da haka).
A Hong Kong ana ba da shawarar yin amfani da abin rufe fuska a lokacin hawa mota ko kuma a wuraren da jama'a suke.
Ma'aikatan kiwon lafiya a Thailand sun ba da shawarar yin fitsari a gida da wankewa kowace rana.
Ƙasar Czech da Slovakia sun hana mutane fita daga gida idan ba su saka abin rufe fuska ba ko kuma idan ba su rufe hanci da baki ba.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa da kowa ya sanya abin rufe fuska a cikin jama'a don kare kansa da kuma kare wasu.
Gwamnatin Austriya ta ce dole ne a saka abin rufe fuska a cikin shaguna.
Isra'ila ta bukaci kowane dan kasa ya sanya abin rufe fuska a duk lokacin da yake cikin jama'a.
Taiwan, wacce ke kera abin rufe fuska miliyan 10 a kowace rana tun tsakiyar watan Maris, a ranar 1 ga Afrilu ta umarci fasinjoji a jiragen kasa da bas da ke tafiya cikin birane da su sanya abin rufe fuska.
Panama ta sanya wa kowa tilas ya sanya abin rufe fuska a gida, kuma a halin yanzu ana ƙarfafa mutane su yi abin rufe fuska a gida ga waɗanda ba za su iya ba.
An kuma yi amfani da mashin a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Nesa yana nufin kiyaye kamuwa da cuta ta hanyar rage kusanci da mutane.
Abubuwan da ake yi sun haɗa da keɓewa; ƙuntata zirga-zirga; da rufe makarantu, wuraren aiki, filayen wasa, wuraren shakatawa da shagunan.
Mutane suna iya kasancewa a gida, su rage yawan tafiya, su guji zama a inda mutane suke da yawa, su yi gaisuwa da kyau, kuma su yi watsi da mutane.
Gwamnatoci da yawa suna tilasta wa mutane su ware kansu daga wasu a wuraren da cutar ta bulla.
Matsakaicin adadin mutanen da hukumomin Amurka da hukumomin kiwon lafiya ke ba da shawarar ya ragu daga 250 (idan babu cutar COVID-19 a cikin al'umma) zuwa 50 da kuma 10 kawai.
A ranar 22 ga watan Agusta, 2020, Jamus ta soke taron mutane fiye da biyu. Manya da waɗanda ke da wasu cututtuka kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini da rashin aiki na jijiyoyin jiki suna cikin haɗari kuma CDC ta ba da shawarar su zauna a gida idan ya yiwu musamman a wuraren da cutar ta ɓarke. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara amfani da kalmomin "keɓewa" da "keɓewa" don sanar da cewa an yi niyyar rage hulɗa amma mutane sun bar hulɗa da juna ko kuma sun ware kansu.
Amfani da kalmar nan "keɓe kai" ya nuna cewa mutane suna bukatar su ware kansu daga juna, maimakon su ci gaba da sadarwa ta wasu hanyoyi.
Wannan ya haɗa da ƙarfafa su su yi jima'i da mutumin da suke zama tare da shi, wanda ba shi da cutar ko kuma wanda ba shi da alamun cutar.
Ana ba da shawarar keɓewa ga waɗanda aka gwada su da COVID-19 da waɗanda ake zargi da kamuwa da cutar.
Hukumomin kiwon lafiya sun ba da umarnin keɓewa. Gwamnatoci da yawa suna tilasta mutane ko kuma ba da shawarar keɓewa ga duk waɗanda ke cikin yankunan da cutar ta shafa.
An ba da umarnin keɓewa mafi tsauri a yankunan da ke da haɗari.
Ana ba da shawarar cewa waɗanda ke da alaƙa da wani mutum mai cutar COVID-19 da waɗanda suka yi tafiya zuwa ƙasashe ko yankuna da ke fama da cutar su keɓe kansu na kwanaki 14 daga lokacin da suka kasance a cikin alaƙar cutar.
Dabaru a farkon farawa sun haɗa da yaƙi da su ko hana su da hana su.
Ana yin rigakafin cutar a farkon lokacin barkewar cutar kuma yana nufin ganowa da keɓe waɗanda abin ya shafa da kuma samar da wasu matakan rigakafi da hana yaduwar cutar a cikin sauran al'umma.
Idan ba za a iya hana yaduwar cutar ba, to, za a mayar da hankali kan magance cutar: ana yin matakan rage yaduwar cutar da hana tasirin cutar a cikin al'umma da al'umma.
Za a iya amfani da makamai biyu a lokaci guda.
Rage yaduwar cutar yana buƙatar matakan da za a iya ɗauka don rage yaduwar cutar a cikin ƙananan ƙananan ƙananan 1.
Wannan yana rage haɗarin aikin kiwon lafiya da ke da aiki da yawa da kuma ba da isasshen lokaci don yin allurar rigakafi.
Hanyoyin da ba na magani ba don magance cutar sun haɗa da ayyukan rigakafin mutum, kamar wanke hannu, sanya abin rufe fuska, da keɓewa; ayyukan zamantakewar da ke da niyyar nisantawa kamar rufe makarantu da kuma dakatar da taron jama'a; ƙarfafa yin jima'i; da kuma ayyukan kare al'umma kamar tsabtace wurare da kayan aiki.
Sauran ƙasashe ma sun kafa wasu matakan da za su rage yaduwar cutar.
Koriya ta Kudu ta kafa keɓewa da keɓewa ga jama'a, da kuma gargadi ga masu tafiya da ke da cutar.
Singapore ta taimaka wa waɗanda suka keɓe kansu da rashin lafiya ta hanyar ba su kuɗi da kuma biyan waɗanda suka ƙi.
Taiwan ta kara samar da alluran rigakafi da kuma hana masu ɓoye magunguna.Binciken da aka yi a Birtaniya da Amurka ya nuna cewa rigakafi (ragewa ba dakatar da yaduwar cutar ba) da kuma rage kamuwa da cuta (hana yaduwar cutar) suna da kalubale masu yawa.
Matakan da suka fi dacewa don magance cututtuka na iya rage yawan buƙatun kiwon lafiya da kashi biyu bisa uku na mutuwar da kuma rage yawan mutuwar amma a lokaci guda yana haifar da dubban mutuwar da rashin asibitoci.
Za a iya rage yawan kamuwa da cuta amma ya kamata a yi haka muddin cutar tana yaduwa (ko har sai an sami maganin rigakafi, idan ya fara), amma cutar za ta iya dawowa idan an yi mata magani.
Yin ƙoƙari don a magance cututtuka yana jawo wahala da kuma kashe kuɗi sosai.
Babu wani magani da aka tabbatar da cutar COVID-19, amma ana ci gaba da ƙoƙarin samar da maganin, wanda ya haɗa da gwajin maganin da ake da shi a yanzu.
Shan maganin mura da shan giya da kuma hutawa zai iya taimaka maka ka rage alamun cutar.
Idan haɗarin ya yi tsanani, ana iya bukatar a yi amfani da iska da ruwa da kuma na'urorin numfashi.
Yin amfani da steroids zai iya sa yanayin ya yi muni.
Za a yi nazarin magungunan da aka yi amfani da su a baya don magance wasu cututtukan ƙwayoyin cuta don amfani da su don magance COVID-19.
WHO ta kuma ce "wasu magungunan gargajiya" na iya rage wasu alamun da SARS-CoV-19 ke haifarwa.
Ƙara ƙarfin aiki da daidaitawa don kula da buƙatun marasa lafiya na COVID-19 kamar yadda WHO ta bayyana a matsayin babban mataki na magance cutar.
ECDC da ofishin WHO na Turai sun ba da jagororin asibiti da na farko don daidaitawa a matakai daban-daban ciki har da kula da sabis na gwaji don gano COVID-19, jinkirta wasu ayyukan da ba na yau da kullun ba da wuri-wuri, warewa da keɓewar marasa lafiya na COVID-19, da haɓaka ƙwarewar kulawa ta hanyar horar da ma'aikata da haɓaka yawan kayan aikin taimako da gadaje.
Akwai ra'ayoyi daban-daban game da asalin mai haƙuri na farko (wanda ake kira mai haƙuri zero).
An gano mutum na farko da ya kamu da cutar coronavirus a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin wata guda, yawan masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
Waɗannan suna da alaƙa da kasuwar kifin Huanan (Huanan Seafood Wholesale Market), wanda ke sayar da dabbobi masu rai, kuma wata da'awar ita ce kwayar cutar ta samo asali ne daga ɗayan waɗannan dabbobin; ko, a wasu kalmomin, asalinsa yana cikin dabbobi.
A ranar 30 ga Disamba, ƙungiyar likitoci a asibitin Wuhan ta yi gargadin abokan aikinta game da sabon kwayar cutar da ke kama da "SARS coronavirus".
An tuhumi likitoci takwas, har da Li Wenliang, da yin ƙarya, sai kuma aka tuhumi Ai Fen da yin ƙarya.
Hukumar Kula da Lafiya ta Birnin Wuhan ta fitar da sanarwa a ranar 31 ga Disamba don sanar da WHO.
An sanar da hukumomi a Wuhan cewa an fara binciken wasu marasa lafiya da ke dauke da cutar da ba a sani ba a farkon watan Janairu.
A farkon da tsakiyar watan Janairun 2020, cutar ta yadu zuwa wasu sassan kasar Sin, tare da karfafawa da bikin Sabuwar Shekarar China da kuma yanayin Wuhan a matsayin babban birni da tashar jirgin kasa.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton cewa tana da sabbin mutane 140 a rana guda, ciki har da mutane biyu a Beijing da daya a Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa mutane 6,174 sun kamu da cutar a ranar 20 ga Janairu, 2020.A ranar 26 ga Maris, Amurka ta zarce China a yawan masu cutar a duniya.A ranar 9 ga Afrilu, 2020, an gano mutane 1.61 a duk duniya; sama da mutane 97,000 sun mutu kuma 364,000 sun warke.
Kimanin kasashe 200 sun sami aƙalla mutum ɗaya da ya kamu da cutar.
Tun da na zo Turai, ƙasashe da yawa da ke cikin yankin Schengen sun hana mutane yin tafiya da kuma hana mutane shiga ƙasashen da suke.
Wasu daga cikin matakan da aka ɗauka a cikin ƙasashe sun haɗa da keɓewa (wanda aka sani da dokar tsare-tsare, dokar hana fita, ko kullewa) da kuma kullewa.A ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'a a Amurka suna cikin wasu nau'ikan kullewa, sama da mutane miliyan 50 a kan iyakar Philippines, kusan mutane miliyan 59 a kan iyakar Afirka ta Kudu, da mutane biliyan 1.3 a kan iyakar Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya sun yi allurar rigakafi kuma adadin ya karu zuwa biliyan 2.6 kwanaki biyu bayan haka - kusan kashi ɗaya bisa uku na yawan mutanen duniya.
Ana tsammanin an gano mutum na farko da ke dauke da COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; akwai rahoto na farko da aka samu a ranar 17 ga Nuwamba.
Likita Zhang Jixian ya gano wasu marasa lafiya da ba a san su ba a ranar 26 ga Disamba, bayan haka asibitin da yake aiki ya sanar da hukumomin Wuhan Jianghan CDC a ranar 27 ga Disamba.
Binciken farko na kwayoyin halitta na samfurin marasa lafiya a ranar 27 ga Disamba 2019 ya nuna cewa suna da kwayar cutar coronavirus mai kama da SARS.
Hukumar Kula da Lafiya ta Birnin Wuhan ta ba da sanarwar jama'a a ranar 31 ga Disamba.
An sanar da WHO a ranar.
Bayan sanarwar, an gargadi likitocin Wuhan da 'yan sanda kan yada labarin barkewar cutar.
Hukumar Lafiya ta Kasa ta kasar Sin a baya ta ce babu "bayanan da suka dace" game da yaduwar mutum-zuwa-mutum.
A ƙarshen watan Janairu, gwamnatin China ta ƙaddamar da wani babban kamfen da Sakataren Jam'iyyar Kwaminis ta Sin Xi Jinping ya bayyana a matsayin "yaƙin mutane" don dakile yaduwar cutar.
A cikin sanarwa a matsayin "keɓewa mafi girma a tarihin ɗan adam", an sanar da dokar kulle a ranar 23 ga Janairu don dakatar da zirga-zirga zuwa ko daga Wuhan, kuma an faɗaɗa ta zuwa birane 15 a Hubei, yana shafar mutane kusan miliyan 57.
An hana amfani da motocin jama'a a cikin birni.
An soke bikin sabuwar shekara ta kasar Sin (Janairu 25) a wurare da dama.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, Huoshenshan Hospital, wanda aka kammala a cikin kwanaki 10.
An gina asibiti na biyu, wanda aka kira asibitin Leishenshan, don kula da ƙarin marasa lafiya.
Baya ga sabon asibitin da aka gina, kasar Sin ta sake gyara wasu wurare 14 a Wuhan, kamar wuraren zama na kwamitin zartarwa da filayen wasan kwallon kafa da kuma asibitocin wucin gadi.A ranar 26 ga Janairu, gwamnati ta kafa wasu dokoki don magance barkewar COVID-19, gami da rubuta takardun lafiyar matafiya da kuma tsawaita bukukuwan hutun bazara.
Jami'o'i da makarantu a duk fadin kasar sun rufe.
An kafa wasu takunkumi a Hong Kong da Macau, musamman a makarantu da jami'o'i.
An kafa tsarin aiki a wasu yankuna na kasar Sin.
An sanya takunkumin hana zirga-zirga a cikin da wajen Hubei.
An sauya hanyoyin sufuri, kuma an rufe wuraren shakatawa na ɗan lokaci.
An kafa takunkumin hana zirga-zirgar jama'a a birane da yawa, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) sun sami wasu matakan rigakafi.
Alal misali, Beijing ta sanya dokar killacewa ta kwanaki 14 ga duk mutanen da suka shigo kasar Sin daga kasashen waje.A ranar 23 ga watan Maris, mutum daya ne kawai a kasar Sin da ya kamu da cutar a cikin kwanaki biyar da suka gabata, kuma shi matafiyi ne da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga watan Agusta, 2020, Firayim Ministan kasar Sin Li Keqiang ya sanar da cewa an rufe yaduwar cutar a cikin kasar Sin kuma an shawo kan barkewar cutar a kasar Sin.
A ranar da ta gabata ne aka soke takunkumin hana zirga-zirga a Hubei, ban da Wuhan, bayan rufewar wata biyu.Ma'aikatar Harkokin Wajen China ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da takardar izinin shiga China ko izinin aiki daga ranar 28 ga Maris zuwa gaba ba tare da bayyana lokacin da za a dakatar da dokar ba.
Wadanda suke son shiga kasar Sin za su buƙaci neman biza daga ofishin jakadancin kasar Sin.
Gwamnatin kasar Sin ta bukaci kamfanoni da kamfanoni su bude a ranar 30 ga watan Maris, kuma ta samar da abubuwan jan hankali ga kamfanoni. Majalisar kasa ta fara da kafa ranar makoki ta kasa da ta fara da yin shiru na minti 3 da karfe 4 na ranar 4 ga watan Afrilu, wanda ya yi daidai da bikin Qingming, amma gwamnatin tsakiya ta nemi iyalai su ba da sakon makoki ta yanar gizo yayin da suke shirin yin taro don hana sake yaduwar COVID-19.
An tabbatar da cewa COVID-19 ya isa Koriya ta Kudu a ranar 20 ga Janairu 2020 daga China.
Ma'aikatar Lafiya ta Kasa ta ba da rahoton karuwar masu cutar a ranar 20 ga Fabrairu, ta danganta hakan da taron da aka yi a Daegu na sabon addinin da ake kira Shincheonji Church of Jesus (Cocin Yesu na Shincheonji).
Ana zargin cewa mabiyan Shincheonji da suka yi tafiya zuwa Daegu daga Wuhan ne suka haifar da barkewar cutar.
A ranar 22 ga Fabrairu, mutane 9,336, 1,261 ko kusan kashi 13% na masu bin coci sun ba da rahoton cewa suna da alamun cutar.Koriya ta Kudu ta ba da sanarwar gargaɗi mafi tsanani a ranar 23 ga Fabrairu 2020.
A ranar 28 ga Fabrairu, an ba da rahoton sama da mutane 2,000 da suka kamu da cutar a Koriya kuma sun haura zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin soji a Koriya ta Kudu bayan da aka tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma yi tasiri ga tsarin zirga-zirgar jiragen sama kuma saboda haka an canza shi.Koriya ta Kudu ta aiwatar da tsarin da ake ganin ya fi dacewa a duniya don keɓe masu cutar, keɓe duk wani mai cutar ta hanyar sa ido da kuma keɓe duk wanda ya taɓa saduwa da mai cutar.
Hanyoyin da aka tsara sun haɗa da tilasta yin allurar rigakafi ga masu alamun cutar daga ƙasashen waje ta amfani da aikace-aikacen wayar hannu, tuki zuwa cibiyar gwajin cutar don sakamakon gwajin gobe, da haɓaka ƙarfin gwajin don tabbatar da gwajin 20,000 kowace rana.
An yi la'akari da shirin Koriya ta Kudu a matsayin mai nasara wajen magance barkewar cutar duk da cewa ba a keɓe dukkan biranen ba.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman Moon ya sauka daga mulki, suna mai cewa gwamnati ba ta kula da barkewar cutar yadda ya kamata ba, yayin da wasu ke sukar matakin.
A ranar 23 ga watan Maris, an ba da rahoton cewa Koriya ta Kudu ta kasance ƙasa da ƙasa a cikin makonni huɗu.
A ranar 29 ga watan Maris an sanar da cewa daga ranar 1 ga Afrilu duk masu tafiya daga ƙasashen waje za a keɓe su na makonni biyu.
A ranar 1 ga Afrilu, kafofin watsa labarai sun ruwaito cewa Koriya ta Kudu ta nemi taimakon kayan gwaji daga kasashe 121.
Iran ta sanar da tabbatar da cutar SARS-CoV-2 ta farko a ranar 19 ga Fabrairu a Qom, kuma Ma'aikatar Lafiya da Ilimin Likita ta ba da rahoton mutuwar mutane biyu a wannan ranar.
Matakan farko da gwamnati ta sanar sun hada da soke bukukuwa da al'adu, wasanni, da sallar Juma'a, da rufe jami'o'i, kwalejoji, da makarantu.
Iran ta ba da dala tiriliyan biyar don magance cutar.
A ranar 26 ga Fabrairu, 2020, Shugaba Hassan Rouhani ya ce babu wani shiri na sanya keɓewa a yankunan da abin ya shafa kuma dole ne a keɓe mutane.
An sanar da shirin rage zirga-zirgar jiragen sama tsakanin biranen a ranar Laraba duk da cewa yawancin zirga-zirgar jiragen sama na bikin Sabuwar Shekarar Farisa (Persian New Year Nowruz) sun ci gaba.
An bude wuraren ibadar Shia a Qom don masu yawon bude ido har zuwa 16 ga watan Agusta 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A yayin da ake zargin cewa an rufe cutar a Iran, sama da kasashe goma sun gano masu cutar a Iran a ranar 28 ga Fabrairu, wanda ke nuna cewa cutar ta fi yawan masu cutar 388 da gwamnatin Iran ta bayyana a kasar a ranar.
An dakatar da majalisar dokokin Iran, tare da 'yan majalisa 23 daga cikin 290 da aka ce sun kamu da cutar a ranar 3 ga watan Maris.
A ranar 12 ga watan Fabrairu, Human Rights Watch ta bukaci hukumomin kurkuku na Iran da su saki masu aikata laifin kare hakkin dan adam ba tare da wani takunkumi ba tare da sun kama duk fursunonin da suka cancanci a sake su ba.
An ce ana iya samun kamuwa da cutar a wuraren da mutane da yawa suke zama kamar kurkuku da kuma wuraren da babu magani.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana ɗaya, wanda shi ne mafi girma a ƙasar tun barkewar cutar.
A ranar 17 ga watan Agusta, akalla shugabannin Iran 12 da ke kan gaba sun mutu sakamakon cutar.
A ranar 23 ga watan Agusta, Iran tana samun sabbin mutane 50 a kowace awa da kuma mutuwar mutum daya a kowane minti goma daga cutar coronavirus.
A cewar jami'in WHO, adadin masu cutar a Iran na iya zama sau biyar fiye da yadda aka bayyana.
An kuma yi zargin cewa takunkumin da Amurka ta sanya wa Iran na iya lalata ikon kasar na yaki da cutar.
Babban Kwamishinan 'Yancin Dan Adam na Majalisar Dinkin Duniya ya bukaci a mayar da kudaden da aka baiwa kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da aka gwada masu yawon bude ido biyu na China da cutar SARS-CoV-2 a Roma.
Yawan masu cutar ya karu sosai wanda hakan ya sa gwamnatin Italiya ta dakatar da dukkan jiragen da ke tashi daga China da kuma sanar da dokar ta baci.
An gano cutar da ba ta da alaƙa da COVID-19 daga baya, wanda ya fara daga marasa lafiya 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu.A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabon tsarin kula da cutar, wanda ya haɗa da sanya mutane sama da 50,000 daga biranen da ke cikin keɓewa a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "A wuraren da cutar ta bulla, ba za a yarda a shiga ko fita ba.
An dakatar da ayyukan wasanni da abubuwan da suka shafi wasanni a waɗannan wuraren. "A ranar 4 ga Maris, gwamnatin Italiya ta sanar da rufe makarantu da jami'o'i a duk faɗin ƙasar lokacin da Italiya ta sami mutuwar mutane 100.
Duk manyan wasannin motsa jiki, gami da wasannin kwallon kafa na Serie A, an shirya za a buga su a cikin gida har zuwa 1 ga Afrilu, amma a ranar 9 ga Maris, an dakatar da dukkan wasannin na aƙalla wata guda.
A ranar 11 ga watan Maris, Firayim Minista Conte ya ba da sanarwar dakatar da kusan duk ayyukan kasuwanci sai dai manyan kantuna da kantunan magunguna.A ranar 6 ga Maris, Kwalejin Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) ta ba da umarnin game da hanyoyin da za a bi don gwajin da ke da tsarin triad (triad protocols) da za a iya amfani da su a cikin binciken.
A ranar 19 ga watan Maris, Italiya ta zarce China a yawan mutanen da suka mutu a duniya sakamakon cutar coronavirus lokacin da ta ba da rahoton mutuwar mutane 3,405 a farkon lokacin annobar.
A ranar 22 ga Agusta, an sanar cewa Rasha ta aika da jiragen sama tara zuwa Italiya.
A ranar 5 ga Afrilu, an samu mutane 128,948 da suka kamu da cutar, 15,887 sun mutu, 21,815 kuma an warkar da su a Italiya, mafi yawansu a yankin Lombardy.
Kafofin watsa labarai na CNN sun ce, saboda yawan tsofaffi a Italiya da ke nuna rashin amincewa da gwajin cutar, hakan na iya kara yawan wadanda ke mutuwa.
Farkon aikin da Burtaniya ta yi da cutar ya kasance mafi kwanciyar hankali a cikin ƙasashen da cutar ta shafa, kuma har zuwa 18 ga Agusta 2020, gwamnatin Burtaniya ba ta sanya dokar hana fita ko keɓewar jama'a a cikin ƙasar ba.
A sakamakon haka, an zargi gwamnati da rashin kula da matsalar da ke fuskantar jama'a.A ranar 16 ga watan Maris, Firayim Minista Boris Johnson ya ba da sanarwar cewa ya shawarci mutane da su guji tafiye-tafiye da hulɗa da jama'a, yana cewa idan ya yiwu su yi aiki daga gida kuma su guji wuraren shakatawa, wuraren shakatawa da wuraren shakatawa.
A ranar 20 ga watan Maris, gwamnati ta sanar da cewa duk wuraren shakatawa kamar mashaya da gidajen giya za su rufe da wuri-wuri, kuma ta yi alkawarin biyan kashi 80% na albashin ma'aikata har zuwa £2,500 a kowane wata don hana rashin aikin yi a cikin rikicin.A ranar 23 ga Maris, Firayim Minista ya ba da sanarwar tsauraran matakan nesa, ya hana tarurruka na mutane sama da biyu da kuma hana yin tafiya a waje idan ya zama dole.
Baya ga ayyukan da aka kafa a baya, 'yan sanda suna sa ido kan aiwatar da wannan dokar ta hanyar tara kuɗi da kuma rushe duk tarurruka.
An umarci rufe yawancin kasuwancin da aka yi ban da waɗanda ake ganin "masu amfani" ne, kamar manyan kantuna, kantunan magani, bankuna, shagunan kayan masarufi, shagunan mai da gidajen gyaran motoci.
A ranar 20 ga Janairu, an tabbatar da cutar COVID-19 ta farko a jihar Pacific Northwest na Washington wani mutum ne da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa Hukumar Kula da Coronavirus ta White House a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya a kasar kuma ta sanya takunkumi kan matafiya daga China.
A ranar 28 ga Janairun 2020, Cibiyar Kula da Cututtuka ta Amurka ta sanar da cewa ta samar da kayan aikin gwajin cutar.
Duk da haka, Amurka ta fara yin bincike, wanda hakan ya hana sanin girman cutar.
Gwajin ya kawo ƙarshen amfani da gwaje-gwaje marasa kyau a watan Fabrairu, gwamnati ta hana amfani da gwaje-gwaje marasa amfani (waɗanda masu bincike, kamfanoni da asibitoci ke amfani da su) har zuwa ƙarshen Fabrairu, kuma ta hana mutane yin gwaji har zuwa Maris (bayan haka ana buƙatar takardar likita).
A ranar 27 ga watan Fabrairu, jaridar The Washington Post ta ruwaito cewa mutane kasa da 4,000 ne aka gwada a Amurka.
A ranar 13 ga Maris, jaridar The Atlantic ta ba da rahoton cewa an gwada mutane 14,000.
A ranar 22 ga watan Agusta, Associated Press ta rubuta: "Mutane da yawa da ke nuna alamun cutar da suka sami izinin likita suna jira na sa'o'i ko kwanaki don a gwada su. Bayan mutuwar mutum na farko a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, kuma wasu jihohi sun bi sahu.
An dakatar da makarantu a yankin Seattle a ranar 3 ga Maris kuma a tsakiyar watan Maris, an rufe makarantu a duk faɗin ƙasar.A ranar 6 ga Agusta, 2020, ƙungiyar masu binciken cututtuka a Kwalejin Imperial ta London ta ba da shawara ga Amurka game da matsalar cutar.
A ranar da Shugaba Trump ya sanya hannu kan Dokar Shirye-shiryen Cutar Korona da Dokar Amincewa da Karin Kuɗi ta $ 8.3 biliyan ga gwamnatocin jihohi don magance cutar.
An hana ma'aikata yin aiki, an soke taro, kuma an ce ma'aikata su riƙa aiki daga gida.
An soke shirye-shiryen wasanni da aka shirya.A ranar 11 ga watan Maris, Trump ya ba da sanarwar hana zirga-zirga a yawancin Turai, ban da Burtaniya, na kwanaki 30, farawa daga 13 ga Maris.
Washegari, ya ba ni umurni na ƙara zuwa ƙasar Ingila da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci a duk fadin kasar wanda ya sa aka kashe kudaden gwamnati na lardin don magance cutar.
Tun daga ranar 15 ga watan Maris, yawancin kasuwancin sun rufe ko rage lokacin aiki a duk faɗin Amurka a ƙoƙarin rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da cutar a jihohi 50 da Gundumar Columbia.A ranar 23 ga watan Maris, an ba da rahoton cewa New York City tana da masu cutar coronavirus 10,700, wanda ya wuce adadin masu cutar a Koriya ta Kudu.
A ranar 25 ga watan Maris, gwamnan ya ce nisantar da mutane daga juna ya yi tasiri sosai saboda yawan masu cutar ya ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga Maris, akwai mutane 32,308 da suka kamu da cutar a Birnin New York, kuma mutane 672 sun mutu sakamakon cutar. A ranar 26 ga Maris, an ba da rahoton cewa Amurka tana da mafi yawan masu kamuwa da cutar a duniya, ciki har da China da Italiya. A ranar 8 ga Afrilu, akwai mutane 400,335 da suka kamu da cutar a Amurka da kuma mutane 12,841 da suka mutu.
Kafofin watsa labarai na Per a ranar 30 ga Maris sun ruwaito cewa Shugaban Amurka Trump ya yanke shawarar tsawaita dokar hana fita har zuwa 30 ga Afrilu.
A ranar, jirgin ruwa mai suna USNS Comfort, wato asibitin da ke cikin jirgin ruwa mai gadaje 1,000 ya isa birnin New York.
A ranar 3 ga watan Afrilu, Amurka ta samu mutuwar mutane 884 daga coronavirus a cikin sa'o'i 24 kawai.
A New York, an samu karin mutane 100,000 a ranar 3 ga watan Afrilu. An zargi Fadar White House da rashin kula da matsalar da kuma sarrafa bayanai ta hanyar umarci ma'aikatan kiwon lafiya da masana kimiyya su aika da duk bayanan da aka fitar zuwa ofishin Mataimakin Shugaban Amurka Mike Pence.
A gaba ɗaya, yadda Trump ya yi amfani da wannan shafin ya zama abin ƙyama.
Wasu jami'an Amurka da kafofin yada labarai sun soki Amurka saboda dogaro da kayayyakin da ake bukata daga kasashen waje, ciki har da magunguna daga kasar Sin.
An yi amfani da nazarin tafiya ta iska don gano yadda cutar ke yaduwa kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
A cewar rahoton 2018 na Ƙungiyar Sufurin Jiragen Sama ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei sun fi yawan fasinjoji daga Wuhan.
An kuma bayyana Dubai, Sydney, da Melbourne a matsayin manyan wuraren da mutane ke zuwa daga Wuhan.
An bayyana garin Bali a matsayin mafi ƙarancin ƙarfi a cikin manyan biranen 20 da aka fi dacewa da shirye-shiryen, yayin da aka kwatanta biranen Ostiraliya da ƙarfi.
An ce akwai abubuwa da yawa da za a gano game da COVID-19, kuma Australia ta mai da hankali sosai kan iyakokinta da hanyoyin sadarwa don magance cutar.
A ranar 21 ga Maris, an yi dokar hana fita a Ostareliya.
Bayan nasarar da aka samu na keɓewar kai tsaye a Wuhan da Hubei, ƙasashe da yawa sun shirya fitar da 'yan ƙasa da jami'an su daga yankin, ta hanyar jigilar jiragen sama daga ƙasar da ke da' yan ƙasa huɗu tare da izinin hukumomin China.
Kasashen Kanada, Amirka, Japan, Indiya, Sri Lanka, Ostareliya, Faransa, Ajantina, Jamus, da Thailand ne ƙasashe na farko da suka shirya su kai 'yan gudun hijirarsu.
Pakistan ta ce ba za ta kori wani dan kasar ta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe mutane 34 ko kuma dangi guda ciki har da 'yan Poland hudu da kuma wani dan Indiya.
'Yan ƙasar Poland da China da kuma Indiya sun tashi daga ƙasar Poland sa'ad da jirgin Brazil ya yi hatsari kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan kasar Brazil da suka je Wuhan a sansanin soji kusa da Brasília.
A ranar, an tashi 'yan Kanada 215 (176 daga jirgin farko, da 39 daga jirgin na biyu da gwamnatin Amurka ta yi hayar) daga Wuhan zuwa CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama mai dauke da 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Australia sun kwashe 'yan kasar 277 a ranakun 3 da 4 ga watan Fabrairu zuwa cibiyar tsare mutane ta tsibirin Christmas, wanda aka kafa a matsayin wurin keɓewa kuma za a tsare su a can na kwanaki 14.
Jirgin New Zealand ya sauka a Auckland a ranar 5 ga Fabrairu; fasinjojinsa (ciki har da wasu daga Australia da Pacific) an kebe su a Whangaparoa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta tsere daga Amurkawa a cikin jirgin ruwa, Diamond Princess.
A ranar 21 ga Fabrairu, jirgin da ke ɗauke da fasinjoji 129 na Kanada da aka kwashe daga jirgin Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar ta zuwa Iran. A ranar 14 ga watan Maris, gwamnatin Afirka ta Kudu ta yi hayar jirgin saman South African Airways don kwashe 'yan kasar 112.
An yi gwajin lafiya kafin tashi kuma an bar 'yan Afirka ta Kudu da ke nuna alamun cutar coronavirus a baya don rage haɗarin.
'Yan Afirka ta Kudu da ba su da cutar ne kawai aka dawo da su.
Sakamakon binciken ya nuna cewa dukkan 'yan Afirka ta Kudu suna cikin koshin lafiya, ciki har da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal,' yan sanda da sojoji da ke cikin aikin agaji, kuma dukansu sun kasance cikin tsaro kuma an killace su na tsawon kwanaki 14 a The Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iraki a sakamakon annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen China ta ce kasashe 21 (da suka hada da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun ba da taimako.
Daliban kasar Sin da ke karatun jami'o'in Amurka sun hada kai don taimakawa yankunan da cutar ta fi shafa a kasar Sin, kuma wata kungiya a Chicago ta aika da mashin N95 50,000 zuwa asibitocin Hubei a ranar 30 ga Janairu.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da tallafin dala miliyan 100 ga WHO don gudanar da bincike kan alluran rigakafi da samar da magani da kare "al'ummomin da ke cikin mawuyacin hali a Afirka da Kudancin Asiya".
Interaksyon ta ruwaito cewa gwamnatin China ta ba da alluran rigakafi 200,000 ga Philippines a ranar 6 ga Fabrairu bayan da Sanata Richard Gordon ya ba da alluran rigakafi miliyan 3.16 a Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Red Cross ta Singapore ta sanar da cewa za ta tura tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da allurar rigakafi miliyan ɗaya ga Wuhan, Turkiyya ta ba da kayan aikin likita, Rasha ta aika da tan 13 na kayan aikin likita zuwa Wuhan, Malaysia ta ba da sanarwar cewa ta ba da safar hannu miliyan 18 ga China, Jamus ta ba da kayan aikin likita da suka haɗa da Hazmat suits 10,000, kuma Amurka ta ba da tan 17.8 na kayan aikin likita ga China kuma ta yi alkawarin ba da ƙarin dala miliyan 100 don taimakawa ƙasashen da abin ya shafa.
A watan Maris, China, Chuba da Rasha sun aika da kayan aikin likita da kuma kwararrun likitoci don taimakawa Italiya game da cutar coronavirus.
Wani dan kasuwa mai suna Jack Ma ya aika da kayan gwaji miliyan 1.1, abin rufe fuska miliyan 6, da alluran rigakafi 60,000 zuwa Addis Ababa, Habasha cibiyar Tarayyar Afirka.
Daga baya ya aika da kayan gwaji 5,000, abin rufe fuska 100,000 da na'urorin shan magani 5 zuwa Panama.
Ma ya kuma ba da kayan aikin likita ga Kanada. Netherlands, Spain, Turkey, Georgia, da Jamhuriyar Czech sun koka game da cutar sankarar bargo da kayan gwajin da ake yi a China.
Misali, Spain ta soke gwajin kwayar cutar coronavirus 58,000 da ake yi a China wanda ya kasance kashi 30% ne kawai, yayin da Netherlands ta soke alluran rigakafin 600,000 na China da suka mutu.
Belgium ta yi watsi da abin rufe fuska guda 100,000 da aka ɗauka cewa daga ƙasar Sin ne, amma a gaskiya daga Kolombiya ne.
A gefe guda kuma, an yi maraba da taimakon da kasar Sin ta bayar a Latin Amurka da Afirka.A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da tallafin gaggawa ga kasashe masu tasowa.
WHO ta yaba wa kokarin da kasar Sin ke yi na dakile yaduwar cutar.
WHO ta gano bambanci tsakanin barkewar cutar SARS a 2002 da 2004, lokacin da aka matsa wa jami'an kasar Sin su yi shiru game da ayyukan rigakafin da suka hana su, da kuma halin da ake ciki yanzu yayin da gwamnatin tsakiya "ke gargadi mutane da su guji kamuwa da cutar a lokacin bukukuwan sabuwar shekara".
A ranar 23 ga watan Janairu, a lokacin da yake amsawa ga shawarar da jami'an gwamnati suka yanke na dakatar da zirga-zirga daga Wuhan, wakilin WHO Gauden Galea ya ce "duk da cewa ba WHO ce ta yanke shawarar ba", amma "aiki ne mai kyau da kuma sadaukarwa ga yaƙi da cutar a cikin yanki mafi kyau" kuma ya bayyana shi a matsayin "wanda ba a taɓa gani ba a tarihin kiwon lafiya".A ranar 30 ga Janairu, bayan an tabbatar da yaduwar mutum zuwa mutum a waje da China kuma yayin da adadin masu kamuwa da cutar ke ƙaruwa a wasu ƙasashe, WHO ta ayyana cutar a matsayin Babban Lamari na Kiwon Lafiyar Jama'a na Duniya (PICHE), wanda shine matakin gaggawa na duniya tun lokacin da cutar ta sake barkewa a 2009.
Darakta Tedros Adhanom na Hukumar Lafiya ta Duniya ya ce PHEIC ya faru ne domin "yana yaduwa a dukan duniya, musamman a ƙasashe masu arziki da masu arziki da ba su da isashen kiwon lafiya.
Da yake amsawa ga dakatar da zirga-zirga, Tedros ya ce "babu wani dalili da zai sa a dakatar da zirga-zirga da cinikayya a duniya" kuma "WHO ba ta goyi bayan rage zirga-zirga da kasuwanci ba".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga duniya da ta ba da dala miliyan 675 don tallafawa shirye-shirye a ƙasashe masu tasowa, tana mai nuna buƙatar gaggawa don tallafawa ƙasashe waɗanda "ba su da tsarin gano cutar, idan akwai barkewar cutar".
Tedros ya kuma bayyana cewa "ƙarfinmu ya fi ƙarfinmu" kuma ya yi kira ga mutane a duk duniya da su "shuka yau ko kuma su biya diyya gobe".A ranar 11 ga Fabrairu, WHO a wani taron manema labarai ta sanar da COVID-19 a matsayin sunan cutar.
A wannan ranar, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya António Guterres ya amince da ba da "dukan ƙarfin Majalisar Dinkin Duniya don yaƙi da cutar".
An kafa ƙungiyar kula da rikice-rikice ta Majalisar Dinkin Duniya don daidaita ayyukan Majalisar Dinkin Duniya, wanda WHO ta ce zai taimaka musu "su mai da hankali kan kiwon lafiya yayin da sauran hukumomi ke ba da ƙwarewarsu don taimakawa al'amuran zamantakewa, tattalin arziki da ci gaba a lokacin annobar".
A ranar 14 ga Fabrairu, an kafa wata ƙungiya ta haɗin gwiwa ta WHO a China don ba da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙ
A kan barkewar cutar a Iran, WHO ta tura Tawagar Haɗin gwiwa don nazarin halin da ake ciki.A ranar 28 ga Fabrairu, jami'an WHO sun ce za a ɗaga kimantawa na cutar coronavirus a duniya daga "mai tsanani" zuwa "mai tsanani", wanda shine matakin da suka fi dacewa don tantance cutar.
Mike Ryan, darektan shirin gaggawa na lafiya na WHO, ya yi gargadi: "Wannan gwaji ne ga kowace gwamnati a duniya: Ku farka.
Ana iya samun cutar a hanya kuma kuna buƙatar kasancewa cikin shiri", ya yi gargadin cewa samun matakan da suka dace na iya taimaka wa duniya ta guji "mafi munin".
Ryan ya kara da cewa bayanan da ake samu a yanzu ba su sa hukumomin kiwon lafiya su sanar da cutar a duniya ba, yana mai cewa irin wannan sanarwar na nufin "muna da tabbacin cewa kowa a duniya zai kamu da cutar".
A ranar 11 ga watan Maris, WHO ta ayyana cutar coronavirus a matsayin cutar ta duniya.
Darakta Janar ya ce WHO "ta damu sosai game da yawan saurin yaduwar cutar da kuma yadda cutar ta zama mai saurin yaduwa, da kuma yadda ba a sami wani sakamako mai mahimmanci ba". WHO ta yi matukar damuwa game da rashin aikin da ake ganin ta yi wajen magance cutar, gami da jinkirin ayyana matsalar gaggawa ta kiwon lafiya da kuma ayyana ta a matsayin bala'i na duniya.
Wannan zargi ya tilasta wa Darakta Janar na WHO Tedros Adhanom ya yi murabus, yayin da aka sami sa hannu 733,000 a kan wannan kamfen a ranar 6 ga Afrilu.
A ranar 26 ga watan Maris na 2020, masana kan hakkin dan adam na Majalisar Dinkin Duniya sun yi kira ga girmama hakkokin kowa a lokacin annobar COVID-19.
Ƙungiyar ta ce kowane ɗan Adam yana da 'yancin yin amfani da magunguna kuma gwamnati ce ke da hakkin yin hakan.
Kungiyar ta jaddada cewa rashin kayan aiki ko inshorar lafiya bai kamata a yi la'akari da shi a matsayin uzuri don nuna bambanci ga wasu mutane ba.
Masana sun tabbatar da cewa kowa yana da hakkin samun lafiya, gami da nakasassu, ƙananan ƙungiyoyi, tsofaffi, waɗanda ke cikin sansanin 'yan gudun hijira, marasa gida, waɗanda ke rayuwa cikin mawuyacin hali, fursunoni, da' yan gudun hijira da duk waɗanda ke buƙatar taimakon gwamnati.
Hukumomin gwamnati a duk duniya suna ba da amsa ga tasirin COVID-19 ga tattalin arziki da zamantakewar jama'a.
Wace Kungiyar Hadin Kan Tattalin Arziki da Ci Gaban ta kafa wata hanya ta samar da bayanai a kan lokaci da kuma cikakkun bayanai kan ayyukan da aka tsara a kasashe a duniya, da kuma shawarwari da dabaru.
Daga manufofin inganta kiwon lafiya da tattalin arzikin duniya zuwa magance matsalolin kulle-kulle da kulle-kulle na zirga-zirga, wannan shirin ya ƙunshi Mai Kula da Manufofin Kasashe, wanda ke nufin taimaka wa ƙasashe su koya daga juna da kuma haɗa kan ƙoƙarin duniya don ƙalubalen coronavirus.
Gwamnatin China ta fuskanci zargi daga Amurka, Ministan Harkokin Wajen Burtaniya Michael Gove, da dan shugaban Brazil Jair Bolsonaro Eduardo Bolsonaro saboda yadda suka magance cutar, wacce ta fara ne a lardin Hubei na kasar Sin.
An kori wasu shugabannin jam'iyyar kwaminis ta kasar Sin (CPC) a lardin saboda yadda suka gudanar da aikin killacewa a tsakiyar kasar Sin, a matsayin wata alama ta rashin jin dadin yadda hukumomi ke kula da cututtuka a yankunan.
Wasu masu lura da al'amura sun yi imanin cewa an yi wannan ne don hana Sakataren Jam'iyyar Kwaminis ta kasar Sin Xi Jinping fushin jama'a game da annobar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian sun musanta abin da aka yi imani da shi a baya cewa cutar coronavirus ta samo asali ne daga Wuhan, suna goyon bayan ra'ayoyin maƙarƙashiya cewa COVID-19 ya samo asali ne daga Amurka ko Italiya.
Shugaban Amurka Donald Trump ya kira coronavirus "Cutar ta China" ko "Cutar ta Wuhan" yana mai cewa "rashin nasarar China ya sa suka kirkiro kwayar cutar da ta zama matsalar duniya", wanda wasu ke zargin wariyar launin fata "saboda gazawar shugabancinsa wajen magance cutar".
Daily Beast ta samu wani rahoto daga gwamnatin Amurka game da wata dabara ta sadarwa daga Majalisar Tsaro ta Kasa, wadda ta ce "Dukkanin ya shafi China.
An umurce mu da mu yi kokarin yada wannan labarin ta duk wata hanyar da za mu iya, ciki har da taron manema labarai da kuma nunawa a talabijin". Kafofin yada labarai kamar su Politico, Foreign Policy, da Bloomberg sun ce kokarin da China ke yi na ba da tallafi ga kasashen da cutar ta shafa wani bangare ne na kokarin da take yi na samun karbuwa a duniya.
Shugaban harkokin wajen EU Josep Borrell ya yi gargadin cewa akwai "siyasa ta kasashen waje da ke da alaka da 'yancin kasa da siyasa ta kishin kasa".
Borrell ya ce "China tana ƙoƙari ta nuna cewa, ba kamar Amirka ba, ita ce mai alhakin abin da ta yi da kuma abin da za a iya dogara da ita".
China ta kuma nemi Amurka ta sayo sinadarin daga Syria, Venezuela da Iran, yayin da take ci gaba da aikawa da wadannan kasashen tallafi.
An dakatar da tallafin Jack Ma na allurar rigakafi 100,000 ga Cuba saboda takunkumin Amurka a ranar 3 ga Afrilu.
An zargi hukumomin Amirka da hana su ba da taimako.
An kuma sami sabani game da cutar sankarar daji tsakanin wasu ƙasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Ƙari ga haka, Turkiyya ta ba da ɗarurruwan na'urorin numfashi da ake kaiwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki Tarayyar Turai saboda rashin goyon bayan Italiya a lokacin annobar coronavirus.
Maurizio Massari, wakilin Italiya a Ƙungiyar Tarayyar Turai, ya ce: "China ce kaɗai ta damu.
Ko ta yaya, wannan ba alama ce mai kyau ba ga haɗin kan Turai".
A ranar 22 ga watan Agusta, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya sojojin Rasha su aika da likitocin soja, injunan allura, da sauran kayan aikin likita zuwa Italiya.
Jaridar Italiya La Stampa ta yi ƙaulin "mutumin siyasa mai girma" da bai cika alkawarinsa ba, ta ce kashi 80 cikin ɗari na taimakon da Rasha ta ba da "ba shi da amfani ko kuma ba shi da amfani sosai ga Italiya".
Wannan ɗan siyasa ya yi wa Rasha kashedi cewa ta yi "siyasa" ta 'yan iska.
Shugaban ƙasar Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi godiya don labarin.
Rasha ta kuma aika da jirgin sama mai jigilar kayayyakin kiwon lafiya zuwa Amurka.
Kakakin gwamnatin Rasha Dmitry Peskov ya ce: "Da yake ba da taimako ga Amirka, [Putin] yana fatan cewa idan har ma'aikatan lafiya na Amirka suka dawo cikin aikin, za su iya biyansa idan ya dace".
Shirin "Defender 2020" na NATO a Jamus, Poland, da ƙasashen Baltic, wanda shine mafi girman shirin soja na NATO tun ƙarshen Cold War, za a gudanar da shi a kan hanya.
Kate Hudson, marubuciya a Kamfen na Kashe Makaman Nukiliya, ta soki shirin Defender 2020: "A cikin halin da ake ciki na matsalar lafiya, yana barazanar rayuwar sojojin Amurka da na kasashen Turai da yawa da kuma 'yan ƙasa na ƙasashen da suke aiki".
Shugaban Iran Hassan Rouhani ya rubuta wasiƙar neman taimako ga shugabannin duniya a ranar 14 ga Maris, 2020, yana mai cewa kasarsa za ta fuskanci kalubale wajen magance cutar da Amurka ta sanya wa Iran. Cutar ta kara matsawa Amurka ta bi manufofin zamantakewar da ake samu a wasu kasashe masu arziki, ciki har da kiwon lafiya ga kowa, kula da yara ga kowa, hutu mai sauki, da kuma saka hannun jari mai yawa a cikin al'umma.
Masu lura da siyasa sun yi hasashen cewa hakan na iya shafar damar da Donald Trump ke da ita na sake zaɓar shugaban kasa a zaben 2020.
Koriya ta Kudu ta soki manufofin "keɓewa na yaudara da rashin daidaituwa" na Japan bayan da Japan ta sanar da cewa duk wanda ya zo Koriya ta Kudu za a keɓe shi a wuraren da gwamnati ta keɓe na tsawon makonni biyu.
A baya dai, an raba kan jama'ar Koriya ta Kudu saboda yadda Shugaba Moon Jae-in ya magance cutar.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman a kori Moon saboda abin da suka kira rashin kulawar gwamnati game da cutar, yayin da wasu ke goyon bayan manufofinsa.
Wasu masu lura sun nuna tsoro cewa wannan zai iya sa gwamnati ta ci gaba da mulki.
A Hungary, majalisar ta kada kuri'ar amincewa da firaministan kasar, Viktor Orbán, ya yi mulki a cikin wata sanarwa da ba a yi ba, ya dakatar da majalisar da kuma zaben da kuma hukunta wadanda ake zargi da yada labaran karya game da cutar da kuma yadda gwamnati ke magance cutar.
An ba da hujjar barkewar cutar coronavirus don rage yawan ayyukan, sakamakon karuwar amfani da kayan aikin duniya a cikin barkewar cutar, sayayya da yawa, da katsewar masana'antu da sauran ayyukan.
Hukumar Abinci da Magunguna ta Amurka ta yi gargadin cewa akwai karancin magunguna da magunguna saboda karuwar bukatar su da kuma katsewar samar da su.
A wasu wurare kuma, ana cin abinci da yawa a lokaci ɗaya, kuma hakan ya sa ana cin abinci da kayan abinci da ruwa da kuma kayan da ake bukata a kasuwa.
Musamman masana'antun na'urori masu kaifin baki sun yi gargadin cewa za a sami raguwa a cikin amfani da na'urori masu kaifin baki.
A cewar shugaban WHO Tedros Adhanom, bukatar kayan kariya ta kara ninka sau 100.
Wannan buƙatar ta haifar da ƙaruwar farashin abubuwa sau ashirin kuma ta haifar da ƙarancin kayan aikin likita na watanni huɗu zuwa shida.
Hakan ya kuma haifar da karancin kayan aikin lafiya a duniya, wanda WHO ta yi gargadin cewa hakan zai kawo hatsari ga lafiyar likitoci.
A Ostiraliya, annobar ta ba da dama ga masu sayar da kayayyaki na daigou don sayar da kayayyakin Australiya a China.
Wannan ya haifar da karancin abinci ga jarirai a wasu manyan kantunan kuma daga baya gwamnatin Ostiraliya ta dakatar da shi.Duk da cewa akwai karin masu cutar COVID-19 a Arewacin Italiya da yankin Wuhan, wanda hakan ya haifar da karancin abinci, ba a sami karancin abinci a yankuna biyu ba.
Hanyoyin da China da Italiya suka bi wajen hana cin hanci da rashawa da kuma cinikayya da ba ta da izini sun taimaka wajen hana yunwa da ake tsammani a Turai da Arewacin Amirka.
A arewacin Italiya da ake noma da yawa, ba a taɓa samun ƙarancin abinci ba, amma farashin zai iya ƙaruwa, in ji wakilan masana'antu.
An samu madara mai gina jiki a cikin ɗan gajeren lokaci, har ma a Wuhan, yayin da hukumomin kasar Sin suka bude shagunan naman alade don tabbatar da wadataccen abinci.
Irin wannan dokar tana aiki a Italiya inda masu samar da abinci ke buƙatar adana abinci saboda irin wannan ƙwayoyin cuta.
Tasirin tattalin arzikin duniya a China: a cewar rahotannin da aka buga a ranar 16 ga Maris, tattalin arzikin kasar Sin ya sha wahala sosai a farkon watanni biyu na 2020 saboda matakan da gwamnati ta dauka don hana yaduwar cutar, kuma tallace-tallace ga jama'a ya ragu da kashi 20.5%.
A matsayinta na ƙasa mai tattalin arziki da samar da kayayyaki da yawa, annobar ta shafi tattalin arzikin duniya sosai.
Agathe Demarais na Economist Intelligence Unit ta yi hasashen cewa kasuwar za ta kasance cikin rashin tabbas har sai an ga cikakken hoto game da yiwuwar raguwa.
A watan Janairun 2020, wasu masana sun yi hasashen cewa tasirin cutar ga ci gaban tattalin arzikin duniya zai iya zama mafi girma fiye da yadda cutar SARS ta 2002-2004 ta kasance.
Wani mai bincike a Jami'ar Washington da ke St. Louis ya kimanta cewa ana iya kashe dala biliyan 300 ko fiye a duniya a cikin shekaru biyu.
An ce kungiyar kasashen da ke fitar da man fetur (OPEC) ta fadi sakamakon faduwar farashin man fetur da kasar Sin ta yi.
Kasuwancin hannayen jari na duniya ya fadi a ranar 24 ga Fabrairu saboda karuwar yawan masu kamuwa da COVID-19 a wajen China.
A ranar 27 ga Fabrairu, saboda ci gaba da damuwa game da cutar coronavirus, yawancin alamun hannun jari na Amurka ciki har da NASDAQ-100, S&amp;P 500 Index, da Dow Jones Industrial Average sun nuna ragin farashin mafi girma tun 2008, tare da Dow ya faɗi da maki 1,191, wanda shine mafi girma tun lokacin da bala'in tattalin arzikin 2007-08.
Dukkanin lambobi uku sun kasance a ƙasa da kashi 10% a cikin mako guda.
A ranar 28 ga watan Fabrairu, Scope Ratings GmbH ta tabbatar da darajar bashi na kasar Sin, amma ta nuna cewa wannan zai iya canzawa (Negative Outlook).
Hannun jari sun sake raguwa saboda tsoron coronavirus, tare da raguwa mai yawa a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai yi sanyi.
Shugaban kasa Mohamed El-Erian ya yaba da manufofin babban bankin lardin.
Babban bankin ya farfado da sauri fiye da yadda ya yi a lokacin matsalar tattalin arziki ta 2008.
Yawon shakatawa yana daya daga cikin bangarorin da aka fi shafawa sakamakon dakatar da zirga-zirga, rufe wuraren da ake da shi da kuma gargadin gwamnati game da duk wani tafiya a duniya.
Sakamakon haka, yawancin kamfanonin jiragen sama sun soke zirga-zirgar su saboda rashin inganci, ciki har da British Airways, China Eastern Airlines, da Qantas, kuma kamfanin jirgin saman Flybe na Burtaniya ya fadi.
Abin da kamfanonin jirgin ruwa suka kawo ba a taɓa ganin irin shi ba.
An rufe tashoshin jirgin ƙasa da yawa da kuma gidajen abinci.
Cutar ta zo ne a daidai lokacin da ake gudanar da bikin Chunyun, lokacin da ake yawan tafiya don shirya hutun Sabuwar Shekarar China.
Gwamnatin tsakiya da ta lardin sun soke manyan bukukuwa, gami da bikin Sabuwar Shekara, tare da rufe kamfanoni masu zaman kansu da wuraren shakatawa kamar Hong Kong Disneyland da Shanghai Disneyland.
Yawancin bukukuwan Sabuwar Shekara da wuraren yawon bude ido sun rufe don kauce wa taron jama'a, gami da Forbidden City a Beijing da kuma wuraren shakatawa a tsoffin masallatai.
A larduna 24 daga cikin 31, da kananan hukumomi da yankuna, hukumomi sun tsawaita hutun sabuwar shekara zuwa ranar 10 ga watan Fabrairu, kuma sun ba da umarnin a dakatar da ayyukan da suka shafi aikin har zuwa ranar.
Waɗannan yankuna suna da kashi 80% na GDP da kashi 90% na fitarwa.
Hong Kong ta kara matakan rigakafin kamuwa da cuta zuwa matakin mafi girma kuma ta ayyana dokar hana fita, rufe makarantu har zuwa Maris da kuma soke bukukuwan Sabuwar Shekara.
Sayayya a waɗannan dillalan a Turai da Latin Amurka ya ragu da kashi 40%.
Masu sayar da kayayyaki a Arewacin Amurka da Gabas ta Tsakiya sun sami raguwar ayyukan su na kashi 50 zuwa 60%.
Wannan kuma ya haifar da raguwar kashi 33 zuwa 43% na masu tafiya zuwa shaguna a ranar Laraba idan aka kwatanta da Talata.
Masu kula da manyan kantunan sayar da kayayyaki a duniya sun kafa wasu ƙa'idodi, kamar inganta tsafta, auna zafin jiki na abokan ciniki, da kuma jinkirta al'amuran al'ada.A cewar ƙididdigar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki da cutar ta haifar na iya barin mutane miliyan 14 zuwa 22 cikin talauci a Latin Amurka fiye da yadda zai kasance idan ba a magance matsalar ba.
A watan Janairu da Fabrairun 2020, lokacin da cutar ta kai kololuwa a Wuhan, kusan mutane miliyan 5 a China sun rasa ayyukansu.
Yawancin mutane miliyan 300 da ke gudun hijira a China sun makale a gida a lardin ciki ko lardin Hubei.A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Barkewar cutar coronavirus na iya haifar da asarar ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi ya kai kashi 32%, a cewar kimantawar Babban Bankin Tarayya na St. Louis. Kullewar Indiya ta bar miliyoyin ma'aikatan gwamnati na Indiya ba tare da aiki ba. Binciken Cibiyar Angus Reid ya gano cewa kashi 44% na iyalai a Kanada sun sami matsalar rashin aikin yi. Kimanin ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka shiga cikin kullewar a tsakiyar Maris 2020.
A rabin rabin watan Maris, ma'aikata miliyan 4 a Faransa sun nemi taimakon rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 a Burtaniya sun nemi tsarin bashi na duniya. Kimanin kamfanoni dubu hamsin a Jamus sun tura ma'aikatansu zuwa tsarin gwamnati na aiki na ɗan lokaci da aka sani da Kurzarbeit.
An kafa tsarin aiki na ɗan lokaci na Jamus a Faransa da Ingila.
Har ila yau, an yi wa wuraren shakatawa da al'adu mummunan rauni, wanda ya shafi ayyukan hukumomi da masu zaman kansu da ke aiki a duk faɗin duniya.
Ƙungiyoyin al'adu da al'adu sun yi ƙoƙari su ci gaba da ayyukan su (wanda yawanci ana biya su) na ba da izinin jama'a zuwa wuraren al'adu, kiyaye ma'aikata da sauran jama'a lafiya, da kuma tallafawa masu kirkiro idan ya cancanta.
A watan Maris na 2020, a duk faɗin duniya, gidajen cin abinci, dakunan karatu, wuraren shakatawa, da sauran cibiyoyin al'adu sun rufe yayin da aka soke ko kuma aka tsawaita baje kolin, da sauran abubuwan da suka faru.
Sakamakon cutar ya haɗa da dakatar da ayyukan addini, wasanni, ayyukan nishaɗi, kamar kide kide da wake-wake, darussan fasaha, da kuma abubuwan da suka shafi tufafi.
An kuma katse gidan wasan kwaikwayo. Vatican ta sanar da cewa an sake gudanar da bikin mako mai tsarki a Rome, wanda aka yi a makon karshe na Lent.
Wasu majami'u sun umurci dattawa su zauna a gida maimakon su yi Idin Ƙetarewa a ranar Lahadi; wasu majami'u sun yi addu'o'i a rediyo, a Intane ko kuma a talabijin, wasu kuma suna yin addu'o'i a cikin motoci.
Sa'ad da limaman Katolika a Roma suka rufe majami'unsu da kuma majami'unsu a St. Peter's Square kuma suka rasa masu hidima, wasu addinai ma suka rage bautarsu kuma suka rage taron jama'a a majami'u, masallatai, majami'u, masallatai, da kuma masallatai.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa kuma daga baya an rufe masallatai, yayin da Saudiyya ta hana mahajjata daga kasashen waje da 'yan kasarta shiga wuraren alfarma na Makka da Madina.
Cutar ta haifar da babbar katsewa a cikin kalandar wasanni tun bayan Yaƙin Duniya na II.
An soke ko kuma an ƙara wasanni da yawa masu daraja, gami da gasar zakarun Turai ta 201920, Premier League ta 201920, UEFA Euro 2020, NBA ta 201920, da NHL ta 201920.
Cutar ta katse shirye-shiryen gasar Olympics ta bazara ta 2020, wanda aka shirya fara a ƙarshen Yuli; Kwamitin Olympics na Duniya ya ba da sanarwar ranar 24 ga Maris cewa za a sake shirya wasannin bayan 2020 amma ba a wuce bazara na 2021 ba. "
Hakan ya sa mutane da yawa sun soma yin caca a Intane, kuma rukunin caca na Intane sun nuna cewa yawan masu yin caca ya ƙaru sosai.
Ƙungiyoyin 'yan'uwa da ke birnin New York sun yi zanga-zanga a kan wani babban bene da ke birnin Brooklyn.
Wasu masu fasaha sun gwada wasu hanyoyin da za su iya samarwa da kuma rarraba ayyukansu ta hanyar Intanet maimakon hanyar da aka saba amfani da ita ta yin waƙoƙin da ke cikin layi, kamar su wasan kwaikwayo na raye-raye na raye-raye ko kuma "bikin" na yanar gizo inda masu fasaha zasu iya yin waƙa, watsawa, da kuma inganta ayyukansu.
A kan intanet, labarai masu ban tsoro game da coronavirus sun bazu saboda mutane da yawa sun fara yin dariya da wasa tsakanin rashin sani da gaskiya.
Tun bayan barkewar COVID-19, an yi ta nuna nuna bambanci, ƙiyayya da wariyar launin fata a tsakanin mutanen da suka fito daga China da Gabashin Asiya, da kuma mutanen da suka fito daga yankunan da cutar ta fi shafa a Turai, Amurka da sauran ƙasashe.
An yi rahoton tsoro, zalunci, da kuma mugunta a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka, da kuma yankin Asiya da Fasifik.
Rahotanni daga watan Fabrairu (wanda yawancin masu cutar har yanzu suna cikin China) sun nuna nuna bambancin launin fata ga ƙungiyoyin Sinawa a duk duniya cewa ya kamata su kasance masu kamuwa da cutar ko kuma a ba su abin da ake ganin daidai ne.
Wasu ƙasashen Afirka ma sun ga ƙiyayya da ake yi wa China.
Yawancin mazauna Wuhan da Hubei sun ce ana nuna musu wariya saboda asalin su.
An ba da tallafi ga Sinawa, a kan layi da kuma wasu wurare, har ma ga waɗanda ke zaune a yankunan da cutar ta shafa.
Bayan cutar ta yadu zuwa wasu ƙasashe, mutanen Italiya, ƙasar da ta fi fama da cutar COVID-19 a Turai, sun fuskanci nuna bambanci da nuna bambanci. 'Yan ƙasa a ƙasashe kamar Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun fara sanya hannu kan takardun da ke buƙatar hana Sinawa shiga ƙasashensu don ƙoƙarin dakatar da cutar.
A Japan, taken #ChineseDontComeToJapan ya zama sananne a shafin Twitter.
Sinawa da wasu mutanen Asiya a Ingila da Amirka suna tsoron ƙiyayya da kuma zalunci.
Shugaban gurdwaras Donald Trump ya fuskanci zargi saboda kiran coronavirus "Cutar ta China", kalmar da masu gurdwaras suka kira nuna wariyar launin fata da nuna ƙiyayya ga China.
Masu zanga-zangar a Ukraine sun kai hari kan bas din da ke dauke da 'yan kasar Ukraine da wasu kasashen waje daga Wuhan zuwa Sanzhary.
An ce dalibai daga arewa maso gabashin Indiya, wanda ke da alaƙa da China, suna karatu a manyan biranen Indiya saboda cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata a jihar West Bengal Dilip Ghosh ya ce kasar Sin ta lalata muhalli kuma "Allah ne ya yi musu horo".
Bayan haka, an soki wannan bayanin da jakadan kasar Sin a Kolkata, wanda ya kira shi "kuskure".A kasar Sin, cutar ta lalata ƙiyayya da wariyar launin fata ga baƙi da ba Sinawa ba, inda ake kiran baƙi "sharar baƙi" kuma ana bin sa "a bayan gida".
Yawancin jaridu da ke da shafukan da aka biya sun cire su kuma sun sanya bayanan da suka shafi coronavirus a wasu ko duka.
Masu wallafa littattafan kimiyya da yawa sun ba da littattafan da suka yi magana game da cutar kyauta.
Wasu masana kimiyya sun yanke shawarar raba abubuwan da suka gano a kan wani dandamali mai sauƙi kamar bioRxiv.
Cutar cututtuka  Cutar cututtuka da ke tasowa, sau da yawa ba a san inda ta fito ba kuma ba a san yadda take yaduwa ba
Ƙasashen duniya da cututtuka  Labaran duniya game da yaduwar cututtuka
Lissafin cututtuka da annoba Lissafin mutuwar cututtuka masu yaduwa
Hadarin kiwon lafiya daga fataucin namun daji da cututtukan dabbobi
Gwajin gwaji na cutar coronavirus 2019 (COVID-19) da cutar SARS-CoV-2 yana da tsarin gano ƙwayoyin cuta da ƙwayoyin cuta.
Ana tabbatar da kwayar cutar a cikin samfuran gwajin ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
An yi gwajin ne kawai don nazarin RNA na SARS-CoV-2.
Ana amfani da shi don gano ko mutum yana da kwayar cutar ko kuma ya daɗe yana taɓa shi.
Ana iya amfani da maganin rigakafi don gano cutar ko kuma gano yawan mutanen da ke fama da cutar.
Gwajin rigakafi na gano yawan mutanen da suka kamu da cutar, har da waɗanda ba su da alamun cutar da ba su bukaci zuwa asibiti ko kuma waɗanda ba su da alamun cutar.
Za a iya gano ainihin adadin mutanen da suka mutu da kuma yadda cutar ta shafi mutane ta hanyar wannan gwajin.
Saboda rashin isasshen gwaji, a watan Maris na 2020, babu wata ƙasa da ke da cikakken bayani game da yanayin cutar a cikin al'ummarta.
A ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawanta, kuma akwai bambance-bambance masu yawa a cikin adadin waɗanda aka gwada a duniya.
Waɗannan bambance-bambance na iya shafar yawan mutuwar marasa lafiya, wanda zai iya zama mai girma a wasu ƙasashe.
Ta amfani da ainihin lokacin juyawa na juyawa na polymerase chain reaction (rRT-PCR) ana iya yin gwajin akan samfuran ƙwayoyin cuta da aka samo ta hanyoyi daban-daban, gami da allurar hanci da hanci ko samfurin da aka sarrafa.
Ana samun sakamako a cikin sa'o'i kalilan zuwa kwanaki biyu.
Gwajin RT-PCR da kuma maganin rigakafi na ciki suna da inganci idan an yi su a farkon makon kamuwa da cutar.
Bayan haka, ƙwayoyin cuta suna iya ɓacewa daga cikin ƙwayoyin cuta kuma su ci gaba da yawaita a cikin huhu.
Ga marasa lafiya da aka gwada a mako na biyu, ana iya cire samfuran gwajin daga cikin iska ta hanyar amfani da catheter na tsotsa ko kuma ana iya amfani da sutura.
An haɓaka ɗayan gwajin PCR na farko a Charité a Berlin a watan Fabrairun 2020 ta amfani da ainihin lokacin juyawa na polymerase chain reaction (rRT-PCR), wanda ya haifar da kayan aikin gwaji 250,000 da Hukumar Lafiya ta Duniya (WHO) ta rarraba.
Kasar Ingila ta kuma samar da tsarin gwaji a ranar 23 ga Janairu 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya samar da gwajin SARS-CoV-2 mai tushen PCR (PowerChek Coronavirus) a ranar 28 ga Janairu 2020.
Yana neman kwayar halitta "E" a cikin dukkanin kwayar cutar beta, tare da kwayar halitta RdRp a cikin SARS-CoV-2 kawai.A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami izinin gaggawa daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta China don amfani da gwajin SARS-CoV-2 na PCR.A Amurka, Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) suna ba da gwajin 2019-Novel Coronavirus (2019-nCoV) na Real-Time RT-PCR Diagnostic Panel don gwajin gwamnati ta hanyar International Reagent Resource.
Daya daga cikin gwaje-gwajen kwayoyin halitta guda uku a cikin tsohuwar hanyar gwaji ta gano sakamakon da ba daidai ba saboda magungunan da ba daidai ba, da kuma matsalar gwaji a CDC a Atlanta; wannan ya sa samfurori kasa da 100 a rana suna aiki a ƙarshen Fabrairu 2020.
Ba a tabbatar da ingancin gwajin biyu ba har zuwa 28 ga Fabrairu 2020, kuma har zuwa lokacin ba a ba da izinin gwajin gwaji na jihohi ba.
Hukumar Abinci da Magunguna ta ba da izinin gwajin ta hanyar izinin Amfani da Gaggawa. Gwaje-gwajen Amurka na kasuwanci sun fara a farkon Maris 2020.
A ranar 5 ga Maris 2020 LabCorp ta sanar da cewa an fara gwajin COVID-19 a duk faɗin ƙasar bisa ga RT-PCR.
Hakanan, Quest Diagnostics ya ba da damar gwajin COVID-19 a duk faɗin ƙasar har zuwa 9 ga Maris 2020.
Ba a sanya iyaka kan yawan ba; dole ne a tattara gwaje-gwaje da sarrafa su bisa ga bukatun CDC.
A Rasha, Cibiyar Nazarin Virology da Biotechnology VECTOR ta ƙasa ce ta haɓaka da kuma samar da gwaje-gwajen COVID-19.
A ranar 11 ga Fabrairu, 2020, an yi rajistar gwajin a cikin Hukumar Kula da Kiwon Lafiya ta Tarayya. A ranar 12 ga Agusta, 2020, Mayo Clinic ta haɓaka gwajin COVID-19. A ranar 13 ga Agusta, 2020, Roche Diagnostics ta sami izinin FDA don gwajin da za a iya yi a cikin awanni 3.5, yana ba da damar na'urar guda ɗaya don yin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin gaggawa ga Abbott Laboratories don gwada tsarin m2000 na Abbott; FDA ta riga ta ba da irin wannan izinin ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta sami izinin gaggawa daga FDA don gwajin da ya ɗauki minti 45.
FDA ta gudanar da gwaji don amfani da fasahar haɓaka nucleic acid ta isothermal maimakon PCR.
Domin ba a bukatar a canja yanayin zafin jiki, ana iya samun sakamako mai kyau cikin minti biyar da kuma marar kyau cikin minti 13.
Akwai kimanin 18,000 na'urori a Amurka a halin yanzu kuma Abbott yana fatan haɓaka samarwa don yin gwaje-gwaje 50,000 a kowace rana. Gwaje-gwaje ta amfani da ƙwayoyin cuta na monoclonal wanda ke ɗaure da nucleocapsid protein (N protein) na sabon coronavirus da ake haɓakawa a Taiwan, ana tsammanin zai iya ba da sakamako a cikin mintuna 15 zuwa 20 kamar yadda yake a cikin gwajin mura mai sauri.
Binciken da aka yi a watan Maris na 2020 ya kammala cewa "Binciken kirji ba shi da amfani a farkon lokacin, kuma sakamakon CT [komputa mai kwakwalwa] na iya haifar da alamun cutar kafin a lura da su".
Abubuwan da aka fi sani da CT sun haɗa da filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen fila
Babban matsayi na subpleural, hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan
Nazarin kwatancen PCR da CT a Wuhan a yankin da cutar ta fara ya nuna cewa CT ya fi sauri fiye da PCR, duk da cewa ba shi da ƙwarewa sosai, saboda yawancin hotunansa suna rikitar da wasu cututtukan huhu da cututtuka.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "ba za a yi amfani da CT don tantancewa ko yin gwajin farko na COVID-19 ba". A watan Maris na 2020, CDC ta ba da shawarar PCR don amfani da gwajin farko.
Wani aikin kwayoyin halitta na mutum shine samar da kwayoyin cuta da suka hada da IgM da IgG.
Ana iya amfani da su don gano cutar a cikin mutane daga kwanaki 7 na bayyanar cututtuka, don gano ƙwayoyin cuta, da kuma lura da yawan masu kamuwa da cutar.Ana iya yin gwajin a cikin cibiyoyin bincike na tsakiya (CLT) ko a cikin gwajin wurin kulawa (PoCT).
Tsarin sarrafa kansa mai ƙarfi a cikin gwaje-gwaje da yawa zai iya yin wannan gwajin amma kasancewar sa zai dogara ne da yawan kowane tsarin da aka samar.
A CLT ana amfani da jinin da aka gwada sau ɗaya, ko da yake ana iya amfani da wasu jini don lura da tsarin jini.
A PoCT, ana samun jini sau ɗaya ta hanyar yin allurar rigakafi a fata.
Ba kamar PCR ba, ba a buƙatar matakin cirewa kafin gwaji.A ranar 26 ga Agusta 2020, FDA ta sami hukumomi 29 da suka ba da sanarwar da aka tsara kuma yanzu suna iya rarraba kayan aikin gwajin rigakafin su.
A ranar 7 ga Afrilu 2020, FDA ta ba da izinin gwajin guda ɗaya a cikin tsarin amincewa da gaggawa.A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan aikin gwajin su, wanda zai iya gano ƙwayoyin cuta na IgG da IgA a cikin samfurin jini.
Suna iya gwada ɗaruruwan samfurori a cikin fewan awanni kaɗan kuma saboda haka sun fi sauri fiye da hanyoyin PCR na yau da kullun don gwajin RNA na kwayar cuta.
Ana yawan gano ƙwayoyin cuta a cikin kwanaki 14 bayan kamuwa da cutar.A farkon watan Afrilu, Burtaniya ta gano cewa babu ɗayan kayan gwajin ƙwayoyin cuta da aka saya da ke aiki yadda ya kamata.
Hong Kong ta kafa tsarin da ke nuna cewa mutanen da ake zargi da cutar suna zama a gida, "sashen gaggawa zai ba da tabarau na gwaji", wanda mai haƙuri zai iya ɗaukar shi, ya dawo da shi kuma ya sami sakamakon gwajin daga baya.
Cibiyoyin gwajin ta hanyar tuki sun taimaka wa Koriya ta Kudu ta gwada mutane da sauri, fiye da kowace ƙasa.A Jamus, Ƙungiyar Likitocin Inshorar Lafiya ta Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dokokin Dok
Inshorar ta biya kuɗin idan likita ya ba da shawarar yin gwajin.
A cewar shugaban cibiyar Robert Koch, Jamus na da damar yin gwaji 160,000 a mako.
A ranar 19 ga watan Maris an gudanar da gwajin mutane a manyan birane.
A ranar 26 ga watan Agusta na shekarar 2020 ba a san adadin mutanen da aka gwada a Jamus ba, saboda sakamakon cutar ne kawai ake bayar da rahoto.
Binciken farko na gwaji ya nuna cewa a cikin makon 12/2020 jimlar samfuran 483,295 da aka gwada har zuwa makon 12/2020 wanda ya haɗa da samfuran 33,491 (6.9%) sun kasance masu dauke da cutar SARS-CoV-2.A Isra'ila, masu bincike daga Asibitin Technion da Rambam sun haɓaka da gwada tsarin gwajin samfurin daga marasa lafiya 64 a lokaci guda, haɗa samfurin da sake dubawa don ganin idan samfurin ya nuna cutar.A Wuhan gwajin gwajin ya kai mita-murabba'in mita 2,000 na "Huo-Yan" (Cinese: 火眼, "Fire Eye" a Turanci, "Fire Eye" a Turanci) wanda za'a iya cirewa a ranar 5 ga Fabrairu, 2020 ko kuma a ranar 5 ga watan Fabrairu.
Wanda ya kafa BGI Wang Jian ne ya jagoranci aikin kuma ya ɗauki kwanaki 5, kuma an kiyasta cewa adadin masu cutar a Hubei zai karu da kashi 47% kuma farashin keɓewa zai ninka sau biyu idan ba a gina cibiyar gwajin ba.
An yi saurin bin gwajin Wuhan da Huo-Yan a Shenzhen, Tianjin, Beijing, da Shanghai, a birane 12 a duk faɗin China.
A ranar 4 ga Maris, 2020, yawan gwajin yau da kullun ya kai 50,000. An samar da samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samfuran samf
A ranar Laraba, karancin maganin da ake amfani da shi don gwaji ya zama tushen gwaji mai mahimmanci a cikin EU da Burtaniya da Amurka.
Wannan ya sa wasu masu bincike suka gwada tsarin shirya samfurin da zafin jiki na 98 °C (208 °F) na tsawon minti 5 don samar da kwayoyin RNA don ƙarin gwaji.A ranar 31 ga Maris an ba da sanarwar cewa Hadaddiyar Daular Larabawa tana gwada mutane da yawa don Coronavirus a duniya, kuma tana da niyyar ƙara yawan gwaji ga yawancin mutane a cikin ƙasar.
An yi wannan ne ta hanyar haɗa tsarin gwajin mutum-mutumin da aka yi a wuraren gwajin, da siyan gwajin gwaji mai yawa daga Group 42 da BGI (wanda ya dogara da gwajin gwajin gaggawa na "Huo-Yan" a China).
Wannan gwajin da aka gina a cikin kwanaki 14 yana da ikon yin dubunnan gwaje-gwaje na RT-PCR a kowace rana kuma shine na farko a duniya da aka yi aiki a wajen China.
An samar da wasu gwaje-gwaje masu yawa da ke nuna kwayoyin halittar coronavirus a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Hukumar Lafiya ta Duniya ta amince da kamfanin Jamus don samar da gwaje-gwaje ga kasashe masu tasowa waɗanda ba su da damar yin hakan.
An fitar da allurar rigakafin Jamus a ranar 17 ga Janairun 2020; ba a fitar da tsarin da Cibiyoyin Kula da Cututtuka na Amurka suka haɓaka ba har zuwa 28 ga Janairu, suna jinkirta gwaji a Amurka.China da Amurka suna da ƙarancin kayan gwaji a farkon lokacin annobar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isasshen kayan aikin don biyan buƙatu da shawarwarin masana kiwon lafiya don yin gwaji ba.
Akasin haka, masana sun ce yin gwaji a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar coronavirus.
An gina ikon gwaji, musamman a dakunan gwaje-gwaje masu zaman kansu, shekaru da yawa da suka gabata ta gwamnatin Koriya ta Kudu.
A ranar 16 ga watan Maris, Hukumar Lafiya ta Duniya ta ba da shawarar ci gaba da shirye-shiryen gwaji a matsayin babbar hanyar rage yaduwar cutar COVID-19.Bukatun gwaji da yawa saboda yaduwar kwayar cutar ya haifar da ƙarancin gwaji a dakunan gwaje-gwaje masu zaman kansu a Amurka, kuma samar da kayan gwaji yana ƙarancin.
A watan Maris na shekarar 2020, kasar Sin ta bayyana cewa akwai matsala a cikin ingancin kayan gwajin.
A Amurka, kayan gwajin da aka samar da CDC sun sami matsala; don haka gwamnati ta cire takunkumin da ke hana gwajin gwaji na kamfanoni masu zaman kansu.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba zai iya zama sakamakon rashin tattara samfurori ko amfani da gwaje-gwaje daidai.
Ma'aikatar ta Spain ta ce za ta cire wasu gwaje-gwaje na mutuwa da aka ba Shenzhen Bioeasy. 80% na gwaje-gwajen da Jamhuriyar Czech ta saya daga China sun ba da mummunan sakamako. Slovakia ta sayi gwaje-gwaje miliyan 1.2 daga China wanda aka gano ba daidai ba.
Firayim Minista Matovič ya ce za a jefa wadannan a cikin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce gwajin da Turkiyya ta saya daga China yana da "damar yin kuskure" kuma "ba a yi amfani da shi ba".
Gwajin, wanda aka bi don keɓe waɗanda ke da cutar da kuma gano waɗanda ke da alaƙa da SARS-CoV-2, ya ba da sakamako mai kyau.
Masu bincike a Vò, Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu na mutane 3,400, kwanaki goma a tsakanin juna.
Kusan rabin mutanen da suka kamu da cutar ba su da alamun cutar, kuma an killace duk waɗanda suka kamu da cutar.
Saboda an hana su zuwa wurin mutane, an rage yawan sabbin masu kamuwa da cutar.
Tsananin bincike na kusanci, hana shiga, gwaji, da keɓewar marasa lafiya, sun taimaka wajen hana cutar coronavirus ta 2020 a Singapore fiye da sauran ƙasashe masu tasowa, amma ba tare da rufe abubuwa da yawa kamar kantunan abinci da ƙananan shaguna ba.
An soke abubuwa da yawa, kuma Singapore ta fara ba da umarnin zama a gida daga 28 ga Maris, amma makarantu za su buɗe a kan lokaci bayan hutu a ranar 23 ga Maris.
Yawancin ƙasashe sun yi nasarar magance cutar ta hanyar keɓe masu kusanci, hana shiga, gwaji, da keɓewa, amma ba tare da yin allurar rigakafi ba, kamar Iceland da Koriya ta Kudu.
Binciken da aka yi ya nuna cewa ƙasashe da suka yi gwaje-gwaje da yawa, idan aka kwatanta da yawan mutanen da suka mutu, suna da ƙananan adadin waɗanda suka mutu, watakila saboda waɗannan ƙasashe suna iya gano waɗanda ba su da alamun cutar ko kuma ba su da alamun cutar.
WHO ta ba da shawarar cewa ƙasashe da ba su da ƙarfin gwaji da ƙwarewar COVID-19 su aika da samfuran farko na biyar na marasa lafiya na COVID-19 da samfurori 10 na farko na lafiya zuwa ɗayan cibiyoyin gwajin 16 na WHO da aka tuntuba don tabbatar da gwajin su.
Daga cikin gwaje-gwaje 16 da aka yi, 7 a Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amirka, da 1 a Ostareliya.
A cikin jadawalin da ke ƙasa, yawan adadin masu cutar da aka gwada ya dogara da tsarin gwajin ƙasa.
Kasashen da ke gwada marasa lafiya kawai a asibitoci za su sami kashi sama da kashi na marasa lafiya da aka gwada fiye da ƙasashen da ke gwada jama'a gaba ɗaya, ko suna da alamun cutar ko a'a, idan duk sauran abubuwa sun kasance daidai.
Wanke hannu, wanda kuma ake kira tsabtace hannu, aikin tsabtace hannu ne don kawar da datti, man shafawa, ƙwayoyin cuta, ko wasu abubuwa marasa amfani.
Wanke hannu da sabulu a "lokaci mafi muhimmanci" na rana yana hana yaduwar cututtuka da yawa, kamar su tari, da ake yaɗawa ta hanyar numfashi.
Mutane suna iya kamuwa da cututtukan ƙwayoyin cuta kamar mura, idan ba su wanke hannayensu ba kafin su taɓa fuska, hanci, ko baki (watau wurare masu sanyi).
Lokaci biyar mafi muhimmanci a rana da wanke hannu da sabulu ya fi zama dole: kafin ko bayan fita daga bayan gida, bayan ka wanke bayan jariri ko canza masa takalmin wanka, kafin ciyar da jariri, kafin cin abinci da kuma bayan ka fita ko bayan ka shirya abinci ko ka sha nama ko kifi.
Idan babu sabulu da ruwa, za a iya wanke hannaye da toka.
Kafin ka ci abinci, bayan ka shirya abinci, da kuma bayan ka gama.
Kafin ka kula da marar lafiya da kuma bayan ka gama.
Bayan na canja takalmi ko kuma na wanke jariri bayan na fita daga bayan gida.
Bayan ka yi fitsari ko tari ko kuma tari.
Bayan ka taɓa dabba ko naman dabbar ko kuma ɓarnar da ta yi.
Tsabtace hannu na likita yana nufin tsabtace hannu don dalilai na kiwon lafiya.
Wanke hannu kafin a ba da magani ko kuma a yi jinya zai iya hana kamuwa da cuta.
Babban manufar wanke hannu a likitanci shine kashe ƙwayoyin cuta (ƙwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta masu sa cututtuka) da kuma kawar da ƙwayoyin cuta masu cutarwa ko cututtuka.
Wannan yana da mahimmanci ga masu kula da abinci ko masu aiki a masana'antar kiwon lafiya, amma yana da kyau ga kowa.
Wanke hannu yana da fa'idodi da yawa, gami da rage yaduwar mura, coronavirus, da sauran cututtukan da ake ɗauka; guje wa abubuwa masu guba; rage cututtukan da ke tattare da cutar sankarar bargo;
rage mutuwar yara a gida.
Wani bincike na 2013 ya nuna cewa ƙara yawan wanke hannu na iya inganta ci gaban yara 'yan ƙasa da shekaru biyar.
A ƙasashe masu tasowa, ana iya rage yawan yara da ke mutuwa daga cututtukan ƙanƙara da kuma zazzaɓi ta wajen yin canje-canje a yadda ake wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage mutuwar mutane da kashi 50 cikin ɗari.
Ƙaddamar da aikin wanke hannu zai iya rage yawan ɓarnar ruwa da kashi ɗaya bisa uku, wanda ya yi daidai da samar da ruwa mai tsabta a yankunan da ba su da kuɗi.
Rage yawan kamuwa da cutar da kashi 48% za a iya daidaita shi da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da tsada don hana kamuwa da cuta ta hanyar kamuwa da cuta, kamar yadda ake yi a gida, makarantu da al'ummomi a duniya.
Ciwon huhu, wanda shi ne mafi yawan cututtukan da ke shafar jiki, shi ne babban dalilin mutuwar yara 'yan kasa da shekara biyar, yana kashe yara miliyan 1.8 a kowace shekara.
Cutar zazzabin cizon sauro da cutar tarin fuka suna kashe yara miliyan 3.5 kowace shekara.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da bayan bayan bayan gida na iya ceton rayuka fiye da allurar rigakafi ko magani, yana rage yawan mutuwar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututut
Wanke hannu yana zuwa tare da sauran ayyukan tsabtace jiki a matsayin wani ɓangare na aikin ruwa, tsaftacewa da tsabta (WASH).
Wanke hannu yana hana kamuwa da cutar sankarar bargo, wadda ke yaduwa ta hanyar taɓa mutum kai tsaye.
Ƙananan haɗari na wanke hannuwan hannu a kai a kai shine ƙarancin fata.
Wani bincike da aka yi a Denmark a shekara ta 2012 ya nuna cewa yawan wanke hannu yana sa mutum ya yi zazzabi da kuma fari.
Ana kuma ganin wanke hannu sau da yawa a matsayin alamar wani abu da ake kira obsessive-compulsive disorder (OCD).
Akwai lokuta guda biyar na rana da wanke hannu da sabulu ke da mahimmanci don rage kamuwa da cututtukan da ke wucewa ta bakin: bayan amfani da bayan gida (numfashi, wankewa), bayan wanke jariri (canza takalmin wanka), kafin ciyar da jariri, kafin cin abinci da lokacin da za a shirya / bayan cin abinci ko taɓa nama ko kifi.
Wasu yanayi da ake bukatar wanke hannu sosai don hana yaduwar cuta sun haɗa da kafin ko bayan an taɓa ƙwaro ko ƙwaro; bayan an husu, tari, ko hancin mutum; bayan an taɓa ƙwaro ko dabba; da kuma bayan an taɓa shara.
A ƙasashe da yawa, wanke hannu da sabulu ba shi da muhimmanci.
Binciken wanke hannu a cikin kasashe 54 a shekarar 2015 ya gano cewa a matsakaita, kashi 38.7% na iyalai suna wanke hannayensu da sabulu.Binciken na 2014 ya nuna cewa Saudi Arabiya ta kasance mafi girma a wanke hannu da kashi 97 cikin dari; Amurka tana cikin matsakaici da kashi 77 cikin dari; kuma China tana da kashi 23 cikin dari.A halin yanzu akwai canje-canje da yawa a cikin halayyar jama'a don inganta al'adun wanke hannu da sabulu a lokacin bala'i.Wasu yara suna wanke hannayensu a cikin rukuni a lokacin makaranta a rana tare da yin amfani da hannu a cikin yara a cikin ci gaban duniya.
Shirin Kula da Kiwon Lafiya na Muhimmanci wanda Ma'aikatar Ilimi ta Philippines ta aiwatar shine misali na ayyukan inganta kiwon lafiya da ilimin yara.
Shan maganin kashe kwari sau biyu a shekara, wanda ya haɗa da wanke hannu da sabulu kowace rana, goge haƙori kowace rana da fluoride, suna cikin jerin abubuwan da aka tsara a cikin wannan ƙasar.
An yi amfani da wannan shirin a ƙasar Indonesia.
Ana ƙara cire ƙwayoyin cuta daga fata ta hanyar haɗa sabulu da ruwa.
Ainihin aikin sabulu shi ne rage hana ruwa daga shiga cikin ruwa, yana sa ya yi saurin zubowa.
Ruwa kaɗai ba zai iya sa fata ta yi kyau ba domin mai da kuma furotin, da suke cikin ƙasa, ba sa narkewa.
Maimakon haka, ana yin wanka ne da taimakon ruwa mai gudana.
Sabulu da aka yi da kwalba, da yake ana sake amfani da shi, zai iya kasancewa da ƙwayoyin cuta daga waɗanda suka yi amfani da shi.
Wasu bincike da aka yi a kan ƙwayar cuta da ke cikin sabulu da aka yi amfani da shi a cikin giya sun nuna cewa ƙwayar cuta tana da wuyar tafiya domin tana cikin ƙwayoyin cuta.
Hukumar Kula da Cututtuka ta ce "sabulu da ruwa da ba a taɓa su ba suna da kyau".
An ƙarfafa masu kula da lafiyarsu su yi amfani da sabulu da ke kashe ƙwayoyin cuta.
A yanzu, babu tabbaci cewa maganin kashe ƙwayoyin cuta yana kashe ƙwayoyin cuta.
Maimakon haka, sabulu da ke kashe ƙwayoyin cuta yana ɗauke da maganin kashe ƙwayoyin cuta kamar su triclosan, wanda ke ɗauke da abubuwa da yawa da ke kashe ƙwayoyin cuta.
Saboda haka, maganin hana yaduwar cuta ba shi da maganin hana yaduwar cuta, kuma ba zai yi aiki yadda aka ce ya yi ba.
Baya ga kayan aikin fata, magungunan da ke da magunguna daban-daban na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) kamar mai kula da pH, antimicrobially active benzoic acid da sauran abubuwan da ke sa fata ta zama mai laushi (aloe vera, bitamin, menthol, abubuwan da aka samo daga tsire-tsire).
Ruwan da ke da zafi sosai ba zai iya kashe ƙwayoyin cuta ba.
Kwayoyin cuta suna girma da sauri a zafin jiki (37 °C).
Akasin haka, ruwan zafi, mai sabulu yana da tasiri fiye da ruwan sanyi, mai sabulu wajen kawar da ƙwayoyin cuta da ƙwayoyin cuta.
Amma, akasin abin da mutane suke tunani, binciken da masana kimiyya suka yi ya nuna cewa shan ruwan zafi ba ya rage yawan ƙwayoyin cuta a hannaye.
Sanitizer na hannu ko antiseptic na hannu shine mai tsabtace hannu wanda ba ya dogara da ruwa.
A ƙarshen shekarun 1990 da farkon ƙarni na 21, an soma amfani da maganin wanke hannu da aka yi da giya (wanda ake kira rubs na hannu da ke ɗauke da giya, rubs na hannu da ke kashe ƙwayoyin cuta, ko kuma masu tsabtace hannu).
Yawancin lokaci ana yin su ne daga isopropyl alcohol ko ethanol tare da wani abu mai wuya kamar Carbomer (polymer na acrylic acid) don yin su a cikin kayan shafawa, ko kuma mai laushi kamar glycerin don yin ruwa, ko kuma mai laushi don sauƙaƙe masu amfani da su da kuma rage yawan barasa.
Ƙarin hydrogen peroxide mai narkewa yana ƙara ƙarfin kashe ƙwayoyin cuta. Sanitizers na hannu da ke da kashi 60 zuwa 95% na barasa suna kashe ƙwayoyin cuta.
Magungunan tsabtace jiki na barasa suna kashe kwayoyin cuta, kwayoyin cuta masu jurewa da yawa (MRSA da VRE), tarin fuka, da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccinia, mura, da hepatitis) da fungi.
Ruwan shafawa na giya da ke dauke da kashi 70% na barasa yana kashe kashi 99.97% na kwayoyin cuta (3.5 log reduction, idan aka kwatanta da ragewar decibel 35) a hannaye bayan minti 30 da amfani da kashi 99.99% zuwa 99.999% (4 zuwa 5 log reduction) na kwayoyin cuta a hannaye bayan minti 1 da amfani.
Masu tsabtace hannu da aka yi da giya ba su da tasiri sosai a kan kwayar cutar norovirus (ko Norwalk), wanda shine babban dalilin cututtukan cututtukan ciki.
A gaban da bayan kowane yatsan hannu da kuma a cikin ƙafar yatsan hannu da ke kusa da su, a yi amfani da ruwa na minti 30 har sai ruwa, ƙura, ko kuma ƙura sun bushe.
Hakanan ya kamata a wanke hannayen hannu sosai, tare da wankewa a duka sassan.Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka sun ba da shawarar wanke hannu fiye da amfani da mai tsabtace hannu, musamman idan hannayen sun kasance masu datti.
Ana amfani da waɗannan kayan aikin da yawa saboda sauƙin amfani da saurin kashe ƙwayoyin cuta; duk da haka, ba za a maye gurbin su da tsabtace hannu ba sai dai idan sabulu da ruwa suna nan.
Yin amfani da kayan tsabtace jiki na giya da yawa na iya sa fata ta zama mai laushi sai dai idan an haɗa su da kayan shafawa da / ko kayan shafawa.
Ana iya rage ko kawar da ƙwanƙwasawa ta hanyar haɗa kayan shafawa ko wasu kayan shafawa.
A binciken da aka yi a kan lafiyar jiki, maganin wanke jiki da aka yi da giya da kuma wasu kayan shafawa sun rage yawan ƙonewa fiye da sabulu ko sabulu mai kashe ƙwayoyin cuta.
Allergic contact dermatitis, contact urticaria syndrome ko rashin haɗuwa da barasa ko kuma abubuwan da aka haɗa da giya a cikin kayan tsabtace jiki ba su da yawa.
Wani abu da ya fi saurin haifar da cutar fata (irritant contact dermatitis) ya jawo hankalin mutane idan aka kwatanta da wanke hannu da sabulu da ruwa.
Ko da yake suna da amfani, masu tsabtace hannu da ba a yi su da ruwa ba suna kashe ƙwayoyin cuta ne kawai.
Wannan shine dalilin da ya sa sanitizer ba ta da tasiri kamar sabulu da ruwa wajen hana yaduwar ƙwayoyin cuta da yawa, saboda ƙwayoyin cuta suna kasancewa a hannu.
Sanitizers marasa barasa suna da tasiri sosai, kuma a tarihi ba su da tasiri kamar masu tsabtace jiki da ke da barasa.
A baya-bayan nan, an gano cewa maganin da ke amfani da benzalkonium chloride yana da tasiri sosai wajen kashe ƙwayoyin cuta idan aka yi amfani da shi, fiye da barasa, wanda aka gano cewa yana da tasiri sosai idan aka ci gaba da amfani da shi, watakila saboda cutar fata.
A ƙasashe masu tasowa, mutane da yawa ba sa samun sabulu, saboda haka, suna amfani da toka da ƙasa.
Ƙura da ƙasa suna iya yin aiki fiye da ruwa, amma ba su da amfani kamar sabulu.
Matsalar ita ce, ƙura da ƙasa da ke cike da ƙwayoyin cuta suna iya sa cutar ta yaɗu maimakon ta rage.
Kamar sabulu, ƙura tana kashe ƙwayoyin cuta ta wajen haɗuwa da ruwa kuma ta zama alkaline.
WHO ta amince da amfani da toka ko yashi maimakon sabulu idan babu sabulu.
Tsabtace hannu da aka ba da shawarar Cibiyoyin Kula da Cututtuka na Amurka don hana yaduwar cututtuka sun haɗa da waɗannan matakan:
Kada ka wanke hannuwanka da ruwan sanyi ko mai zafi.
Ana ba da shawarar ruwa mai gudana domin ruwa mai gudana yana iya ɗauke da ƙwayoyin cuta, kuma zafin jiki na ruwa ba ya bambanta.
Ka wanke hannayenka da sabulu da kuma sabulu mai tsabta, a bayan yatsun hannu, a kan yatsun hannu, da kuma a ƙarƙashin ƙafarka.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa wanke hannu da sabulu ya fi kyau fiye da wanke hannu da ruwa.
Na yi kusan minti 20.
Wanke hannu yana sa su yi tsafta, kuma hakan yana kawar da ƙwayoyin cuta daga fata.
Ina tafiya cikin ruwa mai gudana.
Idan aka saka shi cikin ruwa mai zurfi, zai sake sa ƙwayoyin cuta a hannunsa.
Ka wanke hannayenka da tawul ko kuma ka bar su su bushe.
A wasu wurare, ana iya manta da inda ake yin wanka da kuma inda ake yin wanka da kuma inda ake yin wanka da kuma inda ake yin wanka da wanka.
Ƙarancin abinci da kuma cin abinci mai gina jiki zai iya ɓoye ƙwayoyin cuta.
Ana ba da shawarar yin amfani da kayan shafawa don kiyaye hannayen hannu; bushewar fata na iya haifar da rauni a fata wanda zai iya ƙara haɗarin kamuwa da cuta.
Akwai wasu hanyoyin da za a iya amfani da su don wanke hannu idan babu ruwan famfo ko sabulu don zubar da ruwa daga bututun da aka rataye ko bututun da aka ɗora da kuma / ko amfani da toka idan ya cancanta a ƙasashe masu tasowa.A cikin yanayin rashin isasshen ruwa (kamar makarantu ko ƙauyuka a ƙasashe masu tasowa), akwai matakan rage amfani da ruwa, kamar "tippy-taps" da sauran hanyoyin da ba su da tsada.
Tippy-tap hanya ce mai sauƙi ta amfani da igiya mai ɗaure da igiya, wanda aka ɗora a kan ruwa kaɗan kuma aka shafa a kan hannu da sabulu.
Wanke hannu da kyau yana da muhimmanci wajen tsabtace hannu, amma akwai jayayya game da yadda za a wanke hannu a bayan gida.
Bincike da yawa sun nuna cewa takarda tana da amfani sosai fiye da na'urorin tsabtace gida.
A shekara ta 2008, Jami'ar Westminster da ke Landan da kuma wata masana'antar da ke sayar da tawul na takarda da ke Turai sun yi bincike don su gwada yadda tsabtace hannu yake sa hannu ya yi kyau idan aka yi amfani da tawul na takarda da kuma na'urar busar hannu.
Bayan wanke hannu da iska mai zafi, an sami ƙaruwa na kwayoyin cuta a hannaye da kashi 194% da kuma fata da kashi 254%.
Wanke hannu da iska mai ƙarfi ya haifar da ƙaruwa na kwayoyin cuta a hannaye da kashi 42% da kuma a kan goshi da kashi 15%.
Bayan wankewa da wanke hannu da tawul na takarda, ƙwayoyin cuta sun ragu da kashi 76% a kan hannaye da kashi 77% a kan gashin baki. Masana kimiyya sun kuma gudanar da gwaje-gwaje don gano ko masu amfani da bayan gida suna iya hana ƙwayoyin cuta da yanayin bayan gida daga nau'ikan wanke hannu daban-daban.
Mai sanyaya iska mai ƙarfi, yana busa iska a saurin mita 180 a kowane dakika (650 km/h; 400 mph), yana iya fitar da ƙwayoyin cuta daga hannaye da kuma daga ciki kuma yana iya cutar da sauran masu amfani da bayan gida da kuma yada su a cikin bayan gida a cikin nisan mita 2.
Ana amfani da iska mai zafi don fitar da ƙwayoyin cuta a nisan mita 0.25 daga inda suke.
Takaddun takarda ba su nuna yiwuwar yaduwar ƙwayoyin cuta ba. A cikin binciken da TÜV Produkt und Umwelt ya yi a shekara ta 2005, an bincika hanyoyin tsabtace hannu daban-daban.
An gano canje-canje masu zuwa a cikin adadin kwayoyin bayan wanke hannu:
Ana yin wanke-wanke a wurare da yawa, kuma ana kwatanta wanke-wanke da wanke-wanke da takarda.
Ana amfani da wanke hannu da takarda mai laushi don tafiya ba tare da sabulu da ruwa ba.
Ya kamata a yi amfani da kayan tsabtace jiki da ke ɗauke da giya da kashi 60 cikin ɗari na giya.
Bayan da wani likita mai suna Ignaz Semmelweis ya gano cewa wanke hannu yana da amfani sosai a asibiti (a shekara ta 1846) ne aka soma yin amfani da shi sosai.
Akwai na'urorin tunatarwa da ke aiki a asibitoci da ke tuna wa ma'aikatan su wanke hannayensu idan sun manta.
Wasu bincike sun nuna cewa idan mutum ya yi amfani da na'urar lantarki, zai rage yawan kamuwa da cututtuka.
Wanke hannu don hana kamuwa da cuta yana ɗaukar aƙalla mintuna 15, ta amfani da sabulu da ruwa mai yawa don wankewa da kuma wanke kowane ɓangaren hannu.
Dole ne a haɗa yatsunsu da yatsunsu.
Idan akwai ƙwayoyin cuta a cikin abinci, ana iya amfani da wani abu mai tsabta don kawar da shi.
Tun da yake ƙwayoyin cuta suna iya kasancewa a cikin ruwa, yana da muhimmanci a sha ruwa sosai kuma a share shi da tawul mai tsabta.
Bayan an bushe, sai a yi amfani da tawul na takarda don rufe ruwa (kuma a buɗe ruwan idan ya cancanta).
Hakan zai hana hannayenmu sake kamuwa da ƙwayoyin cuta.
Mahimmancin wanke hannu a asibiti shine kawar da ƙwayoyin cuta da hana yaduwar su.
Jaridar New England Journal of Medicine ta ce, rashin wanke hannu ya ci gaba da zama matsala a asibitoci da yawa, inda likitoci da ma'aikatan jinya da yawa suka manta su wanke hannayensu kafin su taɓa marasa lafiya, kuma hakan yana sa su yi amfani da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da kuma wasu matakai masu sauƙi suna rage yawan ƙwayoyin cuta da ke shiga cikin jini da kashi 66 cikin ɗari.
Ana kuma iya samun jagorar wanke yatsun hannu na hukumar a shafin yanar gizon ta don masu amfani su yi tsokaci.
Whitby da abokansa sun yi nazari sosai.
Akwai na'urori da za su iya gwada tsabta idan ya cancanta.
Hukumar Lafiya ta Duniya ta bayyana "Matsayi Biyar" na wanke hannu:
bayan  taɓa jini/ruwan jiki
Ina so in yi wani abu marar cutarwa, kuma
Bayan ka taɓa mai ciwo, kana iya yin amfani da sabulu da aka yi da maganin ƙwayoyin cuta don ya kashe ƙwayoyin cuta.
Ana iya buƙatar maganin rigakafi kafin a yi wa mai haƙuri tiyata ko kuma a yanayin da kwayoyin cutar ke da ƙoshin lafiya.Tsabtace hannu kafin aikin tiyata, ana buƙatar tef mai cirewa da za a iya cirewa ba tare da taɓa hannu ba, wanka da chlorhexidine ko iodine, tawul ɗin da aka dafa don wanke hannu bayan wanka, da tawul ɗin da aka dafa da sauran kayan wankewa.
Dole ne a cire duk wani abin da ke da lahani.
Wannan aikin yana buƙatar wanke hannuwanku da rabin hannu har zuwa ƙwanƙolin hannu, na tsawon minti 2.6.
Ba a bukatar a wanke hannuwanku na tsawon lokaci (minti 10) ba.
Kada ka bar ruwa ya shafe hannunka sa'ad da kake motsa shi.
Bayan wanke hannu, ana wanke hannaye da tawul mai tsabta kuma ana wanke rigar.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko amfani da maganin kashe ƙwayoyin cuta kafin da kuma bayan taɓa mai haƙuri.
Don hana kamuwa da cutar staphylococcal a asibitoci, an gano cewa mafi yawan fa'idodin wanke hannu sun fito ne daga kashi 20% na farko na wanke hannu, kuma mafi ƙarancin fa'idodin wanke hannu ya karu da kashi 35%.
Wanke hannu da sabulu da aka yi da giya ya kara yawan kamuwa da cuta ta hanyar abinci fiye da sau uku idan aka kwatanta da wanke hannu da sabulu da aka yi da barasa. Kwatanta wanke hannu da sabulu da aka yi da barasa da wanke hannu da sabulu da aka yi da barasa na minti 30 kowannensu ya nuna cewa wanke hannu da sabulu da aka yi da barasa ya rage kwayoyin cuta da kashi 26% fiye da sabulu da aka yi da barasa.
Sabulu da ruwa suna da tasiri sosai fiye da wankewa da kuma tsabtace hannu da ke dauke da barasa wajen rage kamuwa da cutar H1N1 influenza A virus da Clostridium difficile spores daga hannaye.
Akwai buƙatar ƙarin bincike kan abin da waɗannan hanyoyin ke aiki mafi kyau a cikin yanayin asibiti daban-daban.
A ƙasashe masu tasowa, ana ɗaukan wanke hannu da sabulu a matsayin hanyar rage kuɗi, da kuma inganta lafiyar jiki da kuma abinci mai gina jiki.
Amma rashin ruwa, sabulu ko kayan wanke hannu a gidajen mutane, makarantu da wuraren aiki yana da matukar wahala wajen yada da kuma inganta al'adar wanke hannu a ko'ina.
Alal misali, a yankunan karkara na Afirka, yawancin bututun wanke hannu suna da iyaka a kusa da duk wani bayan gida na jama'a ko na jama'a, duk da cewa akwai hanyoyin da ba su da tsada na gina wuraren wanke hannu.
A maimakon haka, wanke hannu a hankali zai iya zama al'ada da mutum ya saba da shi ba don rashin sabulu da ruwa ba.
Talla da kuma karfafawa mutane su wanke hannayensu da sabulu na iya canza tsarin al'umma, ilimantar da mutane game da fa'idodin wanke hannu da kuma canza rayuwar al'umma gaba ɗaya.
Amma don yin wannan, ana buƙatar kulawa da kulawa da kuma lura da ayyukan mutane.
Bincike mai zurfi na 70 ya gano cewa manufofin al'umma a ƙasashe masu tasowa (LMICs) suna da tasiri sosai wajen ƙarfafa wanke hannu; a maimakon haka, kamfen ne na talla da ba ya aiki a wannan hanyar. Misali na ƙarfafa wanke hannu a makarantu shine "Hanyar Tauraruwa Uku" ta UNICEF; wannan dabarar ta ƙunshi ƙarfafa makarantu don amfani da hanyoyi masu sauƙi da araha don ƙarfafa ɗalibai su wanke hannu da sabulu, a matsayin ɓangare na bukatun tsabta.
Idan aka kai ga matakin farko, za a iya ƙara makarantu daga tauraro ɗaya zuwa taurari uku.
Samar da wuraren wanke hannu na iya zama wani ɓangare na kamfen don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya ita ce misali mai kyau na yadda za a iya amfani da ita don ƙarfafa canjin halaye.Domin annobar coronavirus 2019-2020, UNICEF ta ƙirƙiri wani dandamali na kan layi don ƙarfafa wanke hannu.
Akwai wasu ƙananan nazarin da suka bincika tasirin kuɗi na wanke hannu a cikin ƙasashe masu tasowa idan aka kwatanta da ƙimar DALYs da aka kauce wa.
Amma, wasu bincike sun nuna cewa, yawan wanke hannu da sabulu ya fi sauran hanyoyin tsabtace ruwa.
Muhimmancin wanke hannu ga lafiyar mutum musamman ga mutanen da suke cikin yanayi mai tsanani kamar mata masu ciki ko sojoji da suka ji rauni a asibitoci an fara gane su a tsakiyar karni na 19 da likitan Hungary Ignaz Semmelweis na asibitin Vienna, Austria da kuma Florence Nightingale, "mai kafa magani na zamani" na Ingila.
A lokacin, an yi imani cewa ciwon yana zuwa ne daga ƙwari.
A cikin shekarun 1980, cututtukan da ke tattare da abinci da kuma cututtukan da ke tattare da magunguna sun sa Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ba da shawarar cewa a wanke hannaye don hana yaduwar cututtuka.
Cutar mura ta alade a cikin 2009 da COVID-19 a cikin 2020 sun sa ƙasashe da yawa su fahimci mahimmancin wanke hannu da sabulu don hana kamuwa da cututtukan da aka ambata a sama.
Alal misali, an saka takardu da ke ɗauke da kalmomin nan "daidaitaccen wanke hannu" a bayan gida da kuma bayan gida a ofisoshin gwamnati da kuma filayen jirgin sama a Jamus.
Furcin nan "wanke hannu" yana nufin cewa mutum ya ce ya bar wani aiki ko kuma ya bar wani abu.
An yi amfani da wannan furucin a cikin littafin Matta sa'ad da Pontius Bilatus ya wanke hannunsa don ya yanke shawarar kisa Yesu Kristi.
A littafin Shakespeare, Macbeth, an tilasta wa matar Macbeth ta wanke hannayenta yayin da take ƙoƙarin ta yi tunani a kan abin da take tunani a kai, wanda ke nuna cewa ta yi laifi don laifin da ta yi kuma hakan ya sa mijinta ya yi jinkirin.
An kuma gano cewa idan mutane suka tuna da abin da suka yi a dā, sukan wanke hannayensu sau da yawa fiye da sauran mutane kuma suna amfani da na'urar wanke hannu fiye da dā.
Bugu da ƙari, waɗanda aka ƙyale su su wanke hannuwansu bayan sun yi hakan ba za su sake yin ayyukan tsabta ba kamar aikin agaji.
Addini yana ƙarfafa wanke hannu don tsabta da kuma alama. Wanke hannu na alama, wato, amfani da ruwa mara sabulu don wanke hannu, wani ɓangare ne na wanke hannu da aka yi a addinai da dama, ciki har da Bahai, Hindu, tevilah da netilat yadayim a addinin Yahudawa, Lavabo a cikin mabiyan Kristi, da Wudhu a cikin Musulunci.
Addinin Hindu, Yahudanci da Musulunci sun bukaci a wanke hannu bayan an gama bayan gida.
Bugu da ƙari, addinai kamar su Hindu, Buddha, Sikh, Yahudawa, da Musulmai suna ƙarfafa a wanke hannu kafin a ci abinci da kuma bayan an ci abinci.
Ƙuntatawa ga matsalolin aiki da COVID-19 ke haifarwa
Matsalolin da ke tattare da cutar COVID-19 sun haɗa da kafa matakan kariya da kuma hana kamuwa da cutar coronavirus 2019 (COVID-19).
Hanyoyin da suka dace don hana haɗarin aiki sun dogara da wurin aiki da aikin da ake yi kuma ƙalubalen ya dogara da la'akari da tushen haɗarin, girman cutar a cikin al'umma, da haɗarin haɗari ga ma'aikata da ke cikin haɗarin kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aiki ta Amurka (OSHA), ayyukan da ke da haɗari kaɗan suna da ƙananan haɗari ga jama'a da ma'aikata, kuma ana iya magance waɗannan haɗarin ta hanyar kula da lafiya na farko, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ƙa'idodin numfashi, da kuma ƙoƙarin tsabtace wuraren aiki da kuma kashe ƙwayoyin cuta a kai a kai.
Ayyukan da ke da haɗari kaɗan sun haɗa da waɗanda ke da alaƙa da mutanen da ba a sani ba ko waɗanda ake zargi da cutar COVID-19, amma waɗanda ke da haɗarin kamuwa da cutar ta hanyar yaduwar cutar a cikin gida ko ta hanyar tafiya zuwa ƙasashen waje.
Wannan ya haɗa da ma'aikatan da suke aiki da jama'a, kamar makarantu, wuraren aiki, da kuma wuraren kasuwanci.
Irin wannan rigakafin ya haɗa da matakan rigakafin cutar, gami da amfani da iska mai tsabta, da kuma sanya tufafin rufe jiki idan akwai wani mai cutar COVID-19 a kusa.
OSHA ta ba da kulawa ga likitoci / ma'aikatan jinya da ke aiki a wuraren da ake zargin suna da cutar COVID-19 saboda haɗarin su, wanda ke ƙaruwa yayin da ma'aikatan suka ɗauki samfuran gawa daga gawa ko waɗanda ake zargin suna da cutar COVID-19.
Abubuwan da ake yi don hana waɗannan ma'aikatan haɗari sun haɗa da hanyoyin gina gine-gine, kamar su iska mai iska daga ɗaki zuwa ɗaki, da kuma kayan aiki na jiki da ke kai ga aikin da mutum yake yi.
Fashewar COVID-19 na iya haifar da tasiri mai yawa a wuraren aiki.
Ma'aikata suna iya rasa aikinsu domin rashin lafiya, kula da wasu, ko kuma tsoron kamuwa da cutar.
Kasuwanci na iya canzawa, bisa ga abin da mutane suke so da kuma yadda suke sayen waɗannan abubuwa (misali sayayya a lokacin da ake sayarwa ko kuma son kawo musu kayayyaki ko kuma kasancewa a cikin motoci a wuraren da ake sayarwa).
A ƙarshe, ana iya katse jigilar kayayyaki daga yankunan da ke fama da COVID-19. Shirye-shiryen kamuwa da cutar da kuma hanyoyin magance su suna da mahimmanci don taimakawa jagorantar ayyukan rigakafi.
Shirye-shiryen suna la'akari da matakan haɗari da suka shafi wurare daban-daban da kuma aikin da kansa, ciki har da sakamakon cututtuka, haɗari daga gida da al'umma, da sauran abubuwan haɗari kamar shekaru ko rashin lafiya mai tsanani.
Suna kafa matakan da suka dace don magance wannan haɗarin, da kuma tsarin kariya don yanayin da zai iya faruwa a lokacin da cutar ta taso.
Shirye-shiryen kamuwa da cuta na iya dogara da shawarar da kowace ƙasa ko yanki ya bayar.
Manufofin magance cututtukan cututtuka sun haɗa da rage yaduwar cututtuka tsakanin ma'aikata, kare mutanen da ke cikin haɗarin kamuwa da cuta da kuma haɗari, ci gaba da ayyukan, da rage tasirin ga waɗanda ke cikin kasuwancin da ke cikin sabis.
Cutar ta ci gaba da yaduwa a cikin kasuwancin da ke cikin yankin yana haifar da matsala ga yadda za a magance ta.
Tsarin rigakafin rikice-rikice shine tsarin da aka fi amfani dashi a duniya don magance matsalolin aiki da rayuwa ta hanyar rarraba hanyoyin da ake amfani da su bisa ga ingancin su.
A yayin da cutar COVID-19 ba za ta iya jurewa ba, rigakafin ya fi ingancin sarrafa injiniya, wanda ya fi dacewa da sarrafa gudanarwa kuma a ƙarshe, sarrafa mutum.
Gudanar da aikin injiniya yana nufin kawar da ma'aikata daga matsalolin da ke tattare da aikin ba tare da dogaro da dabi'un aiki ba kuma yana da matukar dacewa don aiwatarwa.
Gudanarwa na gudanarwa shine canje-canje a cikin tsarin aiki ko tsarin aiki wanda ke buƙatar ma'aikaci ko mai aiki don yin aiki.
Kayan kariya na mutum (PPE) ba su da tasiri sosai a cikin aikin injiniya ko gudanarwa amma suna iya taimakawa wajen hana kamuwa da cuta.
Ya kamata a zaɓi duk nau'ikan PPE dangane da haɗarin da ma'aikaci zai iya fuskanta, ya kamata a sanya su a inda ya dace kuma a kiyaye su (misali lokacin da aka cire su), a sa su a kowane lokaci kuma a cikin tsari, a bincika su a kai a kai, a kula da su, a gyara su, a cire su a inda ya dace, a tsabtace su, a adana su ko a zubar da su don hana kamuwa da cuta.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aiki ta Amurka (OSHA), ayyukan da ba su da haɗari suna da ƙananan hulɗa da abokan aiki.
Abubuwan da aka ba da shawarar a duk wuraren aiki sun haɗa da wanke hannu da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, al'adun yin fitsari ko hancin ciki har da rufe baki lokacin yin tari ko hancin, rarraba takardun tsabtace jiki da kuma maye gurbin takardun tsabtace jiki, kasancewa a shirye don sadarwa ta waya ko musayar aiki idan ya cancanta, ƙarfafa ma'aikata kada su yi amfani da kayan aikin mutum, tsabtace wuri a kai a kai da kuma ƙoƙarin kashe ƙwayoyin cuta.
Gano mutanen da ake zargi da cutar da wuri da kuma keɓe su yana taimakawa wajen ceton ma'aikata, masu ɗaukar kaya, baƙi da sauran mutane a wuraren aiki.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun ba da shawarar cewa ma'aikata da ke da alamun cututtukan numfashi na yau da kullun su kasance a gida har sai cutar zazzabin cizon sauro ta ƙare, bayan sun sami alamun zazzabin cizon sauro, da sauran alamun aƙalla awanni 24 ba tare da maganin kashe zazzabin ba, kuma cewa tsarin dakatar da ma'aikata ya kamata ya zama mai sauyawa, ya ba ma'aikata damar zama a gida don kula da marasa lafiya, kuma ma'aikata su kasance da masaniya game da waɗannan hanyoyin.
A cewar OSHA, ayyukan haɗari masu haɗari sun haɗa da ayyukan da ke buƙatar mutane su kasance a cikin nisan mita 1.8 daga mutanen da ba a san su da cutar COVID-19 ba, amma waɗanda ke da yiwuwar samun SARS-CoV-2 saboda yaduwar cutar a cikin yankin ko kuma saboda mutumin ya yi tafiya zuwa ƙasashen waje a cikin sanannen yankin da ke da cutar COVID-19.
Waɗannan sun haɗa da ma'aikata da ke hulɗa da jama'a kamar makarantu, wuraren aiki masu cunkoso, da wuraren cin kasuwa masu cunkoso. Gudanar da sarrafawa na injiniya a waɗannan wuraren da ke cikin haɗari sun haɗa da sanya matattarar iska mai ƙarfi a kan gine-gine, ƙara girman abin rufe fuska, samar da ɗakuna masu tsananin haɗari yayin buɗewa, da kuma samar da taga mai faɗakarwa don ba da sanarwar kai tsaye ta hanyar sadarwa. Ana ba da shawarar yin amfani da allon sarrafawa na aikin a kowane lokaci don ƙarfafa masu amfani da haɗari masu haɗari don yin amfani da kayan aiki masu haɗari, kayan aiki masu haɗari don kiyaye lafiyar jiki da kuma kiyaye lafiyar jiki. Masu aiki na iya samun damar yin aiki a cikin gaggawa, yin amfani da kayan aiki masu haɗari, yin amfani da kayan aiki masu haɗari, da kuma yin amfani da kayan aiki masu haɗari don hana COVID-19.
Ma'aikata a cikin wannan rukunin ba sa buƙatar yin amfani da kayan numfashi.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, mafi kyawun hanyoyin hana ma'aikata da fasinjoji su kasance a cikin nisan mita 6 daga sauran ma'aikatan, sa wani ma'aikaci ya kula da mai haƙuri, ba da kwalliya ga mai haƙuri ko kuma tambayar mai haƙuri ya rufe baki da hanci da takardar tsabtace jiki lokacin yin tari ko hancinsa.
Ma'aikatan jirgin suna bukatar su sa safar hannu da za su riƙa amfani da su sa'ad da suke kula da fasinjoji da suke rashin lafiya ko kuma sa'ad da suke taɓa ruwa ko kuma wani abu da ke da ƙwayoyin cuta.
Ana buƙatar sanya safofin hannu da sauran kayan da ake amfani da su a cikin jaka mai haɗari, kuma a tsabtace kayan da aka yi amfani da su kuma a yi amfani da su da maganin shafawa.
A gaskiya, dole ne a sanya ido kan mai cutar a cikin ɗakin da aka sanya shi. A makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsabtace da kashe ƙwayoyin cuta idan mai cutar ya kasance a cikin ɗakin makaranta ko da kuwa ba a yaduwa a yankin ba.
Idan akwai yaduwar cututtuka a cikin al'umma, ana iya amfani da matakan keɓewa, kamar hana ziyarar, yin layi a makaranta, da sauran manyan tarurruka kamar motsa jiki ko ƙungiyoyin rawa ko cin abinci a ɗakin karatu, ƙara yawan kujerun ɗalibai, daidaita lokacin dawowa da dawowar yara, rage baƙi da ba dole ba, da kuma amfani da ofishin kiwon lafiya na musamman don yara masu alamun mura.
Idan akwai yaduwar cutar a cikin al'umma, a matsayin wata dabara ta nisantawa, yana da kyau a ƙara rufe makarantu na dogon lokaci.Ga masu tsaro da ke aiki a yau da kullun, CDC ta ɗauki haɗarin kamuwa da cutar da ƙarancin gaske.
Ana ba da shawarar masu aikin tsaro da ke hulɗa da mutanen da aka tabbatar da cutar COVID-19 su bi ka'idoji iri ɗaya kamar masu aikin jinya, gami da amfani da kayan rufe fuska.
Idan aka yi tuntuɓe da wani wanda ya kamu da cutar, ma'aikata su tsabtace da kuma kashe ƙwayoyin cuta a kan tufafinsu kafin su sake amfani da su ta hanyar amfani da maganin kashe ƙwayoyin cuta na gida ko na iska, kuma su bi ƙa'idodin tsabtace kayan shafawa da wanke tufafi.
OSHA ta ɗauki wasu ma'aikatan kiwon lafiya da ke aiki a wuraren ajiya a matsayin waɗanda ke da haɗarin kamuwa da cuta.
Ayyukan da ke haifar da haɗari sun haɗa da masu kula da gida, masu tallafawa, ma'aikatan gwaji, da ma'aikatan kiwon lafiya waɗanda ke da alaƙa da mutanen da aka sani ko ake zargin suna da COVID-19.
Waɗannan suna cikin haɗari musamman lokacin da ma'aikata ke shiga cikin hanyoyin samar da iska a kan marasa lafiya, ko kuma idan sun taɓa samfuran daga mutanen da aka sani ko ake zargi da COVID-19.
Hanyoyin samar da iska sun hada da tari, bronchoscopies, hanyoyin aikin hakori, ko tarin samfurin.
Ayyukan haɗari na musamman sun haɗa da shirya gawawwakin mutanen da aka sani ko ake zargi da cutar COVID-19 a lokacin mutuwarsu; waɗanda ke cikin haɗari na musamman yayin gwajin gawawwakin. Gudanar da aikin injiniya ga waɗannan rukunin masu haɗari ya haɗa da amfani da ɗakunan keɓewa don mutanen da aka sani ko ake zargi da COVID-19, wanda ya haɗa da hanyoyin samar da iska.
Hanyoyin iska na musamman na iska na iya zama mai kyau a wasu lokuta na kiwon lafiya da kuma lokacin da aka kama gawawwaki.
Ya kamata a kula da samfuran da aka karɓa daga mutane da matuƙar kariya (Hanyar Tsaro ta 3).
WHO ta ba da shawarar keɓe sabbin masu cutar ta hanyar keɓewa idan ana zargin suna da COVID-19. Baya ga sauran kayan aikin PPE, OSHA ta ba da shawarar yin amfani da kayan aikin rufe fuska ga waɗanda ke aiki a nisan ƙafa 6 daga masu cutar SARS-CoV-2 ko waɗanda ake zargin suna da su da waɗanda ke aiki a kan hanyoyin samar da iska.
A Amurka, dole ne a yi amfani da abin rufe fuska na N95 ko fiye da haka da aka amince da NIOSH a cikin yanayin da aka tsara wanda ya haɗa da gwajin farko, horar da masu amfani, horo, da gwajin asibiti.
Sauran nau'ikan maganin hana yaduwar cutar na iya taimakawa sosai wajen kiyaye ma'aikata yayin da suke yin nasu. WHO ba ta ba da shawarar yin amfani da maganin hana yaduwar cutar ba saboda COVID-19 cuta ce ta jijiyoyi kuma ba ta wucewa ta hanyar hanyoyin jiki.
WHO ta amince da amfani da maganin rigakafi ga masu aikin jinya.
Ga waɗanda ke ɗaukar samfuran hayaki daga mutane, kula da, ko jigilar marasa lafiya na COVID-19 ba tare da amfani da hanyoyin samar da aerosol ba, WHO ta ba da shawarar yin amfani da abin rufe fuska, tabarau ko abin rufe fuska, da safar hannu.
A yayin aikin samar da iska, ana sanya kayan shafawa na N95 ko FFP2 a cikin kayan numfashi.
Saboda rashin isasshen kayan shafa na mutum (PPE), WHO ta ba da shawarar rage amfani da kayan shafa na mutum a cikin aikin likita (telemedicine), amfani da abubuwan jan hankali kamar windows masu haske, ba da izinin masu kula da lafiya kai tsaye zuwa ɗakin tare da mai cutar COVID-19, amfani da kayan shafa na mutum kawai waɗanda suka dace da aikin, amfani da kayan shafa na mutum ɗaya don kula da marasa lafiya masu cutar, saka idanu da daidaitawar kayan shafa, da kuma hana amfani da allurar rigakafi ga marasa lafiya marasa alamomi.
Daga: Katherine Maher, Shugaba na Wikimedia Foundation
ERI: Ma'aikatan Gidauniyar Wikimedia
MAGANA: [Covid-19] Rage ayyukan yi da kuma shirya don nan gaba
RANAR/SA'A DA AKA SAUKO: 14 ga Maris, 2020, 00:24 UTC
LABARIN: CC0: Babu wasu haƙƙoƙi
Muna cikin mawuyacin hali a wannan watan.
Fitowar COVID-19 ya nuna mana cewa dukkan mutane a duniya suna aiki tare kuma suna da alhakin juna.
Ba mu da misali na wannan ƙalubalen, amma mun san cewa amsarmu ta dangana ne a kan juyayi, haɗin kai, da haɗin kai na dukan duniya da wannan ƙungiyar ta kafa.
Yadda muke nuna ƙauna da kuma kula a wasiƙunmu da kuma kiran waya da muke yi da kuma ta waya ya nuna cewa muna da dangantaka mai kyau da mutane.
Ba ni da yadda zan gode wa abokaina.
A makon da ya shige, wani ya gode mini don aikin da muke yi.
Ya tunatar da ni game da mahimmancin duniya ta shiga Wikipedia a wannan lokacin, cewa wannan ma alama ce mai ƙarfi cewa Wikipedia tana da daraja kuma ya cancanci kasancewa a kan layi don kowa ya shiga.
Aikinku yana taimaka mana mu cimma wannan nasarar, ta hanyar taimaka mana mu ci gaba da samun damar shiga yanar gizo, ta hanyar taimaka wa ma'aikatanmu ko ma'aikatanmu su sami tsaro.
A yau, duniya tana buƙatar bayanin da ke cikin Wikipedia fiye da kowane lokaci.
Wannan lokaci ne da muke ganin cewa ayyukanmu da kuma yadda muke aikatawa suna shafan duniya.
Domin amfanin wannan sadaukarwa da kuma aikin da kake yi a wannan batun, za mu yi wasu canje-canje a tsarinmu daga mako mai zuwa.
Sauya-sauyen ayyuka da kuma tsarinmu
Kamar yadda Robyn ta ambata a baya, kwamitin ya yi taro a daren jiya don tattauna tsarinmu da kuma shirinmu na kwanaki da watanni masu zuwa.
A cikin jawabinmu, mun tattauna abin da muke ganin zai fi dacewa mu yi don mu jimre da ƙalubalen da ke tafe da kuma yadda za mu ci gaba da kula da ƙungiyar a yanzu.
Dukanmu muna son mu daina yin hakan kuma mu ci gaba da yin hakan.
Idan kana son ka sake buga waya, ba laifi.
Ga dukan ma'aikata, 'yan kwangila, da kuma masu hidima na ɗan lokaci:
Muna iya yin aiki na sa'o'i huɗu a rana ko kuma awa 20 a mako har sai mun sake komawa.
Ba mu sanar da hutu ba  idan za ku iya yin aiki fiye da wannan lokacin, ma'aikatar za ta iya ɗaukar ku.
Amma, a yau, duniya tana cike da yanayi da ke sa mu damu da abin da zai faru idan muka kula da waɗanda muke ƙauna, ko kuma idan muka sayi kayan gida, ko kuma idan muka je asibiti, muna bukatar mu kasance da rai.
Ba za mu yi maka baƙar magana ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ba mu so mu tattauna wannan batun, amma mun ga cewa ya dace mu tattauna.
Babu bukatar hutu na rashin lafiya ko biyan kuɗi  sanar da shugaba kuma ka taimaka wa abokan aikinka su daidaita shirinka don tabbatar da cewa an yi aiki da shi.
(Idan ka gwada ka sami COVID-19, sanar da Bryan a T&amp;C Ops don T&amp;C su ba ka taimako da ake buƙata kuma za su yi ƙoƙari su tabbatar da lafiyarka da kuma samun taimakon da ake buƙata daga jagorancinmu).
Za a biya waɗanda suka yi aiki na sa'o'i da yawa cikakken albashi.
Mun ambata, kuma mun sake jaddada cewa za mu girmama alkawuranmu ga 'yan kwangila da abokan aikinmu na sa'o'i.
Za a biya kowane mutum bisa ga yawan sa'o'insa a yanayi na yau da kullum.
Wannan ya haɗa da yin la'akari da lokacin da ba za ka iya aiki ba ko kuma idan kana rashin lafiya.
Idan kana son ka yi aiki, muna goyon bayanka.
Mutane da yawa suna amfani da aiki a matsayin hanyar da za su iya kawar da matsi daga mutane da kuma abubuwan da ke kewaye da su.
A lokacin da muke hidima, muna samun gamsuwa da kuma sakamako mai kyau.
Amsar ita ce, kai ne za ka kula da kanka.
Abin da muke roƙonku shi ne ku tattauna da shugaban aikinku don mu san abin da za mu yi tsammani kuma mu yi gyara idan da bukata.
Wasu ayyuka suna da muhimmanci sosai.
Wasu abubuwa ba za su tsaya ba.
SRE, HR Ops, Trust &amp; Welfare, da ƙungiyoyin zaɓen (da sauransu) suna yin ayyuka daban-daban waɗanda ke buƙatar ƙarin tallafi.
Za mu yi ƙoƙari mu bincika muradinmu yanzu kuma mu daidaita abin da muke mai da wa hankali yanzu don mu tallafa wa abubuwa da suka fi muhimmanci.
Muna da ayyuka da yawa da za mu yi, amma muna bukatar mu mai da hankali ga ayyuka mafi muhimmanci.
Idan muka rage gudu, hakan ba zai shafi nasararmu ba.
Ba mu shirya ninka lokacinmu na aiki ta hanyar biyan bashin asararmu  kuma mu dawo da wuri.
Kada ka riƙa yin aiki fiye da lokacin da ka saba yi don ana biyanka kuɗi da yawa.
Muna bukatar mu fahimci cewa yanayinmu ya canja, kuma za mu iya canja makasudinmu da kuma kuɗin da muke kashewa idan hakan ya wajaba.
Menene za a yi a Tsarin Shirin Shekara-shekara?
Don sauya yanayin rayuwarmu, ana sa ran a cikin lokutan yau da kullun, muna fatan canzawa a cikin ranakun ƙarshe don cimma burinmu a cikin Shirinmu na Shekarar 2020-2021.
Manufarmu ita ce mu ba da shawarar tsawaita shirinmu na 2019-2020 don ba mu ƙarin lokacin da za mu yi aiki da kasafin kuɗi don ma'aikata su ba da fifiko ga manyan ayyuka, kula da kansu, kula da danginsu da kuma kula da waɗanda ke son yin aiki na ɗan lokaci a cikin 'yan makonni masu zuwa.
Wannan karuwar ta rage yawan ayyukan da ake yi a yanzu kuma an ba da damar kammala ayyukan da ake yi a yanzu a duk sashen.
Za mu gabatar da shawarwarinmu ga Hukumar Mulki a mako mai zuwa kuma mu sanar da masu halartar taron da kuma wasu game da gyare-gyare da za mu yi idan aka amince da su.
Na gode wa dukkan abokan aiki don shiri da jagoranci a kowane fanni.
Yanayin ofishi, yadda ake saka kayan aiki, da kuma tsabtace su
A makon da ya gabata, an sanar da mu cewa wani abokin aikinmu a San Francisco ya kamu da cutar COVID-19.
Maimakon haka, da hankali, mun yi amfani da maganin kashe ƙwayoyin cuta kuma muka yayyafa dukan fili da kuma kayan aiki a ofishin San Francisco.
Sun yi amfani da maganin kashe ƙwayoyin cuta don su kashe ƙwayoyin cuta a kowane abu da ke cikin ofishinmu.
Masu ginin ma sun yi amfani da nasu hanyoyin kula da ma'aikatansu.
Muna farin ciki cewa za a gyara ofishin da kyau sa'ad da muka soma aiki.
Ofishinmu na DC yana cikin WeWork, kuma cibiyar ta sanar da mu game da shirin COVID-19 kuma duk ma'aikatan cibiyar sun aiwatar da shirin.
A ƙarshen makon da ya gabata, an ƙaura ofishinmu da ke D.C. zuwa wani wuri mai nisa a ƙarƙashin ja-gorar San Francisco.
Kuma kamar yadda wasu abokanmu a birnin New York suka sani, mun yi kwanan wata kuma mun yi hayar wani gida a Brooklyn.
Wannan ya ci gaba amma ana iya yin faɗa.
Wasu abokan aikinmu suna aiki daga gida kuma wannan ne lokaci na farko da suke yin hakan.
Wasu abokan aikinmu da suka daɗe suna yin hakan sun san cewa yin hakan ba shi da sauƙi, kuma suna so su ba da wasu shawarwari:
Ka bar shi a cikin sa'a ɗaya ko biyu.
Idan ana bukatar a yi taro na dogon lokaci, ka nemi hanyoyin da za a iya canja lokacin taron zuwa wasu ranaku.
Kowace majalisa ta tattauna batun, ta shirya shawarwari, kuma ta ba da abin da ake bukata a karanta a kan lokaci.
Bidiyo na farko da aka yi amfani da su ta hanyar aikace-aikace kamar Google Docs da Zoom don taimakawa wajen sadarwa.
Akwai shugaban kowane taro, wanda zai kula da tattaunawar da tambayoyin da aka ba da lokaci da kuma wanda zai kula da masu magana da kuma wanda zai yi shawarwari (ko kuma ya yarda da juna).
Idan kana buƙatar kayan ji na kunne, aika imel zuwa masu fasaha don samun kayan ji na kunne.
Yi amfani da kuɗin da aka ba da don gyarawa da kuma gyarawa.
Shiga shafin #remoties a Slack kuma ka tattauna da abokanka game da ayyukan da aka ba ka
Ma'aikatar Ma'aikata tana kula da jagorancin yanar gizo na yanar gizo don taimakawa ayyukan da aka ba su a duk Sashen.
A makon da ya gabata, mun nemi masu ba da tallafi su dakatar da duk ayyukan da Wikimedia ke tallafawa kamar su editan edita, har sai WHO ta sanar da cewa an dakatar da aikin.
Mun gaya musu cewa mun fahimci cewa ba za mu iya yin wasu abubuwa da muka shirya ba kuma ba za mu hukunta kowa ba don jinkirin ko kuma canja shirin.
A mako mai zuwa, za mu ci gaba da duba ƙarin bayanai a kan Wikimania da kuma kan dandalin nazarin harshe da kuma a wasu wurare.
Abinda muka fi gani a cikin 'yan uwantaka a duk duniya shine' yan uwantaka suna baƙin ciki da irin wannan ɓarnatarwar amma suna jin tsoro idan sun fahimci cewa dole ne su ba da kansu ga al'ummarsu, Wikimedia da sauransu.
A cikin abubuwan da ke zuwa, CRT tana aiki koyaushe don ƙirƙirar shafin yanar gizo na Meta-Wiki don ba mutane damar bin diddigin abubuwan da suka faru da kuma bin hanyoyin sadarwarmu.
Ci gaba da sadarwa kan batutuwan da suka shafi COVID-19
Za mu gayyace ku ta kalandarku zuwa taron musamman na Alhamis mai zuwa, da karfe 14:00 UTC/07:00 PT.
Za mu yi amfani da wannan lokacin don mu tattauna wani batu, mu amsa tambayoyinku kuma mu ɗan ɗan tattauna.
Dukanmu muna cikin wannan yanayin kuma muna bukatar mu taimaka wa juna.
A halin yanzu, zaku iya samun wannan bayanin ta imel da kuma wasu shafukan yanar gizo masu ba da bayani game da COVID-19, da kuma a cikin Wiki na Office.
CRT za ta yi ƙoƙari ta tattara bayanan da aka samu a kwanan nan a wuri guda.
Muna kuma ƙoƙarin ci gaba da sadarwa tare da ma'aikata a ƙasashen da abin ya shafa sosai a yanzu.
Idan kana da wasu tambayoyi game da tafiye-tafiye, ayyuka, aiki ko ƙalubalen da kake da shi, ko kuma kana bukatar taimako, kada ka yi jinkirin tuntuɓar CRT.
Muna shirye mu taimaka kuma mu yi aiki tare da kai a kan batun da ake bukata.
Idan kana da wasu tambayoyi masu sirri ko na sirri, da fatan za a aika da imel zuwa Bryan Judan, Daraktan Ayyukan HR na Duniya.
Duk waɗannan canje-canjen ba za su sa mu ji kamar mun daina yin aikinmu da kuma hakkokinmu ba.
Maimakon haka, suna taimaka mana mu fahimci cewa aikinmu da kuma hakkinmu a yanzu zai iya zama dabam da na dā.
Mun gaskata cewa waɗannan abubuwa suna da muhimmanci domin mu tallafa wa juna don mu ci gaba da aikinmu, mu tallafa wa ƙungiyarmu a kowane hanya da ta dace, kuma mu yi wa mutane hidima da kuma hidimar da ta dangana a kanta.
Ayyukan da muka shirya za su kasance a shirye a lokacin da ya dace.
A yanzu, yana da kyau mu taimaki juna kuma mu keɓe lokaci don yin ayyuka masu muhimmanci a makonni ko watanni masu zuwa.
Dukanmu muna bukatar mu sa hakan ya faru, saboda haka, dukanmu muna bukatar mu kula da kanmu da kuma iyalinmu don mu kasance da koshin lafiya a lokacin da muke bukatar hakan.
Yanzu, ka ce  a hannunka kuma kada ka taɓa fuskarka!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran shugabannin (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
Kwayar halitta ta Angiotensin-converting enzyme 2 (ACE2) shine kwayar halitta da ke rufewa (a kan ƙwayoyin halitta) don hana ƙwayoyin cuta a cikin jijiyoyi, jijiyoyi, zuciya, kodan, da hanji.
ACE2 yana hana aikin enzyme mai canza angiotensin (ACE) ta hanyar rage yawan angiotensin-II ta hanyar kara Ang ((1-7) don sanya shi magani mai amfani don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin mai farawa don shiga cikin rigakafin wasu coronavirus.
A cikin mutane, wannan sinadarin ana kiransa hACE2.
Kwayar halitta ta Angiotensin-converting enzyme 2 tana dauke da sinadarin zinc wanda ya ƙunshi wani sinadarin da ke cikin jini da kuma sauran kwayoyin halitta.
Kwayar ACE2 ta ƙunshi N-terminal peptidase M2 yankin da kuma C-terminal collectrin renal amino acid transporter yankin.
ACE2 yana wucewa ta hanyar fata sau ɗaya, tare da manyan abubuwan da ke cikinsa suna bayyana a kan ƙwayoyin cuta a cikin kasusuwa da sauran tsokoki.
Ana cire ACE2 daga fata kuma ana amfani da shi ta hanyar sheddase, wanda ke fitar da furotin zuwa cikin jini kuma daga bisani ya zama ruwa.
Ana samun ACE2 a yawancin sassan jiki: ACE2 yana kama da kwayoyin halitta na fata musamman na nau'in II na ƙwayoyin cuta a cikin ganuwar huhu, ƙananan ƙwayoyin cuta, ƙwayoyin cuta da ƙwayoyin jijiyoyin jini, da ƙwayoyin jijiyoyi a yawancin sassan jiki.
Ana kuma samun ACE2 mRNA a cikin ƙwaƙwalwar ƙwaƙwalwa, ƙashin ƙugu, hypothalamus, da ƙashin ƙugu.
Babban aikin ACE2 shine daidaitawa ACE
ACE yana ɗaure da hormone angiotensin I a cikin angiotensin II mai ƙuntatawa.
ACE2 sai ya ɗaure zuwa carboxyl-terminal amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma ya haɗa kansa cikin angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma yana da ikon ɗaure kansa ga wasu ƙwayoyin cuta da suka haɗa da [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana sarrafa motsi na amino acid mai tsaka tsaki SLC6A19 wanda ake zargi da haifar da cutar Hartnup.
A matsayin furotin mai ɗaukar hoto, ACE2 yana aiki a matsayin babbar hanyar shiga cikin kwayar cutar don wasu coronaviruses, gami da HCoV-NL63; SARS-CoV (kwayar cutar SARS); da SARS-CoV-2 (kwayar cutar COVID-19).
Musamman, haɗuwa da furotin S1 na SARS-CoV da SARS-CoV2 zuwa babban kwayar halitta ACE2 a farfajiyar ƙwayoyin cuta yana haifar da shigar da kwayar cutar da ƙwayoyin cuta daga wurin da suke zuwa cikin ƙwayoyin halitta.
Wannan hanyar shiga ta kuma buƙatar S protein da kuma kwayar cutar serine protease TMPRSS2, wanda ake nazarin maganin cutar don gano yiwuwar amfani da ita. Wannan ya haifar da wasu hasashe cewa rage yawan ACE2, a cikin sel, na iya taimakawa wajen magance kamuwa da cuta.
A maimakon haka, cibiyoyin bincike da cibiyoyin kulawa da yawa suna ba da shawarar ci gaba da maganin ACE mai hanawa da kuma maganin ARB.
Wani bincike mai zurfi da aka yi daga binciken da aka buga a ranar 11 ga Yuli, 2012, ya gano cewa "amfani da masu hana ACE yana da tasiri 34% a rage haɗarin cutar nimoniya fiye da sauran magunguna
A wani lokaci, "hadarin ciwon huhu ya ragu a cikin marasa lafiya da ke shan maganin hana ACE waɗanda ke da saurin kamuwa da ciwon huhu, musamman waɗanda ke da ciwon zuciya
Ana kuma ganin cewa yin amfani da magungunan hana ACE yana rage mutuwar mutum daga cutar nimoniya, ko da yake sakamakon ba shi da tsanani kamar cutar nimoniya"
Ana tsammanin sake haɗuwa da ɗan adam ACE2 (rhACE2) magani ne mai mahimmanci don cutar huhu mai tsanani, kuma an gano ingantaccen haɓakar jijiyoyi da kuma isar da iska a cikin ƙananan ƙwayoyin cuta da ke fama da cutar ta fatar jiki mai saurin numfashi.
Rashin rhACE2 a cikin mutane yana ɗaukar awanni 10 kuma yana farawa cikin mintuna 30 tare da tsawon lokacin aiki (lokacin da aka ƙayyade) na awanni 24.
Sakamakon binciken da aka samu daga bincike daban-daban ya nuna cewa rhACE2 na iya zama kyakkyawan magani ga waɗanda ba za su iya jurewa da magungunan rigakafin tsarin renin-angiotensin na gargajiya ba (RAS inhibitors) ko kuma a cikin cututtukan da aka inganta haɓakar angiotensin II.An bincika rhACE2 mai karɓar jini a cikin gwaji na asibiti don magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan.
Aikace-aikacen COVID-19 aikace-aikacen software ne na wayar hannu da aka tsara don taimakawa wajen bin diddigin alaƙar da aka samu tsakanin mutane da cutar coronavirus 2019-20, watau tsarin gano mutane (masu alaƙa da cutar) waɗanda wataƙila sun taɓa saduwa da cutar.
An tsara ko kuma an ba da shawarar aikace-aikace daban-daban, tare da tallafin gwamnati a yankuna da yankuna daban-daban.
An tsara wasu hanyoyin da za a gina aikace-aikacen da ke bin diddigin masu hulɗa da marasa lafiya.
An ambaci batun sirri, musamman game da aikace-aikacen da ke da alaƙa da bin diddigin wurin da masu amfani da app suke.
Sauran hanyoyin da ba su da yawa sun haɗa da amfani da raƙuman Bluetooth don haɗa wayar mai amfani da wasu na'urori masu kusa
A ranar 10 ga Afrilu 2020, Google da Apple sun sanar da cewa za su haɗa kai don tallafawa aikace-aikacen Bluetooth a kan Android da iOS kai tsaye a cikin na'urorin su.
A China, gwamnatin kasar Sin, tare da haɗin gwiwar Alipau, ta ƙaddamar da aikace-aikacen da ke ba da damar 'yan ƙasa su gwada idan sun taɓa saduwa da mutanen da ke da cutar COVID-19.
Ana amfani da shi a birane sama da 200 na kasar Sin, a Singapore kuma ana amfani da wata manhaja mai suna TraceTogether.
An kirkiro manhajar ne ta hanyar masu fasaha na IT na cikin gida, kuma an samar da ita don amfanin kowa kuma gwamnati za ta ba da ita. Arewacin Macedonia ta ƙaddamar da "StopKorona!", aikace-aikacen Bluetooth don bin diddigin mahalarta da mutanen da ake zargi da cutar da kuma aika saƙonni kai tsaye ga masu kula da lafiya da hukumomi.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka kirkiro manhajar.
Har zuwa 14 ga Afrilu 2020, har yanzu ba a tabbatar da aikace-aikacen a cikin Google Play Store da Apple App Store ba.
A ranar 12 ga Afrilu, gwamnati ta sanar da cewa aikace-aikacen bin diddigin tuntuɓar mutum yana kan matakin ƙarshe na ci gaba, kuma zai fara aiki a cikin 'yan makonni.
Ostiraliya da New Zealand suna la'akari da aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha na shirin ƙaddamar da aikace-aikacen geofencing don marasa lafiya na COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba su fita daga gida.
Ross Anderson, farfesa a fannin injiniyan tsaro a Jami'ar Cambridge, ya bayyana matsalolin da ke tattare da aikace-aikacen da ke da alaƙa da aikace-aikacen, gami da ƙwarewar da ake tsammani da kuma ƙwarewar da ba za ta iya aiki ba idan ana amfani da aikace-aikacen don lissafi.
Don magance matsalar aikace-aikacen coronavirus masu haɗari ko masu haɗari, Apple ya sanya iyaka kan waɗanne kamfanoni za su iya ƙara aikace-aikacen da suka shafi coronavirus zuwa App Store, suna ba da izinin kawai kasuwanci ko kamfanoni da aka sani.
Google da Amazon sun sanya irin wannan ƙuntatawa.
Masu ba da shawara game da sirri sun nuna damuwa game da tasirin bin diddigin yawan masu amfani da aikace-aikacen coronavirus, musamman tambayar ko za a iya aiwatar da bin diddigin da aka gina don magance matsalolin ɓoye bayan annobar.
Amnesty International da wasu kungiyoyi sama da 100 sun gabatar da takarda mai kira da a kawo karshen wannan tsarin.
Hukumomin sun sanar da takunkumi takwas kan ayyukan gwamnati:
dole ne a yi sa ido a cikin doka, ya zama dole kuma ya dace;
ci gaba da lura da kulawa dole ne ya ƙunshi alkawarin lokacin da zai ƙare;
Za a yi amfani da bayanan ne kawai dangane da COVID-19;
Don kare mahaifinsa daga ɓoyewa dole ne a kiyaye shi kuma a tabbatar da wannan ta hanyar shaida;
kulawar kwamfuta dole ne ta hana ci gaba da gabatar da batutuwan da suka shafi nuna bambanci da nuna wariya;
raba bayanai tare da wasu dole ne a fassara shi ta hanyar doka;
dole ne a samar da hanyoyin da za su hana cin zarafin 'yancin dan adam da kuma' yancin 'yan ƙasa don kare kansu daga nuna bambanci;
"Hadin kai mai ma'ana" ga duk waɗanda aka "ɓata" zai zama dole, gami da ƙwararrun masanan zamantakewar al'umma da ƙungiyoyin da aka azabtar.Kungiyar Kwamfuta ta Chaos ta Jamus (CCC) da kuma 'Yan Jarida ba tare da Iyaka ba (Reporter ohne Grenzen) (RSF) sun kuma buga wasu shawarwari.
Tsarin Google/Apple da aka tsara yana nufin magance matsalar sa ido ta hanyar cire tsarin sa ido daga na'urorin su idan ba lallai ba ne.
Wasu ƙasashe sun yi amfani da wayar hannu don bin sawun wanda ke cikin aikace-aikacen, don hana saukar da aikace-aikacen da kuma ikon kauce wa sa ido.
A Isra'ila, ana iya yin amfani da wayar salula don saka idanu.
Tsarin sa ido na wayar salula wanda ke ba da cikakken bayanin wurin mutum yana da haɗari mai haɗari ga masu haɗari.
Koyaya, ba duk hanyoyin haɗin yanar gizo tare da sabar sadarwar da aka raba ba suna buƙatar samun damar gano wurin da mutum yake; an tsara hanyoyin haɗin yanar gizo da yawa don kiyaye sirrin sirri ta hanyar sabar sadarwar da aka raba don sadarwa ta ciki.
A Koriya ta Kudu, an yi amfani da wata manhaja ta yanar gizo don bin diddigin mutanen da suka kamu da cutar
Maimakon amfani da aikace-aikacen da aka tsara, hanyar sadarwar ta tattara bayanai daga wurare daban-daban da suka haɗa da bin diddigin saƙonnin wayar hannu da bayanan katin katin mutum, kuma an haɗa su don rubuta saƙonni da aka aika ta wayar hannu ga mutanen da ake tsammanin suna da cutar.
Baya ga amfani da wannan bayanin don faɗakar da waɗanda ke da alaƙa da masu cutar, gwamnati da bayanan wurin da mutane ke zaune suna da damar jama'a, wanda aka ba da izinin sabuntawa ga dokar sirri bayan barkewar cutar MERS a ƙasar.
Ana iya samun wannan bayanin ga kowa ta hanyar aikace-aikace da shafukan yanar gizo daban-daban. Ƙasashen da suka haɗa da Jamus sun yi la'akari da amfani da hanyar sadarwa tare da masu kare sirri.
A ranar 6 ga Afrilu 2020, ba a sake sakin hotuna ba tukuna.
Kula da tuntuɓar mai haƙuri abu ne mai tsari, wanda aka yi nazari akai-akai tun daga farkon 2013. A ranar 7 ga Afrilu 2020, ƙungiyoyi da yawa na ƙwararru suna aiki kan haɓaka hanyoyin ɓoyewa, kamar amfani da Bluetooth Low Energy (BLE) don gano wurin mai amfani dangane da wasu wayoyin hannu.
Ainihin, PEPP-PT tsarin haɗin gwiwa ne wanda ke da tsari mai mahimmanci, kuma ba ya bin ƙa'idodi guda ɗaya. Dokokin da aka rarraba sun haɗa da Decentralized Privacy-Preserving Proximity Tracing (DP-PPT/DP-3T), Lambobin Sadarwa na Wuta (TCN, aka Contact Event Numbers, CEN), Privacy Sensitive Protocols da kuma Ma'aikatun Sadarwa na Wayar Hannu (PACT) da sauransu.
A cikin waɗannan dokokin, ba a cire bayanan da za su iya sa mutum ya farka daga cikin na'urar ba, kuma ana yin dukan aiki a nan take.
Kungiyar Twekisize a MIT Media Lab ta kirkiro SafePaths, hanyar da aka sani da amfani da hanyoyin ɓoyewa a cikin bincike da kuma amfani da hanyar ɓoye bayanai don bin diddigin yaduwar COVID-19.
An kafa shi ne bisa binciken da aka yi daga rahoton "Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic" wanda aka buga a watan Maris na 2020. Wani tsari mai kama da shi shine tsarin SafeTrace na Enigma MPC, kamfanin kera fasahar ɓoyewa wanda a baya ya kasance a MIT Media Lab.
SafeTrace yana haɓaka fasaha mai aminci wanda ke ba masu amfani damar raba bayanan sirri na wurin su da lafiyar su tare da sauran masu amfani da masu gudanarwa, ba tare da yin haɗari ga sirrin su ba.
A ranar 5 ga Afrilu 2020, an kafa ƙungiyar TCN Coalition ta duniya ta hanyar haɗuwa da ƙungiyoyi masu amfani da tsari iri ɗaya da ƙa'idodi masu dacewa, da nufin rage ƙungiyoyi, da kuma haɗa kai don haɓaka aikace-aikacen sa ido da aika saƙonni, babban mahimmin abu don samun damar shiga cikin jama'a.
A ranar 9 ga Afrilu 2020, gwamnatin Singapore ta sanar da cewa tana amfani da yarjejeniyar BlueTrace ta hanyar aikace-aikacen hukuma.
A ranar 10 ga Afrilu 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na Android da iOS, sun sanar da tsarin bin diddigin tuntuɓar marasa lafiya, wanda suka ce zai kare sirrin mutum, wanda ya dogara da haɗin fasahar Bluetooth Low Energy da ɓoyewa ta hanyar ɓoyewa.
Sun kuma wallafa game da fasahar da ta fi dacewa da ake amfani da ita wajen yin amfani da sinadarai.
A cewar Apple da Google, ana sa ran za a samar da hanyar sadarwa a matakai uku:
samar da matakan da za su ba da damar gwamnati ta kafa aikace-aikacen da ke kula da cutar coronavirus amma suna da sirri.
kai tsaye haɗa wannan fasalin a cikin tsarin iOS da AndroidGoogle da Apple don magance matsalar ƙyalewa da bin diddigin ba tare da ƙare ba ta hanyar raba wannan hanyar haɗin yanar gizon ta hanyar haɓaka aikin wayar hannu, sannan kuma daga baya cirewa bayan an kawar da ƙarancin.
b Sake sanya magunguna (wanda kuma ake kira sake amfani da magani, sake fasalin, sake aiki ko sauya magani) shine sake amfani da magani wanda aka amince dashi don magance wata cuta ko yanayin jiki daban da wanda aka yi niyya.
Wannan shine ɗayan manyan binciken kimiyya da ake yi yanzu don haɓaka ingantaccen magani na COVID-19.
Sauran binciken da ake ci gaba da yi sun haɗa da haɓaka allurar rigakafin COVID-19 da kuma ƙarin jini. SARS-CoV-2 yana da sunadarai masu ƙwayoyin cuta guda 66, kowannensu yana da wuraren ɗaure ligand da yawa.
Binciken waɗannan wuraren haɗin yana taimakawa wajen haɓaka maganin rigakafin ƙwayoyin COVID-19.
Daga cikin manyan sunadarai masu mahimmanci na SARS-CoV-2 sune papain-like protease, RNA dependent RNA polymerase, helicase, S protein, da ADP ribophosphatase.
Hussein A A, et al sun bincika mahaɗan da yawa tare da manufar kimanta haɓakar kwayoyi da ake buƙata don hanzarta haɓaka maganin anti-SARS-CoV-2 mai ƙarfi a cikin binciken da aka yi kafin a ba da shawarar a cikin tsarin gwajin asibiti.
Chloroquine magani ne na zazzabin cizon sauro kuma ana amfani da shi don cututtukan autoimmune.
A ranar 18 ga watan Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine masu kama da juna za su kasance cikin gwaje-gwaje huɗu na gwaji a matsayin ɓangare na gwajin haɗin gwiwa.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin gwaji na jihar New York na chloroquine da hydroxychloroquine zai fara a ranar 24 ga Agusta.A ranar 28 ga Agusta, FDA ta amince da amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin Amfani da Gaggawa (Emergency Use Authorization, EUA).
Ba a tabbatar da maganin ba ta hanyar gwajin asibiti na FDA kuma an yarda da shi a cikin EUA kawai azaman magani na gwaji don amfani da gaggawa ga marasa lafiya da ke kwance amma ba za su iya samun magani a cikin binciken asibiti ba.
CDC ta ce "ba a san yadda ake amfani da shi ba, yadda ake amfani da shi, ko tsawon lokacin da ake amfani da shi don maganin rigakafin cutar SARS-CoV-2".
Likitoci sun ce suna amfani da wannan maganin ne kawai "a lokacin da babu wani magani".
Wata ƙungiyar masu bincike a Turkiyya a Istanbul suna gudanar da ƙananan bincike kan amfani da chloroquine tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da Jami'ar Oxford.
Makarantar Kiwon Lafiya ta NYU Langone tana gudanar da gwaji na gwaji kan ingancin maganin rigakafin hydroxychloroquine.
Gwaje-gwajen da aka gudanar a Wuhan da Shenzhen sun nuna cewa favipiravir yana da "tasiri a cikin cututtuka".
An gano marasa lafiya 35 a Shenzhen ba su da cutar a cikin kwanaki 4, yayin da cutar ta ci gaba da kwana 11 a cikin marasa lafiya 45 da ba su karɓi maganin ba.
A cikin binciken da aka yi a Wuhan kan marasa lafiya 240 da ke fama da cutar, rabin waɗanda aka ba favipiravir sun sami umifenovir.
Hukumar Kula da Magunguna ta Italiya ta tunatar da mutane cewa akwai bayanai kaɗan da suka tabbatar da maganin.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga kantin sayar da kayayyaki kuma ta yi amfani da sojoji don jigilar magungunan zuwa asibitocin jami'a don amfani da su wajen kula da marasa lafiya na COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya yi zargin shugabancin Trump kan sayan magungunan. Magungunan na iya zama ba su da tasiri ga marasa lafiya masu cutar da cutar.
Ana iya yin amfani da shi a kan mata masu ciki ko kuma waɗanda suke son su yi ciki.
Wani bincike kan lopinavir/ritonavir (Kaletra), wani magani ne na maganin rigakafin cutar lopinavir da ritonavir, ya ce "ba a sami wani amfani ba".
An tsara maganin don hana yaduwar HIV ta hanyar ɗaure shi da protease.
Masu bincike a Jami'ar Colorado suna ƙoƙarin canza maganin don gano wani fili wanda zai taimaka wajan haɗa shi da protease na SARS-CoV-2.Akwai matsala a cikin masana'antar kimiyya don samar da kayan aikin sake amfani da maganin da aka riga aka yi amfani da shi musamman don maganin HIV/AIDS.
WHO ta haɗa lopinavir/ritonavir a cikin gwajin haɗin kai na duniya.
Gilead Sciences ne suka kirkiro da kuma bunkasa Remdesivir a matsayin maganin cutar Ebola da Marburg. Gilead Sciences daga baya ta gano cewa Remdesivir yana da aikin rigakafin cutar a cikin vitro don yaƙi da ƙwayoyin cuta kamar philo-, pneumo-, paramyxo-, da corona-viruses.
Wani dalili na maganin cutar shine samar da kwayar cuta ta hanyar haifuwa wanda zai iya haifar da wasu cututtuka da kuma yada su.
Wani bincike na farko na asibiti ya nuna cewa remdesivir na iya samun maganin hana ƙwayoyin cuta a cikin ƙwayar sa. Akwai gwajin asibiti da ake shirin yi, ciki har da gwaji biyu da Asibitocin Jami'ar Cleveland suka yi; wasu a kan marasa lafiya masu rauni da kuma wasu masu fama da cutar.
Akwai bincike uku na asibiti da aka yi akan maganin bitamin C na intravenous akan marasa lafiya na COVID-19 da ke kwance a gado; biyu sun haɗa da maganin rigakafi don kwatanta (China, Kanada) kuma ɗaya ba shi da kwatancen (Italiya).
Jihar New York ta fara gwajin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya da Magunguna ta Duniya ta Japan (NCGM) tana shirin gwada maganin Teijin na Alvesco (ciclesonide), magani ne da ake ba da shawarar don rage ciwon huhu, don magance marasa lafiya da ke fama da cutar coronavirus a farkon bayyanar amma ba su nuna alamun cutar ba.
Hanyar canza enzyme na angiotensin 2, ana gudanar da binciken kashi na II wanda ya shafi marasa lafiya 200 da za a cire daga marasa lafiya masu fama da cutar a Denmark, Jamus, da Austria don tantance tasirin maganin.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada suna nazarin aikin colchicine wajen rage tari da matsalolin huhu a cikin marasa lafiya da ke fama da rashin lafiya saboda alamun COVID-19.
Binciken da ake kira COLCORONA, ya haɗa da manya 6000 masu shekaru 40 zuwa sama waɗanda aka tabbatar da cewa suna da COVID-19 kuma suna da alamun rashin lafiya waɗanda ba sa buƙatar kwantar da su a gado.
Ba a yarda da mata masu ciki ko masu shayarwa ko waɗanda ba su da maganin hana ɗaukar ciki.
Ana gwada magungunan kashe jini da yawa a Italiya.
Ana amfani da heparin mai ƙananan kwayoyin don kula da marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta buga jagororin amfani da shi.
An sanar da binciken da aka yi a wurare daban-daban kan marasa lafiya 300 da ke nazarin amfani da enoxaparin sodium don rigakafi da allurai masu warkarwa a ranar 14 ga Afrilu.
A cikin cutar SARS-CoV-2, yawancin binciken kimiyya sun mai da hankali kan sake amfani da maganin da aka amince da shi don magance cututtukan da aka riga aka yi amfani da su don cutar farko kamar MERS, SARS, da West Nile virus.
Ribavirin: an ba da shawarar ribavirin don maganin COVID-19 bisa ga umarnin China na 7
An ba da shawarar amfani da miyagun ƙwayoyi na gaba don maganin COVID-19 bisa ga umarnin China na 7
An sake amfani da maganin rigakafi don maganin COVID-19:
Tocilizumab (Anti-IL-6 receptor): An amince da shi a kasar Sin.
Hakazalika, gwaje-gwaje a cikin Italiya da China. duba kuma Tocilizumab#COVID-19.
Allurar rigakafin COVID-19 magani ne na gwaji wanda ake tsammanin zai magance cutar 2019 (COVID-19).
Hakika, babu maganin da ya wuce lokacin gwaji na asibiti, akwai ƙoƙari da yawa da za a yi don a samu irin wannan maganin.
A ƙarshen 2020, WHO ta ce ba ta tsammanin allurar rigakafin SARS-CoV-2, kwayar cutar da ke haifar da cutar, za ta isa kasuwa a cikin ƙasa da watanni 18.
An yi gwajin gwaji na farko a ranar Alhamis da allurar rigakafin rigakafin ta sau biyar.
An gano COVID-19 a watan Disamba na 2019.
Cutar ta coronavirus ta bazu ko'ina cikin duniya a cikin 2020, wanda ya haifar da saka hannun jari mai yawa a cikin bincike don samar da allurar rigakafi.
Yawancin cibiyoyi suna amfani da bayanan kwayoyin halitta don samar da maganin rigakafin SARS-CoV-2.
An fara binciken a ranar Alhamis, abubuwan da ake buƙata don ƙoƙarin CEPI na haɓaka allurar rigakafi sune saurin, iyawa, samar da maganin a cikin adadin da ake buƙata da rarraba shi a duniya.
A ranar Alhamis, masana kimiyya na CEPI sun ba da rahoton cewa cibiyoyin fasaha daban-daban 10 suna kan bincike da ci gaba a farkon 2020 don ƙirƙirar allurar rigakafin COVID-19.
Manyan hanyoyin da aka kawo a cikin binciken Phase I na binciken haɗari sun haɗa da:
nucleic acid (DNA da RNA) (Mai haɓaka Mataki na I da mai ba da rigakafi: Moderna, mRNA-1273)
kwayar cutar (Mai haɓaka Mataki na I da kuma maganin da aka yi niyya: CanSino Biologics, adenovirus type 5 vector)
Kamar yadda masana kimiyya suka sanar da CEPI a watan Mayu, alluran rigakafi 115 masu niyya suna cikin matakan farko na ci gaba, 78 daga cikinsu an tabbatar da su a matsayin ayyukan ci gaba (79, a cewar Cibiyar Milken), kuma an sanar da 37 na gaba, amma babu cikakkun bayanai game da su (ana tsammanin har yanzu suna cikin shiri ko gwaji).
Gwajin gwaji na Mataki na I-II ya ƙunshi binciken farko na haɗarin da gwajin rigakafi, wanda ya ƙunshi sa ido na gwaji, wanda ya haɗa da maganin kashewa, ana gudanar da shi a wurare da yawa, kamar yadda aka yanke shawarar mafi inganci.
Nazarin na III yana da mahalarta da yawa tare da gwajin gwaji na gwaji don gwada tasirin maganin rigakafi, yayin da ake lura da tasirin cutar daga amfani da allurai mafi girma.
Daga cikin alluran rigakafi 79 da ake niyya a cikin ci gaba (wanda aka amince da shi a farkon Afrilu 2020), 74 ba su kai ga gwajin jama'a ba (har yanzu suna cikin "binciken farko").
A ranar 24 ga Janairun 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa za ta yi nazarin yiwuwar allurar rigakafin kwayar halitta wanda zai iya canza tsarin sunadarai na kwayar cutar don sake farfado da cutar.
A ranar 24 ga Janairun 2020 a Kanada, Cibiyar Alurar riga kafi ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aikin samar da allurar rigakafi, tare da tsammanin fara gwajin ɗan adam a 2021.
An sanar da aikin samar da allurar rigakafin a Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin a ranar 26 ga Janairu, 2020, da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairun 2020, Kamfanonin Magunguna na Janssen, karkashin jagorancin Hanneke Schuitemaker, sun sanar da cewa sun fara aikin samar da allurar rigakafi.
Kamfanin Janssen yana aiki tare da Vaxart wajen samar da allurar rigakafi ta hanyar amfani da fasahar kere-kere.
A ranar 18 ga Maris 2020, Emergent BioSolutions ta sanar da samar da maganin tare da haɗin gwiwar Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, gwajin OncoGen a Romania ya buga wata takarda kan tsarin allurar rigakafi ta amfani da fasahar zamani don maganin cutar kansa (ciwon daji neoantigen vaccination therapy).
A ranar 25 ga watan Maris ne daraktan bincike na hukumar ta sanar da cewa an kammala gwajin rigakafin kuma za a fara gwajin.
A ranar 27 ga Fabrairu 2020, kamfanin Generex, NuGenerex Immuno-Oncology, ya sanar da ƙaddamar da aikin samar da allurar rigakafin peptide mai mahimmanci don yaƙar COVID-19.
Sun so su yi allurar da za a gwada a kan mutane "cikin kwanaki 90".
A ranar 5 ga watan Agusta, 2020, Jami'ar Washington a St. Louis ta sanar da aikinta na samar da allurar rigakafi.
A ranar 5 ga watan Maris na 2020, Rundunar Kula da Kiwon Lafiya da Kayan Aiki ta Sojojin Amurka a Fort Detrick da Cibiyar Nazarin Sojojin Walter Reed a Silver Spring, dukansu a yammacin Maryland, sun ba da sanarwar cewa suna aiki a kan allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta kulla yarjejeniya da Novavax Inc.
a cikin ci gaba da samar da allurar rigakafi.
Abokan hulɗar sun kuma sanar da shirye-shiryen gwaji kafin gwajin asibiti kafin a fara gwajin Mataki na I a watan Yuli 2020.
A ranar 12 ga watan Agusta 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa an yi aiki da nau'ikan 11 na musamman, kuma ko da sun kasance masu yawa, zai ɗauki aƙalla shekara ɗaya da rabi zuwa shekaru biyu don samar da allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasahar kere-kere a Quebec City, Quebec, ya ce yana haɓaka kwayar cutar coronavirus-kamar ta karamin tallafi daga Cibiyoyin Binciken Kiwon Lafiya na Kanada.
Magungunan da ake son zuwa yana cikin gwaji na gwaji, tare da gwajin ɗan adam da aka shirya a watan Yuli ko Agusta 2020.
A farkon makon, The Guardian ta ba da rahoton cewa Shugaban Amurka Donald Trump ya ba CureVac "'manyan kuɗaɗe' don gudanar da bincike na musamman kan allurar rigakafin Covid-19", wani abu da gwamnatin Jamus ta musanta.
A ranar 17 ga watan Agusta 2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
allurar rigakafin mRNA mai taken BNT162, wanda a halin yanzu yana cikin gwajin gwaji na farko kuma ana sa ran fara gwajin a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin fasahar kere-kere na Italiya ya sanar da cewa za a gudanar da gwajin farko kafin watan Afrilu na 2020 kuma ana iya fara gwajin rigakafin da aka yi niyya a cikin mutane a watan Satumba.
A Faransa a ranar 19 ga Maris 2020, Coalition for Epidemic Preparedness Innovations (CEPI) ta sanar da cewa ta ba da dala miliyan US4.9 don haɗin gwiwar binciken allurar rigakafin COVID-19 tare da Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya sanya jimlar kuɗin CEPI na binciken allurar rigakafin COVID-19 zuwa dala miliyan US29.
CEPI ta kuma ba da gudummawar kuɗi don samar da alluran rigakafin COVID-19 da suka haɗa da Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga watan Maris na 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi tare da allurar rigakafin cutar mai nau'i biyar.
Masu bincike a Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris 2020 cewa suna kan aikin samar da allurar rigakafin RNA mai kara kuzari don rigakafin COVID-19.
An samar da allurar rigakafin da aka yi niyya a cikin kwanaki 14 bayan samun samfuran daga China.
A ƙarshen Maris, gwamnatin Kanada ta ba da sanarwar cewa ta ba da dala miliyan 275 na C $ don tallafawa ayyukan bincike na COVID-19 guda 96, gami da alluran rigakafi da yawa a kamfanoni da jami'o'i, kamar Medicago da Jami'ar Saskatchewan.
A lokaci guda, gwamnatin Kanada ta ba da sanarwar dala miliyan 192 na C$192 don samar da allurar rigakafin COVID-19, da nufin samar da wani babban kantin magani na musamman don amfani da shi a yayin barkewar sabon cutar coronavirus.
A ranar 2 ga Afrilu 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoto game da gwajin PittCoVacc, maganin rigakafin COVID-19 a cikin beraye, suna cewa "MNA ta samar da wani ɓangare na maganin SARS-CoV-2 S1 daga ƙwayar cuta mai ƙarfi [a cikin beraye] wanda aka gano a makonni 2 bayan allurar.
A Kanada a ranar 16 ga Afrilu 2020, Jami'ar Waterloo School of Pharmacy ta sanar da wani allurar rigakafin DNA; sun ce ana iya amfani da ita ta hanyar hanci.
Ta amfani da kwayoyin cuta, za a gina DNA ta hanyar kwayar cutar ta jiki don samar da kwayar cutar amma ba mai cutarwa ba, wanda zai iya kawar da rigakafin rigakafi don samar da rigakafi ga cutar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun zaɓi kayan aikin kwamfuta na IBM, da kuma kayan aikin kwamfuta na girgije daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Maganin ya ƙunshi sakamako dabam dabam, kuma an san cewa wasu daga cikinsu ba su da tushe.
Wannan yana nufin cewa zai iya zama mafi tasiri wajen hana cutar.
Wani gwaji na kai tsaye a Ostiraliya yana neman yin rajistar likitoci 4,170.
Wataƙila alluran riga-kafi da ake yi yanzu ba za su yi tasiri ba ko kuma su yi lahani.
Binciken farko na ingantaccen maganin rigakafi wanda ke amfani da dabbobi da aka zaɓa waɗanda ke da COVID-19, kamar su ACE2-Virus, sauran dabbobi masu gwaji, da sauran dabbobi, ya nuna buƙatar matakan kariya na matakin 3 na biosafety don magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututut
An gwada alluran rigakafin SARS da MERS a kan dabbobi ba mutane ba.
A shekarar 2020, babu wani magani ko allurar rigakafin SARS da aka tabbatar da cewa yana da lafiya da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, samar da sabon allurar rigakafi da maganin SARS ya kasance babban abin da gwamnatoci da cibiyoyin kiwon lafiya a duniya ke so.
Lokacin da MERS ya fara bayyana, an yi imanin cewa binciken SARS na yanzu zai iya ba da shawarwari masu amfani waɗanda za a iya amfani da su don samar da allurar rigakafi da magani don MERS-CoV.
A watan Maris na 2020, akwai rigakafin guda ɗaya (wanda ya dogara da DNA) wanda ya riga ya wuce gwajin gwaji na mutum na farko, da kuma wasu gwaje-gwaje guda uku da ake ci gaba da yi, waɗanda aka sani da alluran rigakafin kwayar cuta, biyu adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), ɗayan kuma MVA-vectored (MVA-MERS-S).
Akwai jita-jita a shafukan yanar gizo da ke cewa an riga an san cutar COVID-19 kuma an riga an samar da allurar rigakafi.
Abubuwan da aka gano a cikin kafofin watsa labarai da yawa suna magana ne game da abubuwan da aka gano a cikin samar da maganin rigakafi da maganin cututtukan da ke haifar da cutar coronavirus kamar SARS coronavirus.
Cutar Coronavirus ta 2019 (COVID-19) cuta ce mai saurin yaduwa wacce ke haifar da cutar coronavirus mai saurin kamuwa da cuta 2 (SARS-CoV-2).
Alamun da ake gani a fili su ne zazzabin cizon sauro, tari, da kuma numfashi.
Sauran alamun sun haɗa da ƙaiƙayi, ciwon baki, gudu, ƙaiƙayi a cikin ƙuƙwalwa, rashin jin ƙamshi, da ciwon ciki.
Yawanci, lokaci tsakanin kamuwa da cutar da bayyanar cututtuka yana tsakanin kwanaki biyar, amma zai iya bambanta daga kwana biyu zuwa 14.
Hakika, yawancin marasa lafiya suna nuna alamun rashin lafiya, wasu suna samun ciwon huhu da kuma rashin aiki.
Ya zuwa ranar 17 ga Afrilu, 2020, an samu karuwar mutane miliyan 2.24 a kasashe 210 da yankuna, kuma mutane 153,000 sun mutu.
Mutane fiye da 568,000 ne suka warke, kuma yawanci ana yada cutar ne ta hanyar kusanci, musamman ta hanyar taɓa ruwa, ta shafawa, ko ta magana.
Hakika, ana iya samun ruwa a cikin jiki sa'ad da mutum ya sha iska, sau da yawa yakan faɗi a ƙasa ko kuma a kan abubuwa, kuma ba ya shafan mutane da yawa.
Mutane za su iya kamuwa da cutar ta wajen taɓa fuska, hanci, ko kuma baki da cutar ta shafa.
Kwayar cutar tana iya kasancewa a kan abu har tsawon sa'o'i 72.
Ana yin maganin cutar a cikin kwanaki uku bayan bayyanar cututtuka, kodayake ana iya yin maganin cutar ba tare da bayyanar cututtuka ba a cikin matakan ƙarshe na cutar.
Ana ba da shawarar yin allurar rigakafi ga waɗanda ake zargi da cutar da kuma masu kula da su.
Ana ba da shawarar yin amfani da abin rufe fuska a cikin jama'a, yayin da wasu hukumomi ke hana shi, wasu suna ba da shawarar amfani da shi kuma wasu suna ba da umarnin amfani da shi.
A halin yanzu, babu allurar rigakafi ko magani don COVID-19.
An gano yaduwar cutar a cikin ƙasashe a cikin ƙasashe daban-daban a cikin sassan WHO guda shida.
Waɗanda suke da cutar ba za su taɓa nuna alamun cutar ba ko kuma ba za su taɓa nuna alamun mura ba, kamar zazzabi, tari, tari, da kuma numfashi cikin wuya.
Alamun gaggawa sun haɗa da numfashi da wuya, ciwon kirji da ba ya motsawa ko kuma matsawa, rikicewa, rashin motsi da kuma rashin motsi a fuska ko baki; yana da kyau a nemi magani nan da nan idan waɗannan alamun ba su motsa ba.
Alamu da ba safai ake gani ba sun haɗa da alamun ciwon kai kamar su tari, hawaye ko kuma hanci.
An lura da alamun cututtukan ciki kamar su numfashi, amai da gudawa a cikin matakan daban-daban.
Da farko, wasu marasa lafiya a China suna jin nauyin kirji da kuma tashin hankali don yin fitsari.
A wasu mutane, ciwo yana iya ci gaba har ya kai ga ciwon huhu, rashin aiki na gabobin jiki, har ma da mutuwa.
Wannan lokaci ne da ake kira lokacin haihuwa.
Lokacin ɗaukar hoto na COVID-19 yana tsakanin kwanaki biyar zuwa shida amma zai iya wucewa daga kwana biyu zuwa 14.
Kashi 97.5% na masu kamuwa da cutar suna nuna alamun cutar a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba duk masu kamuwa da cutar ba ne ke nuna alamun cutar.
Ba a san cikakken aikin waɗanda ba su da alamun cutar a cikin yaduwar cutar ba; duk da haka, bayanan farko sun nuna cewa suna iya yada cutar.
Ba a san adadin marasa lafiya da ba su da alamun cutar a halin yanzu kuma ana ci gaba da bincike, kuma Cibiyar Kula da Cututtuka da Cututtuka ta Koriya ta Koriya (KCDC) ta ba da rahoton cewa kashi 20% na marasa lafiya da aka yi wa allurar ba su da alamun cutar a lokacin da suke asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara lissafin marasa lafiya marasa alamun cutar a ranar 1 ga watan Afrilu; daga cikin marasa lafiya 166 a ranar, marasa lafiya 130 (78%) ba su da alamun cutar a lokacin da aka gwada su.
Ƙwayoyin cuta da ke cikin ƙura suna iya zama masu guba.
Yin ihu yana sa mutum ya yi baƙin ciki fiye da yin magana da baki.
Wani bincike da aka yi a ƙasar Siwizalan ya nuna cewa idan mutum ya yi tari ba tare da ya rufe bakinsa ba, zai iya yin taɓo mai tsawon mita 4.5 (ƙafa 15).
Ko da yake ba a yawan watsa kwayar cutar ta iska, Cibiyar Kimiyya ta Kasa ta Amurka ta ce ana iya yada kwayar cutar ta hanyar iska kuma an gano RNA a cikin kayan aikin iska da aka sanya a waje da gidaje.
Wasu hanyoyin magani kamar su intubation da cardiopulmonary resuscitation (CPR) suna iya haɗa da ƙwayoyin cuta da ke cikin iska kuma hakan yana haifar da cututtuka na iska.
Ko da yake akwai tsoron cewa cutar za ta iya yaduwa ta hanyar cutar, ana ganin cewa ba ta da haɗari. Kwayar cutar tana kamuwa da ita idan marasa lafiya suna nuna alamomi; kodayake ana iya yin allurar rigakafi idan ba a nuna alamomi ba, amma ba ta da haɗari.
Cibiyar Kula da Cututtuka ta Turai ta ce ko da yake ba a san yadda cutar take yaduwa ba, amma mutum ɗaya yana iya yin saurin yaduwa zuwa mutane biyu ko uku.
An nuna cewa ƙwayoyin cuta suna da ƙarfi sosai bayan kwana ɗaya a kan kwali, kwana uku a kan filastik (polypropylene) da kuma kayan da ba su da ƙarancin ƙarfi (AISI 304), kuma bayan awa huɗu a kan kayan da ke da ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Amma, tsawon lokacin ya bambanta dangane da yanayin ruwan.
Sabulu da kuma kayan wanki suna da amfani idan aka yi amfani da su yadda ya kamata; sabulu yana kawar da ƙwayoyin cuta da ke cikin fata, yana sa jiki ya zama mai laushi kuma yana kawar da ƙwayoyin cuta.
Wasu magunguna masu narkewa kamar su benzalkonium chloride da chlorhexidine gluconate (wani maganin kashe ƙwayoyin cuta da ake amfani da shi wajen tsabtace jiki) ba sa aiki sosai.
Daga cikin mutane shida da aka yi wa gwaji, samfurin farko ya nuna cewa yana da ƙwayar cuta mai yawa, kuma a rana ta biyu an gano cewa mutum na shida yana da ƙwayar cuta mai yawa.
Cutar coronavirus mai saurin numfashi mai tsanani 2 (SARS-CoV-2) wani sabon kamuwa da cutar coronavirus ne, wanda aka fara ganowa a cikin mutum uku da ke fama da cutar nimoniya a cikin wani kamuwa da cutar da aka gano a Wuhan.
Dukkanin alamun sabon kwayar cutar SARS-CoV-2 suna faruwa a cikin dukkanin kwayoyin cuta masu kamuwa da cutar coronaviruses a cikin jinsi.
Lokacin da kwayar cutar ta kasance a waje da jikin mutum ta hanyar sabulu, sabulu yana lalata ƙwayar cuta ta waje. SARS-CoV-2 yana da alaƙa da kwayar SARS-CoV ta farko.
Cutar huhu ce ke da saurin kamuwa da COVID-19 saboda kwayar cutar tana shiga cikin jijiyoyin jiki ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda aka fi nunawa a cikin ƙwayoyin alveolar nau'in II a cikin huhu.
Kwayar cutar tana amfani da wani nau'in glycoprotein na musamman da ake kira "peplomer" don ɗaure kansa ga ACE2 da kuma ƙwayoyin cuta.
An gano mummunan bugun zuciya a cikin kashi 12% na marasa lafiya da aka kwantar a Wuhan, China, kuma yana da yawa a cikin cututtuka masu tsanani.
Yawan cututtukan zuciya da jijiyoyin jini suna da yawa, saboda amsawar kumburi na tsarin jiki da kuma rikicewar jijiyoyin jiki a lokacin ci gaban cutar, amma raunin ƙwayar cuta na iya zama mai haɗari ga masu karɓar ACE2 a cikin zuciya.
Ana nuna masu karɓar ACE2 a cikin zuciya kuma suna da hannu cikin aikin zuciya.
An gano cutar ta jini (31%) da kuma jijiyoyin jini (25%) a cikin marasa lafiya na COVID-19 waɗanda ke buƙatar magani na musamman kuma suna iya ƙin yarda da kuskuren hasashe.
Kodayake SARS-COV-2 yana aiki ne ta hanyar shafar kwayoyin ACE2-da ke cikin ƙwayoyin epithelial na ƙwayoyin cuta, marasa lafiya masu cutar COVID-19 suna da alamun cutar hyperinflammation.
Musamman, an nuna kwayoyin T-cell masu ɓoyewa na GM-CSF masu haɗari tare da ƙwayoyin IL-6 masu ɓoye ƙwayoyin cuta da kuma cututtukan huhu masu tsanani a cikin marasa lafiya na COVID-19.
An gano ƙwayoyin lymphocytic a cikin gwaje-gwajen gawawwaki.
WHO ta wallafa jerin gwaje-gwaje kan yawancin cututtuka.
Mafi yawan gwaje-gwaje shine ainihin lokacin juyawa na polymerase chain reaction (rRT-PCR).
Ana yin gwajin ne akan samfurori da aka samo daga hanci da kuma ƙwayar hanci; amma ana iya amfani da hanci ko kuma ƙwayar cuta.
Ana samun sakamako cikin sa'o'i kaɗan zuwa kwana biyu.
Ana iya amfani da gwaje-gwaje na hankali amma ana buƙatar ɗaukar samfuran biyu a cikin makonni biyu kuma sakamakon ba zai zama mai amfani ba.
Masana kimiyya na kasar Sin sun gano cutar coronavirus kuma sun wallafa jerin kwayoyin halittar cutar, wanda ya sa gwajin duniya ya fara aiki, har yanzu suna aiki kan tsarin gwajin kwayar cutar (PCR).
A ranar 4 ga Afrilu 2020, gwajin rigakafi (wanda zai iya gano cutar ko cutar da ta gabata) yana cikin ci gaba, amma ba a yi amfani da shi ba tukuna.
Kwarewar gwajin a China ya nuna cewa ingancin gwajin ya kasance tsakanin kashi 60 zuwa 70 kawai.
Hukumar FDA ta Amurka ta ba da izinin gwajin wuri na farko don amfani a ranar 21 ga Maris, 2020 a ƙarshen wannan watan. Sakamakon gwajin da Asibitin Zhongnan na Jami'ar Wuhan ya bayar ya ƙunshi tsara hanyoyin kulawa bisa ga alamun cutar da kuma haɗarin cutar.
Bilateral multilobar ground-glass opacities tare da kewayon, asymmetric da kuma rarraba baya suna da yawa a farkon kamuwa da cuta.
Wannan na iya faruwa yayin da cutar ke ci gaba da rinjayar Subpleural, crazy paving (lobular septal thickening with variable alveolar filling), da kuma ƙarfafawa.
Bayanai kaɗan ne game da ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Abubuwan da aka gano a binciken da aka yi a kan gawawwakin mutane sun haɗa da:
Macroscopy: pleurisy, pericarditis, ƙarfafawa na huhu da kuma edema na huhu
Ana iya gano nau'ikan cutar nimoniya guda huɗu masu tsanani:
ciwon huhu mai tsanani: edema na huhu, hyperplasia na pneumocyte, manyan ƙwayoyin cutar pneumocytes, ƙonewa tsakanin ƙwayoyin cuta tare da infiltration na lymphocytic da kuma samuwar kwayoyin halitta masu yawa
cutar huhu mai tsanani: lalacewar alveolar (DAD) da kuma ɓarkewar alveolar.
DAD yana haifar da mummunan sakamako a cikin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
maganin ciwon huhu: ko tsarin ƙwayoyin cuta na ƙwayoyin cuta da ƙwayoyin cuta na ƙwayoyin cuta
Jini: yaduwar jini (DIC); leukoerythroblastic reaction
Matakan da za a ɗauka don rage haɗarin sun haɗa da kasancewa a gida, guje wa wuraren da jama'a suke, wanke hannuwanka da sabulu da ruwa sau da yawa na aƙalla dakika 20, kiyaye tsabta ta hanyar numfashi da kuma guje wa taɓa fuska, hanci ko baki kafin wanke hannuwanku.
CDC ta ba da shawarar rufe baki da hanci a yayin da kake tari ko hancinka kuma yana ba da shawarar samun hannu don yin tari ko tari idan ba ka da damuwa.
Ana ba da shawarar wanke hannu bayan tari ko hancin.
CDC ta ba da shawarar yin amfani da abin rufe fuska a cikin jama'a, tare da manufar hana kamuwa da cuta musamman ga marasa lafiya masu alamun cutar.An tsara matakan nisantarwa don rage hulɗa da mutane masu cutar da manyan ƙungiyoyi yayin da aka rufe makarantu da wuraren aiki, hana motsi da kuma hana tarurruka.
Ana bin ƙa'idodin nesa kuma sun haɗa da jefa ƙafa 6 (mita 1.8).
Babu wani magani da aka sani da zai iya hana COVID-19. Lokacin gaggawa da ake sa ran samun allurar rigakafi shine a cikin 2021, dabarun magance COVID-19 shine ƙoƙarin rage yaduwar cutar, wanda ake kira "sarrafawa".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na akalla dakika 20, musamman bayan sun fita daga bayan gida ko kuma idan hannayensu sun yi taɓawa, kafin cin abinci da kuma bayan yin fitsari, tari ko hancin mutum.
Hukumar ta kuma ba da shawarar yin amfani da kayan tsabtace jiki da ke da kashi 60% na giya, amma aƙalla lokacin da sabulu da ruwa ba su samuwa.A wuraren da ba a sayar da kayan tsabtace jiki ba, WHO ta ba da shawarwari biyu game da yadda za a yi.
A wannan hanyar, ana yin maganin kashe ƙwayoyin cuta daga barasa (ethanol) ko isopropanol.
Ana amfani da sinadarin hydrogen peroxide don kashe ƙwayoyin cuta a cikin giya; ba "mai kashe ƙwayoyin cuta ba".
Ana yin glycerol daga ruwa mai laushi (humectant).
Ana amfani da maganin da ke tallafa wa jiki, wanda zai haɗa da ruwa, iskar oxygen, da kuma taimakon gaɓoɓin jiki da suka lalace.
CDC ta ba da shawarar cewa waɗanda ake zargi da kamuwa da cutar su sanya abin rufe fuska mai ƙarfi.
An yi amfani da iskar oxygen ta hanyar membrane na waje (ECMO) don magance matsalar numfashi amma har yanzu ana nazarin fa'idodin wannan hanyar.
Ana ba da shawarar tsabtace jiki da kula da lafiyar mutum da kuma cin abinci mai gina jiki don haɓaka ƙoshin lafiya.
Kulawa mai mahimmanci na iya taimakawa waɗanda ke da alamun rashin lafiya mai sauƙi. WHO da Hukumar Kiwon Lafiya ta Kasa ta China sun ba da shawarwari don kula da mutanen da ke kwance a gado tare da COVID-19.
Likitocin kulawa da gaggawa da likitocin huhu a Amurka sun rubuta shawarwarin aiki daga kungiyoyi daban-daban kuma sun sanya su a cikin takaddar kyauta, IBCC.
A watan Afrilu na 2020, babu wani magani da aka samu don COVID-19.
Don magance alamun, wasu masana sun ba da shawarar yin amfani da paracetamol (acetaminophen) a kan ibuprofen a matsayin magani na farko.
Dole ne a yi hankali don rage haɗarin kamuwa da cutar, musamman a asibitoci inda ake gudanar da ayyukan da zasu iya haifar da cutar kamar intubation ko iska mai ƙarfi.
Ga likitocin da ke kula da marasa lafiya da ke da cutar COVID-19, CDC ta ba da shawarar yin amfani da iska mai iska (AIIR) tare da kiyayewa na yau da kullun, kiyayewa daga hulɗa da mutane da kiyaye iska.
Abubuwan da aka ba da shawarar su ne: sutura, sutura, sutura, sutura, sutura, da sutura na likita.
Ana ba da shawarar yin amfani da abin rufe fuska na N95 a masana'antu amma FDA ta ba da izinin amfani da abin rufe fuska a cikin gaggawa (EUA).
Ana yin su ne don kare mutum daga ƙwayoyin iska kamar ƙura, amma ba a tabbatar da cikakken kariya daga ƙwayoyin cuta ba idan ba a yi amfani da su ba.
Idan babu allurar rigakafi, CDC ta ba da shawarar cewa idan babu kayan aiki, ana iya amfani da allurar rigakafi na gida.
Yawancin marasa lafiya na COVID-19 ba su da tsufa sosai don yin allurar rigakafi amma akwai adadin mutanen da suke buƙatar ta.
Ana buƙatar nau'in maganin hana numfashi na musamman ga mutanen da ke fama da cutar COVID-19 a cikin numfashi musamman ga mutanen da ke cikin asibiti, kuma akwai wasu bayanai da ke nuna cewa ana iya kauce wa allurar rigakafi ta hanyar amfani da bututun hanci mai zurfi ko matsin lamba mai kyau.
Ba a sani ba ko ɗayan waɗannan yana da sakamako mai kyau ga marasa lafiya masu rauni.
Wasu likitoci sun fi son yin amfani da iska mai iska idan akwai saboda wannan dabarar tana rage yawan kuɗin da ake kashewa idan aka kwatanta da babban kwararar hanci.
Yawancin ƙasashe masu tasowa ba su da isassun gadaje na marasa lafiya dangane da yawan jama'arsu, wanda ke rage ikon asibitoci na kula da marasa lafiya idan akwai wani mummunan yanayin COVID-19 wanda ya haifar da buƙatar gado.
Wani bincike a China ya nuna cewa kashi 5 cikin 100 na waɗanda aka yi wa jinya a asibiti sun yi rashin lafiya, kashi 2.3 cikin 100 suna bukatar na'urar da za ta riƙa saka su a jiki, kuma kashi 1.4 cikin 100 sun mutu.
A China, kusan kashi 30% na masu cutar COVID-19 da ke asibiti sun warke kuma an sanya su a cikin ICU.
Samun iska ta inji yana da matukar wahala saboda cutar ta numfashi mai tsanani (ARDS) da ke tattare da COVID-19 da kuma numfashi yana da matukar wahala.
Ana buƙatar masu numfashi masu numfashi tare da PEEP mai yawa don samar da isasshen iskar oxygen da rage haɗarin rauni na huhu da ke tattare da numfashi da kuma pneumothorax.
Mai yiwuwa ba a samun wannan sauti mai ƙarfi a tsofaffin na'urorin ba.
An fara gwajin magani a watan Janairun 2020, kuma ana gwada magungunan rigakafi da yawa a halin yanzu.
Remdesivir ne kawai ke da alamar bege.
Ko da yake ana iya jinkirta samar da sabon magani har zuwa 2021, an riga an amince da wasu magungunan gwaji don amfani da su don wasu cututtuka kuma yanzu ana ci gaba da gwajin su.
Ana iya gwada maganin rigakafi a kan mutanen da suke da ciwo mai tsanani.
WHO ta ba da shawarar masu sa kai don shiga cikin gwajin gwaji na ingantaccen magani da kuma tabbatar da amincinsa. Hukumar FDA ta ba da izinin ɗan lokaci don maganin plasma mai warkewa a matsayin magani na ɗan lokaci a cikin yanayin rashin lafiya lokacin da rayuwar mutum ke cikin haɗari.
Kafin a yi bincike, za a bincika ko ba shi da lahani kuma a san ko yana warkar da cutar.
A watan Fabrairun 2020, kasar Sin ta ƙaddamar da wata manhajar wayar hannu don taimakawa wajen lura da barkewar cutar.
Ana buƙatar masu amfani su shigar da sunayensu da lambar ID.
Aikace-aikacen na iya gano 'kusa' ta hanyar bayanan sa ido, don haka yana taimakawa wajen hana haɗarin kamuwa da cuta.
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan akwai barazanar kamuwa da cutar, ba wai kawai ana ba da shawarar keɓewa ba, amma ana ba da shawarar ga hukumomin kiwon lafiya na gida. Ana amfani da nazarin bayanai masu yawa akan bayanan wayar hannu, fasahar sa ido, bin diddigin wayar hannu da hankali na wucin gadi don bin diddigin masu kamuwa da cutar da kuma abokan hulɗa a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba da izinin hukumomi su saka idanu kan saƙonnin wayar salula na mutanen da ake zargi da cutar coronavirus.
An yi wannan ne don ƙarfafa al'umma su keɓe kansu da kuma kare waɗanda ke iya kasancewa a cikin hulɗa da waɗanda ke da cutar.
A watan Maris na 2020, Deutsche Telekom ta raba bayanan bayanan mutane tare da cibiyar gwamnati, Cibiyar Robert Koch, don bincike da rigakafin yaduwar cutar.
Rasha ta kirkiro fasahar sanya idanu don gano masu tserewa daga keɓewa.
Jami'in Ma'aikatar Lafiya ta Italiya, Giulio Gallera ya ce an sanar da shi ta wayar salula cewa "kashi 40 cikin 100 na yawan jama'a suna tafiya".
Gwamnatin Jamus ta gudanar da bincike na tsawon sa'o'i 48 a ƙarshen mako da aka yi da mutane fiye da 42,000.
Hakazalika, Shugabar Estonia, Kersti Kaljulaid, ta yi kira ga duniya da ta samar da hanyoyin da za a bi don magance cutar coronavirus.
Mutane suna iya jin tsoron keɓewa, ƙuntata tafiya, rashin lafiya ko kuma tsoron kamuwa da cuta.
"Rashin zaman lafiya, kaɗaici, rashin jin daɗi, matsi da kuma rashin kuɗi, suna shafan rayuwar mutane", in ji Rory O'Connor, in ji BBC.
Ƙari ga haka, cutar tana iya zama marar tsanani kuma ba ta nuna alamun cutar kamar mura.
Sau da yawa, a cikin makonni biyu, ciwo mai tsanani yakan warke, amma a cikin makonni uku zuwa shida, ciwo mai tsanani yakan warke.
Mata masu ciki na iya zama masu haɗarin kamuwa da COVID-19 ta hanyar wasu ƙwayoyin cuta kamar SARS da MERS, amma babu cikakken bayani game da COVID-19 a wannan batun. A cikin mutane, COVID-19 na iya shafar huhu da kuma haifar da cutar nimoniya.
Ga waɗanda cutar ta fi shafa, COVID-19 na iya haɓaka cikin sauri zuwa ciwo mai tsanani na numfashi (ARDS) wanda ke haifar da rashin numfashi, septic shock ko rashin aiki na gabobin jiki.
Cutar rigakafin COVID-19 ta haɗa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An lura da cutar ta jini, musamman ƙaruwar lokacin prothrombin, a cikin kashi 6% na marasa lafiya da aka kwantar a asibiti saboda cutar COVID-19, yayin da rashin lafiyar koda ya bayyana a cikin kashi 4% na marasa lafiya a cikin wannan rukunin.
Kimanin kashi 20-30% na mutanen da ke da COVID-19 suna da cutar kiba (ƙaruwa enzymes hanta, transaminases).
A cewar wannan rahoton, matsakaicin lokacin da alamun cutar suka fara bayyana da kuma mutuwar mutane ya kai kwanaki 10 a asibiti.
A gefe guda, marasa lafiya da ke cikin cibiyar kulawa ta musamman (ICU) suna da matsakaicin matsakaicin matsakaici tsakanin kwana bakwai na asibiti da mutuwa.
A cikin binciken marasa lafiya na farko, yawan alamun cutar da mutuwar sun kasance daga kwanaki 14 zuwa tsakanin kwanaki 6 zuwa 41.
A wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin ta yi, yawan mace-macen ya kai kashi 2.8% da maza 1.7%.
Binciken ilimin lissafi na kwayoyin halitta a kan samfurori na alveolar ya nuna lalacewar lalacewar alveolar da kuma ƙwayoyin fibromyxoid na ƙwayoyin halitta a cikin huhu biyu.
An gano canjin canjin kwayar cutar a cikin ƙwayoyin cuta.
Hoton na numfashi ya yi kama da cutar ta numfashi mai tsanani (ARDS).
A cikin kashi 11.8% na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito, an gano cutar zuciya tare da yawan ciwon zuciya (troponin ko bugun zuciya).
A cewar wani rahoto daga Amurka a ranar Laraba, kashi 89% na waɗanda aka kwantar a asibiti suna da wasu cututtuka. Kula da lafiyar al'umma da tattalin arziki na iya ƙara yawan mutuwar marasa lafiya.
Alƙaluman da ake yi game da adadin mutanen da za su mutu a lokacin bala'i suna canjawa domin yanayin ƙasar ya bambanta da na wasu wurare.
Idan ba a lissafa waɗanda ba su da ciwo sosai a cikin adadin waɗanda suka mutu ba, hakan zai iya sa adadin waɗanda suka mutu ya yi yawa.
Maimakon haka, domin waɗanda suka mutu suna da ciwo ne na kwanan nan, hakan yana nufin cewa ba a yawan mutuwa.
Masu shan sigari suna da kusan kashi 1.4 cikin ɗari na alamun bayyanar cututtuka na COVID-19 tare da sau 2.4 na buƙatar gaggawa ko mutuwa idan aka kwatanta da waɗanda ba su shan sigari.
Hukumomin asibitin Hong Kong sun gano raguwar ƙarfin hanta tsakanin kashi 20 zuwa 30 cikin dari a cikin wasu mutanen da suka warke daga cutar kuma an gano cutar ta cutar huhu.
Wannan kuma na iya haifar da ciwon bayan kulawa mai tsanani bayan murmurewa.
A watan Maris na 2020, ba a san ko wasu cututtukan da aka gano a baya sun ba da damar yin amfani da maganin cutar ga marasa lafiya da suka warke daga cutar ba.
Ana iya ganin cutar, dangane da halin da sauran cututtukan coronavirus ke nunawa, amma an gano cewa marasa lafiya da suka warke daga COVID-19 sun sake yin gwaji.
Ana ganin cewa waɗannan marasa lafiyar suna ci gaba da ciwo, ba su sake ciwo ba.
Ana ganin cewa cutar ta halitta ce kuma ta samo asali ne daga dabbobi ta hanyar kwari zuwa mutane (cutar da ke gudana).
Ba a san ainihin asalin cutar ba, amma a watan Disamba na shekarar 2019 cutar ta yadu ne ta hanyar yawan mutane.
Binciken da aka yi kan marasa lafiya 41 na farko da suka kamu da cutar COVID-19, wanda aka buga a watan Janairun 2020 a cikin The Lancet, ya nuna cewa alamun farko sun bayyana a ranar 1 ga Disamba, 2019.
Bayanan hukuma daga WHO sun nuna cewa an fara samun alamun cutar a ranar 8 ga Disamba, 2019.
Ana amfani da ma'auni da yawa don ƙididdige yawan mutuwa.
Wadannan ƙididdigar sun bambanta daga yanki zuwa yanki kuma suna dogara ne akan yawan gwaje-gwaje, ingancin magani, hanyoyin da ake da su, tsawon lokacin cutar da sauran abubuwan da ke tattare da mutane kamar shekaru, wanda ke haifar da yanayin lafiyarsu gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambar gaggawa ta ICD-10 cutar U07.1 don mutuwar SARS-CoV-2 da aka tabbatar da gwaji da kuma U07.2 don mutuwar COVID-19 ba tare da gwajin gwaji ba don tabbatar da cutar SARS-CoV-2.
Dangane da ƙididdigar Jami'ar Johns Hopkins, yawan mace-mace da kamuwa da cuta a duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu 2020.
Ƙididdigar ta bambanta daga yanki zuwa yanki. Sauran ma'auni sun haɗa da yawan mutuwar marasa lafiya (CFR), yawan adadin waɗanda aka gano sun mutu daga cutar, yawan adadin kamuwa da cutar (IFR), yawan adadin mutane (wanda aka gano kuma sake gwadawa) wanda ya mutu daga cutar.
Waɗannan ƙididdigar ba sa bin sa'a kuma suna bin mutane daga lokacin da suka kamu da cutar har zuwa ƙarshen rayuwarsu (samuwar lafiya ko mutuwa).
Ko da yake ba dukan mutane ba ne suke da rigakafi, amma idan mutum yana da rigakafi zai iya ba mu bayani game da yawan mutanen da suka kamu da cutar.
A Italiya, inda cutar ta fi yawa, ƙaramin ƙauyen Castiglione d'Adda, mutane 4,600, 80 (1.7%) suka mutu.
A Gangelt, cutar ta bazu a lokacin bikin Carnival, inda ta shafi matasa, mutane kalilan sun mutu kuma ba duk wanda ya mutu daga COVID-19 aka tabbatar da cewa ya mutu ba.
Bugu da ƙari, asibitoci a Jamus ba su da yawan marasa lafiya.
A Netherlands, kashi uku cikin ɗari na mutane suna da rigakafi, kamar yadda aka gani a cikin masu ba da jini.
An tabbatar da mutuwar mutane 69 (kashi 0.004 cikin ɗari) daga COVID-19.
Rashin jin daɗi daga ƙonewa da kuma yawan mutuwar ya bambanta tsakanin maza da mata.
Mafi yawan mutanen da ke mutuwa maza ne bisa ga binciken da aka yi a China da Italiya.
Mafi yawan haɗarin a cikin maza, yana cikin waɗanda ke cikin shekarun 50, kuma matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakai
A ƙasar Sin, yawan mace-macen ya kai kashi 2.8 cikin ɗari na maza da kuma kashi 1.7 cikin ɗari na mata.
Ba a san ainihin dalilin da ya sa ake samun wannan bambancin ba amma wataƙila hali ne da kuma kwayoyin halitta ne suke da hannu a wannan bambancin.
Bambanci tsakanin cin kasuwa, mata masu shan taba sigari da maza masu fama da cututtuka kamar su cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututut
A Turai, kashi 57% na masu cutar sun kasance maza kuma kashi 72% na waɗanda suka mutu daga COVID-19 maza ne.
A watan Afrilu na 2020, gwamnatin Amurka ba ta bincika bayanan jinsi a cikin masu cutar COVID-19 ba.
Bincike ya nuna cewa cututtuka kamar Ebola, HIV, mura da SARS suna shafar maza da mata dabam.
Yawancin ma'aikatan kiwon lafiya, musamman mazauna ƙasar, mata ne, wanda ke nufin cewa suna da damar kamuwa da cutar.
WHO ta sanar a ranar 11 ga Fabrairu 2020 cewa sunan cutar "COVID-19".
Darakta na WHO, Tedros Adhanom Ghebreyesus ya bayyana cewa CO yana wakiltar corona, VI don kwayar cutar, D don cuta, da 19 don lokacin da aka fara gano cutar: 31 ga Disamba 2019.
An zaɓi sunan don kauce wa yin magana game da wani wuri (misali China), nau'in dabba ko rukuni na mutane, kamar yadda aka ba da shawarar a duniya don kauce wa nuna bambanci. Kwayar cutar da ke haifar da COVID-19 ana kiranta da cutar sankarar barkwanci mai tsanani coronavirus 2 (SARS-CoV-2).
WHO ta kuma yi amfani da "kwayar cutar COVID-19" da "kwayar cutar da ke da alhakin COVID-19" a cikin sadarwarsu da jama'a.
Dukansu, ana kiran cututtukan ƙwayoyin cuta "coronavirus".
A lokacin da cutar ta fara bulla a Wuhan, China, an kira kwayar cutar da cutar "coronavirus" da "Wuhan coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCov da 2019-nCoV acute respiratory disease a matsayin sunayen wucin gadi don cutar da ke haifar da cutar ta hanyar bin ƙa'idodin 2015 don hana amfani da wuraren da ke da alaƙa da cutar.
An ba da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙarancin iyawa wajen samar da kayayyaki masu inganci, wasu masana'antun suna samar da kayan aikin kiwon lafiya kamar su swabs na hanci da kuma sassan na'urar numfashi.
Alal misali, sa'ad da asibiti a Italiya yake bukatar bawul na na'urar numfashi, masana'antar ta yi ƙoƙari ta yi amfani da wannan na'urar don ta samar da bawul guda 100 a dare ɗaya.
Bayan barkewar cutar COVID-19, jita-jita da jita-jita game da asalin cutar, yawanta, rigakafi da hanyoyin magance cutar da sauran bayanai game da cutar sun bazu a cikin Intanet cikin ɗan lokaci.
Da alama mutane za su iya yaɗa wannan cuta ga dabbobi.
Bincike bai sami wani bayani game da yadda aladu, barbashi, da kaji suke yin kwaɗayi ba.
Babu magani ko allurar rigakafi da aka tabbatar don cutar.
Ana gudanar da bincike na duniya kan allurar rigakafin COVID-19 tare da taimakon hukumomin gwamnati, kungiyoyin bincike, da masu binciken cutar kwalara.
A ranar Laraba, WHO ta ƙaddamar da tsarin "GASKIYA A GAME DA GWAJARA" don nazarin maganin da ake da shi yanzu don gano mafi inganci.
Babu maganin rigakafi amma kungiyoyi daban-daban suna kokarin gano wanda zai taimaka.
Ana amfani da binciken SARS-CoV na farko saboda SARS-CoV da SARS-CoV-2 duka suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin cuta na mutum.
Akwai wasu magungunan rigakafi guda uku da ake bincike a kai.
Da farko, masu bincike suna ƙoƙarin su yi maganin cutar.
Yin amfani da irin wannan kwayar cutar, ba don rayuwa ko mutuwa ba, yana nufin samar da rigakafi ga sabon kamuwa da cuta da COVID-19.
Wani kuma shi ne subunit vaccines, wanda ke nufin samar da rigakafin da ke sa ƙwayoyin cuta su yi tsayayya da cutar.
A kan SARS-CoV-2, binciken ya mai da hankali kan furotin S-spike wanda ke taimakawa kwayar cutar ta shiga cikin mai karɓar enzyme ACE2.
Nau'i na uku shine allurar rigakafin nucleic acid (DNA ko RNA allurar rigakafi, sabon tsarin samar da rigakafi).
Alluran rigakafin da aka gwada daga waɗannan hanyoyin za su buƙaci gwaji don tabbatar da amincin su da ingancin magani.A ranar 16 ga Agusta, 2020, gwajin farko na asibiti ya fara tare da masu sa kai huɗu a Seattle.
An gano cewa maganin yana da kwafin kwayar halitta mai lafiya wanda aka kwafe daga kwayar cutar da ke haifar da cutar. An gano cewa inganta tsarin garkuwar jiki na iya zama ƙalubale ga samar da maganin SARS-COV-2, amma wannan yana da rikitarwa.
A watan Afrilu na shekarar 2020, an gudanar da gwaji sama da 300.
Gwaje-gwaje bakwai sun bincika maganin da aka riga aka amince da shi don maganin zazzabin cizon sauro, gami da gwaje-gwaje huɗu na hydroxychloroquine ko chloroquine.
Magungunan rigakafi na maganin cututtuka sun kasance babban ɓangaren binciken na kasar Sin, tare da gwaji tara na III na remdesivir a cikin ƙasashe da yawa da aka bayar da rahoto a ƙarshen Afrilu.
An gudanar da wani babban gwajin asibiti don samar da allurar rigakafin COVID-19 a watan Afrilu 2020. Ana nazarin magungunan rigakafi da yawa don magance COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir a hade tare da interferon beta.
A watan Maris na 2020, an sami rahotanni da ba a tabbatar da su ba cewa remdesivir na iya zama magani.
An lura da raguwa a cikin marasa lafiya da aka kula da su da remdesivir mai tausayi.
Ana gudanar da gwaji na asibiti na Mataki na III a Amurka, China da Italiya.An gwada Chloroquine, wanda aka yi amfani da shi don magance zazzabin cizon sauro, a China a watan Fabrairun 2020, tare da wasu sakamako na farko.
Maimakon haka, ana bukatar ƙwararrun masana su bincika batun.
Hukumomin kiwon lafiya a Koriya da China suna goyon bayan amfani da chloroquine.
Koyaya, duk da cewa Cibiyar Nazarin Kwayoyin Cutar Wuhan, ta ba da shawarar shan kashi ɗaya na gram a kowace rana, sun yi gargadin cewa yawan shan wannan adadin yana da haɗari kuma yana iya kashewa.
A ranar 28 ga watan Maris na 2020, FDA ta ba da umarnin gaggawa don ba da izinin amfani da hydroxychloroquine da chloroquine bisa ga shawarar likitocin da ke kula da marasa lafiya na COVID-19.
Binciken da aka yi kwanan nan ya nuna cewa ana buƙatar ribavirin mai yawa don hana SARS-CoV-2 a cikin vitro.
An ba da shawarar ƙarin bincike na halitta don nitazoxanide bayan an nuna raunin farawa a cikin SARS- CoV-2. Binciken ya nuna cewa farkon furotin na farko na furotin na serine 2 (TMPRSS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar ɗaure kansa ga mai karɓar ACE2.
Bincike kan chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba yana da raunin da ya hana likitoci amincewa da amfani da maganin ba tare da ƙarin bincike ba. Oseltamivir ba ya hana SARS-CoV-2 a cikin vitro kuma ba a san amfanin COVID-19 ba.
Cytokine hadari na iya zama mummunan rauni yayin da COVID-19 ya mamaye.
Akwai shaidar cewa hydroxychloroquine na iya samun kayan aikin anti-cytokine storm. An sanya Tocilizumab a cikin jerin sunayen da Hukumar Kiwon Lafiyar Kasa ta kasar Sin ke bi don magance cutar bayan an gudanar da wasu bincike.
Yana cikin gwaji na 2 na shirye-shiryen a matakin ƙasa a Italiya bayan nuna alamun cutar a cikin mutane marasa lafiya.
Yanzu an haɗa shi da gwajin jini na ferritin don gano hadari na cytokine, kuma ana nufin ƙaddamar da irin waɗannan abubuwa, waɗanda ake tsammanin suna kashe wasu marasa lafiya.
An amince da mai karɓar mai karɓar interleukin-6 ta FDA bisa ga binciken da aka yi a baya don magance cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Har zuwa yau, babu tabbataccen tabbaci cewa tocilizumab yana magance CRS.
An yi amfani da maye gurbin kwayoyin cuta da aka yi wa allurar rigakafi ta hanyar amfani da maganin rigakafi na COVID-19 da aka yi amfani da su a cikin mutane da ke cikin buƙata don yin la'akari da su a matsayin hanyar da za a fara cutar ba tare da yin gwaji ba.
An gwada wannan hanyar a kan SARS amma ba a kammala sakamakon ba.
Rashin ƙwayar cuta shine tsarin magani wanda ke amfani da ƙwayoyin cuta masu guba don magance SARS-CoV-2.
Sauran hanyoyin, kamar su antibody-dependent cellular cytotoxicity da / ko phagocytosis, suna yiwuwa.
Ana kuma yin wasu hanyoyin maganin rigakafin da ba a yi amfani da su ba, kamar su amfani da rigakafin da aka yi amfani da shi a cikin kwayoyin halitta.
Za a iya ƙara maganin warkewa, wanda ya ƙunshi jini daga marasa lafiya da suka warke kuma yana da ƙwayoyin cuta da ke hana cutar, don ƙara yawan maganin.
Cutar Coronavirus, ƙungiyar alamun bayyanar cututtuka
Li Wenliang, likita a asibitin Wuhan, daga baya ya kamu da COVID-19 kuma ya mutu bayan sanarwar yaduwar cutar.
